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 Streszczenie 
W poszukiwaniu leków przeciwnowotworowych nowej generacji badano potencjalne 
inhibitory enzymu syntazy tymidylanowej. Opisano szereg etapów komputerowo 
wspomaganego projektowania leków. Wybrano dwa miejsca docelowe dla 
poszukiwanych inhibitorów: kieszeń aktywną enzymu oraz kieszeń allosteryczną 
między podjednostkami białka. Potencjalnie obiecujące związki wybrano w drodze 
wysokowydajnej procedury przesiewania (przy zastosowaniu metod dokowania 
molekularnego) dostępnych baz danych leków i proleków, a następnie modyfikację i 
dalszą selekcję wyników dokowania. Dla wybranych potencjalnych inhibitorów syntazy 
tymidylanowej, zarówno kompetycyjnych, jak i allosterycznych, przeprowadzono 
symulacje metodą dynamiki molekularnej w celu oceny dynamiki układu, parametrów 
wiązania i ułożenia ligandów, jak również wskazania wiodących związków do dalszych 
badań in vitro. Ponadto opisano bibliotekę peptoidów, stworzoną w celu projektowania 
nowej generacji związków o pożądanych właściwościach peptydomimetycznych. 
Wykonano również obliczenia metodami mechaniki kwantowej mające na celu 
wspomaganie badań i syntezy nowych inhibitorów enzymów, w tym związków 
zawierających bor. 
 
Summary 
In search of novel anticancer drugs, putative inhibitors of the enzyme thymidylate 
synthase were investigated. The dissertation presents several steps of computationally 
aided drug design. Two targets are described: active site of the enzyme, for competitive 
inhibitors, and an allosteric pocket at the dimer interface. The potential hits were 
selected by computational high-throughput screening (molecular docking calculations) 
of available drug and prodrug databases. The selected compounds were then modified 
and scored further to indicate potential leads. Molecular dynamics simulations were 
performed for selected putative inhibitors of thymidylate synthase, both competitive and 
allosteric, in order to assess their dynamical behaviour, binding properties and 
arrangement of the ligands, and to select lead compounds for further tests in vitro. 
Moreover, a library of peptoids is described, created with the aim to design novel 
compounds with the desired peptide-like properties. Furthermore, quantum mechanics 
calculations were conducted to aid the synthesis and investigation of novel enzyme 
inhibitors, including boron containing compounds. 
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ADMET  adsorption, distribution, metabolism, excretion, toxicity 
AM1-BCC semi-empirical AM1 Hamiltonian Bond Charge Corrections 
DFT Density Functional Theory 
DHF  dihydrofolate 
DMP deoxyuridine monophosphate 
dUMP deoxyuridine monophosphate 
dTTP deoxythymidine triphosphate 
FDA Food and Drug Administration (USA) 
FdUMP 5-fluorodeoxyuridine monophosphate 
FMP 5-fluorodeoxyuridine monophosphate 
5-FU 5-fluorouracil 
hTS human thymidylate synthase 
MD molecular dynamics 
MM molecular mechanics 
MOD dUMP-OCH3 
MS mass spectrometry 
MTF methylenetetrahydrofolate 
mTHF methylenetetrahydrofolate 
OCD dUMP-CH2OH 
OHD dUMP-OH 
PM7*  semi-empirical PM7 Hamiltonian 
RESP restrained electrostatic potential 
RMSD  root-mean-square deviation 
QM quantum mechanics 
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1 Introduction 
1.1 Drug design 
It takes about 7-12 years to design, optimise, test and introduce a new drug into the 
market, at a cost of around USD 0.5-2 billion. According to estimations, only one of 
8000 compounds tested in animals reaches human testing, and of these, only one out of 
five is approved for use. Additionally, some drugs already present on the market may be 
later withdrawn due to serious, sometimes fatal side effects. Alternative approaches that 
would lower the costs, shorten the time and reduce the need for animal testing while 
minimising the risks associated with new substances, are needed. Molecular modelling 
methods can fulfil some of the requirements of the drug design process, and their 
significance increases with the advancements in computing power, development of new 
computational methods applied to biological problems, and an increase of the amount of 
data available in public databases.  
The design and introduction of a new drug involves the following steps:  
• target identification and validation – establishing the target or targets (such as 
specified enzymes) for treatment of a given disease 
• hit discovery – a “hit” is a result of high throughput screening (e.g. 
computational docking of a set of compounds from a database to the protein), a 
molecule with some desired properties towards the established target 
• hit-to-lead conversion – selection and preliminary optimisation of the promising 
ligands in order to find the “lead” compounds, substances that are most likely to 
be useful in further development 
• lead optimisation – modification of the selected lead compound in order to 
improve its ADMET (adsorption, distribution, metabolism, excretion, and 
toxicity) properties 
• pre-clinical tests – performed on animal models in order to establish 
pharmacodynamical, pharmacokinetical, and ADMET properties of the drug 
• clinical trials – performed on patients, comprise of four phases with the aim to 
determine the actual therapeutic effects and toxicity of the drug, appropriate 
therapeutic dosage, side effects, and interactions with other drugs. Clinical tests 
include also post-marketing surveillance of the long-term effects.  
An essential consideration in drug discovery and development are the ADMET 
properties. A compound may be a strong, selective inhibitor of an enzyme in silico and 
in vitro, but it is of limited therapeutical use if it does not cross biological barriers, is not 
soluble, is unstable or accumulates in the body. For example, peptides can bind well to a 
receptor, but are prone to proteolytic digestion and therefore difficult to utilise as drugs. 
There are also traps on the metabolic pathway of the drug – various reactions can lead to 
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the formation of toxic derivatives or interactions can occur with other drugs or receptors 
that are not the intended target [Merino et al., 2010]. 
Several thousand of target proteins are already known, however, effective drugs exist 
for only a small fraction (about 250) of the diseases for which the molecular mechanism 
is established. Thymidylate synthase is an example of an enzyme the action of which is 
well described and competitive (orthosteric) inhibitors exist, but their therapeutic 
potential is somewhat limited. Within this already known protein, a new target was 
recently identified [Cardinale et al., 2011]: the dimer interface that may adapt new, 
allosteric inhibitors of the enzyme.  
1.2 Thymidylate synthase 
The reaction catalysed by human thymidylate synthase (hTS, EC 2.1.1.45) constitutes 
an essential step of the only pathway for producing de novo 2’-deoxythymidine-5’-
triphosphate (dTTP) for DNA synthesis. Therefore the enzyme is a good target for 
anticancer, antifungal and antiviral drugs, inhibiting the growth of rapidly proliferating 
cells by interfering with TS function. Overexpression of thymidylate synthase is 
common in many cancers and the tumours may be less sensitive to TS inhibitors than 
healthy cells. Moreover, the use of inhibitors such as fluoropyrimidines can lead to TS 
gene amplification and increased levels of the protein. In any case, high level of TS in 
cancer cells is correlated with poor clinical response to fluoropyrimidines and the rapid 
progress of the cancer [Li et al., 2001]. 
The subject of this work is methylenetetrahydrofolate-dependent thymidylate synthase, 
found in most organisms, including mammals. It is so well conserved through the 
evolution that bacterial (e.g. E. coli and L. casei) enzymes may be used as models of 
mammalian ones. All these TSes share the same overall fold defined by 8 α-helices and 
10 β-sheets, with a 6-stranded twisted β-sheets forming the dimer interface, and a deep 
active site cavity (Figure 1). There is high sequence similarity between bacterial and 
mammalian TSes in the regions surrounding the active site and dimer interface 
[Carreras and Santi, 1995].  
Some microorganisms produce thymidine via FDTS – flavin-dependent thymidylate 
synthase-catalysed reaction [Koehn and Kohen, 2009], which is not covered here.  
 
1.2.1 Structure, dynamics, and conformational changes of TS 
Thymidylate synthase is a homodimeric protein, molecular weight about 63 kDa, in 
which both subunits contribute to each of the two active sites. However, only one 
active site appears to be functional at a time [Świniarska et al., 2010]. In the absence of 
ligands, the active site of TS shows an open conformation allowing the ligands to enter 
it. The formation of the TS-ligand-cofactor complex (the ternary complex) leads to a 
conformational change in the protein and almost complete burial of ligands. As 
indicated by the structures of the complex of TS with dUMP (the binary complex), and 
by NMR studies, dUMP binding alone does not induce the closure of the protein, and 
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the pyrimidine ring of dUMP is located away from the catalytic Cys146, which 
prevents the initiation of the reaction in the absence of mTHF. After bonding with the 
cofactor, the protein goes into a closed conformation (Figure 1), steering the pyrimidine 
ring of dUMP into the position where thiolation by Cys146 can occur, and the cofactor 
to align for reaction with dUMP (Figure 2) [Montfort and Weichsel, 1997]. 
 
 
Figure 1  Monomeric unit of E. coli TS in open (blue) and closed (magenta) conformation. The blue 
structure is of an apoenzyme (PDB code 1FTQ), and the closed ternary complex of TS with mTHF 
and FdUMP(PDB code 1TSN) is coloured magenta. In the upper part of the drawing the closure of 
protein structure around the ligands is visible. 
 
 
Figure 2 Active centre of TS: ligand arrangement during the ternary complex formation 
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1.2.2 Thymidylate synthase reaction 
TS catalyses the exchange of 5H hydrogen atom of dUMP for a methylene group 
provided by N5,10-methylenetetrahydrofolate (mTHF), with tetrahydrofolate (THF) 
acting subsequently as a reductant in the reaction and undergoing transformation into 
dihydrofolate (DHF). Regeneration of mTHF is catalysed by dihydrofolate reductase 
and serine hydroxymethyltransferase.  
The catalysis is initiated with a nucleophilic attack of the active site cysteine (Cys146 
in E. coli TS) at C6 of dUMP and opening of the methylene bridge in mTHF. 
A nucleophilic attack of pyrimidine C5 at the folyl iminium ion follows and a 
covalently linked complex of Cys146, dUMP and the cofactor is formed. Finally, the 
abstraction of pyrimidine 5H, THF elimination, hydride transfer and dTMP formation 
conclude the reaction (Figure 3). Some aspects of the enzymatic reaction steps still 
remain unclear [Montfort and Weichsel, 1997]. 
 
Figure 3 TS-catalysed reaction mechanism. From: [Montfort and Weichsel, 1997] 
1.2.3 Dynamical behaviour of thymidylate synthase 
The TS ligands are first recruited to a highly conserved large cavity, which 
progressively closes down throughout the first half of the enzymatic reaction. dUMP 
forms 13 hydrogen bonds during its initial binding to the apoenzyme and these bonds 
remain in place throughout the subsequent structural transition. This conformational 
change is not a domain shift, but rather the concerted movement of several protein chain 
segments toward the active centre against a stable protein core, comprised largely of the 
dimer interface. The closure of the active site leads to the alignment of the reactants and 
to the formation of the majority of contacts between the cofactor and protein, including 
hydrophobic interactions of the cofactor PABA and pterin rings with the protein side 
chains and a hydrogen bond network between the C-terminus and pterin ring. It is 
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suggested that the first chemical step in the catalytic reaction is facilitated by the precise 
alignment of the cofactor against dUMP. This alignment depends on the conformational 
change upon cofactor binding, contributing to catalysis by positioning a general acid 
Glu-58 (according to E. coli TS numbering scheme) near the methyl transfer site. It also 
brings together dUMP and three highly conserved residues, Asn-177, Glu-58, and His-
147 (E. coli TS numbering scheme) into a new hydrogen bond network (see Figure 13). 
It is also postulated that the conformational change may contribute to catalysis through 
conformational strain of the substrate and cofactor that leads to their activation, i.e. 
opening of the imidazolidine ring of the cofactor to produce the iminium ion 
intermediate that participates in the covalent ternary complex. The ligands in closed 
ternary complexes are also forced closer to the catalytic cysteine. After the covalent 
ternary complex is formed, only minor changes to the protein conformation take place 
until the products are released. The ligands’ binding to one monomer induces relatively 
small conformational changes in the other protomer that nevertheless inactivates the 
second binding site (half-of-the-sites reactivity) [Stroud and Finer-Moore, 2003]. 
Human thymidylate synthase, unlike the enzyme from other species, exists in the 
equilibrium of active and inactive conformations. In the inactive conformation, the 
catalytic cysteine is twisted almost 180° so that it points toward the dimer interface and 
is unable to bind dUMP without a major conformational change in the protein. It is also 
postulated that the inactive form of hTS interacts with its own mRNA, thus repressing 
TS synthesis. The active-inactive transition of hTS involves rearranging of the active-
site loop that comprises residues 181-197 (hTS numbering scheme) and includes 
catalytic cysteine (C195 in hTS) as well as R185 arginine, which is unique for hTS. 
Computational simulations (targeted molecular dynamics) made by Salo-Ahen and 
Wade indicate that the active site loop rotation occurs sequentially, ending with C195 
positioning in the active site, making the enzymatic reaction possible. It is suggested 
that the hydrophobic pocket unique to the inactive conformation, formed by residues 
F137, Q138, F142, G143, W182 and L187, might accept ligands that stabilise the 
inactive conformation without interfering with mRNA binding. Therefore it may be 
possible to design non-competitive inhibitors targeting this pocket. The advantage of 
these allosteric inhibitors over orthosteric ones would be lack of the induced drug 
resistance [Salo-Ahen and Wade, 2011]. 
1.2.4 Thymidylate synthase ligands 
o dUMP 
Deoxyuridine monophosphate (Figure 4) is a deoxyribonucleotide intermediate in 
synthesis of deoxythymidine triphosphate (dTTP). It is produced from uridine 
diphosphate (UDP) which is converted by ribonucleotide reductase to deoxyuridine 
diphosphate (dUDP), phosphorylated to dUTP, and then dephosphorylated to dUMP by 
dUTPase. dUMP is subsequently methylated to dTMP by the enzyme thymidylate 
synthase.  
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Figure 4    Deoxyuridine monophosphate 
o mTHF 
Folate (known as vitamin B9) is essential to cell growth and, in mammals, has to be 
supplied through the diet or by symbiotic gastrointestinal microorganisms. Folate 
derivatives are needed for DNA synthesis, repairs and methylation, and as cofactors for 
various enzymes. Natural folates are present in various foods, especially dark green 
leafy vegetables. A synthetic oxidised form of folate, folic acid, is converted to 
7,8-dihydrofolate by dihydrofolate reductase (DHFR). Folic acid supplementation is 
generally recommended to pregnant women in order to prevent neural tube defects in 
growing embryos. However, excessive (over 1 mg) daily uptake of folic acid in human 
may lead to DHFR saturation, excretion of high levels of unmetabolised folic acid, and 
some degree of inhibition of the reduction of DHFR physiological substrate 
7,8-dihydrofolate [Bailey and Ayling, 2009].  
Dihydrofolate is further converted by DHFR to 5,6,7,8-tetrahydrofolate (THF), an 
universal one-carbon fragments carrier in various biosyntheses. THF accepts one-carbon 
groups (e.g. from serine) and these one-carbon derivatives adopt different oxidation 
states, from the reduced N5-methyltetrahydrofolate, via 
N5,N10-methylenetetrahydrofolate (mTHF – the cofactor of TS, Figure 5) and 
N5,N10-methenyltetrahydrofolate, to the oxidised form N10-formyltetrahydrofolate.  
 
Figure 5    5,10-methylenetetrahydrofolate 
In solution, methylenetetrahydrofolate adopts flat conformation with almost co-planar 
PABA, imidazolidine and pterin rings. However, as this conformation would not fit in 
the active site of thymidylate synthase, in known ternary complexes the cofactor or its 
analogues display an L-shaped conformation (Figure 6, see also Figure 2).  
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Figure 6    5,10-methylenetetrahydrofolate in bent conformation 
As suggested by the results of molecular modelling, the cofactor in its flat conformation 
binds to thymidylate synthase in an open conformation, and upon closing of the protein 
the cofactor adopts the higher-energy bent conformation that is closer to the transition 
state one, held by extensive hydrogen bond contact network. The ordered sequence of 
ligand binding to TS – first dUMP, then mTHF – becomes random, if 
methylenetetrahydrofolate acquires a γ-linked polyglutamate tail that independently 
binds the protein in the absence of dUMP [Montfort and Weichsel, 1997]. 
 
1.2.5 Existing drugs targeting TS 
Thymidylate synthase is a good target for rational, structure-based drug design. 
Analogues of both the substrate and the cofactor are used in clinical practice as TS 
inhibitors. However, substrate analogues may induce drug resistance. One of the 
mechanisms of this resistance is supposedly the disruption of the autoregulation of 
translational repression. The TS protein binds to its own mRNA, generating a 
regulatory feedback loop for translational repression. Only apo-TS can bind the mRNA, 
ligand binding prevents the interaction. Thus, the presence of inhibitors bound to TS 
induces overexpression of the enzyme, which negates the therapeutic effect of the drugs 
[Garg et al., 2010].  
In addition to this, many of the TS inhibitors also affect healthy proliferating tissue, 
leading to a variety of toxic effects caused by damage to bone marrow cells, blood cells 
and intestinal lining.  
o Substrate analogues 
o 5-Fluorouracil and other FdUMP prodrugs 
5-Fluorouracil (5-FU, Figure 7), an analogue of uracil with fluorine atom replacing 
hydrogen at the C-5 position, was one of the first rationally designed antimetabolites, 
synthesised and patented in the US in late 1950s by Dr. Charles Heidelberger. 
Thymidylate synthase was not known at that time, but it was suspected that 5-FU, being 
a close analogue of uracil, may disrupt the biosynthesis of RNA and DNA. 
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Figure 7    5-Fluorouracil 
5-FU enters the cell rapidly via the same transport mechanism as uracil and is converted 
to a number of active forms, including 5-fluorodeoxyuridine monophosphate (FdUMP), 
which forms a stable ternary complex with thymidylate synthase and 
N5,10-methylenetetrahydrofolate, thus preventing thymidine synthesis in the cell. The 
complex is stabilised by high intracellular concentration of reduced cofactor folate, 
CH2THF. 5-FU is also converted to fluorouridine triphosphate (FUTP), which is 
misincorporated into RNA, disrupting its function, and to fluorodeoxyuridine 
triphosphate (FdUTP), leading to DNA damage, and in consequence to cell death.  
5-FU, given intravenously, is still widely used in the treatment of various cancers such 
as colorectal cancer, breast cancer, and cancers of the aerodigestive tract. The greatest 
impact of this therapy is observed in colorectal cancer, particularly when 5-FU is 
combined with newer chemotherapeutics such as irinotecan and oxaliplatin [Longley et 
al., 2003]. 
However, 5-fluorouracil is toxic to the patients, causing diarrhoea, and, as mentioned 
above, induces drug resistance [Mader et al., 1998]. It also undergoes rapid degradation 
by liver enzymes, which limits its oral bioavailability. Despite the usefulness of 
5-fluorouracil and some improvements such as combination therapies, new strategies of 
using 5-FU are much needed.  
One such approach are the modulation strategies intended either to decrease degradation 
of 5-FU, increase its activation, or increase TS binding activity of FdUMP. One 
example of a drug successfully used to modulate the activity of 5-FU is methotrexate, 
an antifolate inhibitor of dihydrofolate reductase (DHFR) which catalyses the 
conversion of dihydrofolate (DHF) to tetrahydrofolate (THF), the precursor of TS 
cofactor CH2THF and a substrate required in purine biosynthesis. The inhibition of 
purine biosynthesis by methotrexate leads to the increase of the levels of 
phosphoribosyl pyrophosphate, the cofactor needed for the conversion of 5-FU to 
FUMP. Thus, when administered before 5-FU, methotrexate enhances its antitumour 
activity.  
The studies on leucovorin (5’-formyltetrahydrofolate) and interferons, despite 
promising in vitro results, revealed no improvement in overall survival of the patients 
with advanced colorectal cancer; however, using 5-FU/leucovorin combination with 
oxaliplatin or irinodecan proved more successful.  
Other factor that has to be taken into account in predicting response to 5-FU is the 
individual sensitivity to the drug, determined by genetic factors. Investigating the 
molecular determinants of chemosensitivity will enable the individualisation of 
treatment for patients according to their molecular phenotype [Longley et al., 2003]. 
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5-Fluorouracil impacts healthy cells as well as tumours, hence the need for strategies 
enabling the delivery and activation of the drug only where necessary. An example of a 
5-FU prodrug with more specificity for tumour cells is capecitabine 
(N4-pentyloxycarbonyl-5′-deoxy-5-fluorocytidine), designed by Miwa et al. and 
approved by FDA in 1998. It is selectively converted to 5-FU in tumour cells by a 
cascade of three enzymes, one of which, thymidine phosphorylase, is more active in 
tumour cells than in normal tissues. Capecitabine is characterised by better oral 
bioavailability and reduced incidence of diarrhoea, although it may cause other adverse 
side effects such as hand-and-foot syndrome. Other approaches employ enzymes 
delivered to the surface of tumorous tissues that later activate 5-FU prodrugs locally at 
the tumour mass [Garg et al., 2010].  
The formation of the stable ternary complex with FdUMP and the crystallisation of the 
complex is the basis of the most of our knowledge on TS mechanism [Hyatt et al., 
1997]. 
o Analogues of methylenetetrahydrofolate  
• Raltitrexed (Tomudex, TDX, ZD 1694) 
The drug raltitrexed (Figure 8), an antifolate inhibitor of thymidylate synthase, is used 
intravenously since 1998 in the treatment of advanced colorectal cancer in cases where 
5-fluorouracil is not appropriate, e.g. due to intolerance or cardiotoxicity. It concentrates 
easily in the cell and is active in various solid tumours such as gastric cancer, head and 
neck cancer, malignant mesothelioma, pancreatic cancer, and colorectal cancer. The use 
of raltitrexed in advanced colorectal cancer is simpler and is associated with less 
complications than in the case of 5-FU, while leading to an equivalent overall survival 
[Liu et al., 2013]. Raltitrexed may also be suitable for patients with a cardiac history 
[Kelly et al., 2013]. 
 
Figure 8    Raltitrexed 
• Pemetrexed (brand name Alimta)  
Used in the treatment of pleural mesothelioma as well as non-small cell lung cancer, 
pemetrexed (Figure 9) is a folate analogue that inhibits several enzymes: thymidylate 
synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. 
Thus it has therapeutic advantage over other, more specific antifolates [DrugBank]. 
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Figure 9    Pemetrexed 
o Allosteric inhibitors  
Thymidylate synthase, as an obligate homodimer, may also be a target for inhibitors 
disturbing the interaction between protein subunits. Since the use of active-site 
inhibitors such as 5-FU, raltitrexed or pemetrexed leads to an overexpression of hTS, 
supposedly due to the loss of RNA regulatory capacity, it is important to find new hTS 
inhibitors acting through new mechanisms that have no impact on RNA regulation and 
do not lead to an increase in protein levels. Such allosteric inhibitors are investigated by 
various researchers. Some diphosphonic acids have been proposed in this capacity, but 
their potential is limited due to the lack of cellular activity, and in addition to this, the 
mechanism of action remains unknown. Cardinale et al. described the discovery of 
several peptides, with sequences taken from the hTS dimer interface, that inhibit 
thymidylate synthase through binding to a previously undescribed allosteric binding site 
at the dimer interface of the bi-inactive form of hTS. The mechanism of this inhibition 
involves stabilisation of an inactive form of the enzyme. Administered to ovarian cancer 
cells, these peptides, unlike the abovementioned drugs targeting the active site, inhibit 
intracellular hTS – and cell growth – without leading to overexpression of the protein. 
Since the usage of peptides as drugs is limited due to their degradation by proteases, 
poor membrane permeation and absorption properties, the subsequent steps will require 
finding analogous compounds (peptidomimetics) and a detailed analysis of their 
mechanism of action [Cardinale et al., 2011]. 
2 The goals of this work  
This study is focused on applications of modern molecular modelling techniques, such 
as MD simulations and molecular docking, into the pre-clinical stages of drug design 
and development process. The molecular target chosen in this work was the protein 
thymidylate synthase (TS) – an enzyme playing a pivotal role in cancer invasion, 
progression, and metastasis. This makes TS a great target for development of novel 
oncologic drugs. Thus, detailed studies of picosecond-to-nanosecond time scale 
dynamics of this enzyme with its known ligands were performed and the observed 
binding modes were investigated using molecular dynamics simulations. MD 
simulations also enabled the analysis of the energetics of enzyme-inhibitor complex 
formation.  
The results of this part were required for setting up and interpreting the results of virtual 
screening of the databases of small organic compounds in search of potential new 
inhibitors. The results of this virtual screening focused my attention on compounds with 
peptoid and mixed peptide-peptoid scaffolds. Combined with the indications that the 
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competitive (orthosteric) inhibitors may be of limited usage in clinical practice, this 
focus on peptoid compounds gave rise to the next part of this project: the design of 
allosteric TS inhibitors with the peptoid scaffold.  
In addition to using existing methodologies in these processes, the last part of the work 
presented in this thesis included the development of new tools for structure-based ligand 
design – namely, libraries of peptoid residues in the format ready for molecular 
simulations. Moreover, results of collaboration with teams of experimental researchers 
working on thymidylate synthase inhibitors and related compounds are presented in the 
form of attached published papers with short summaries thereof. 
 
Overall, the goals of this work may be summarised as follows:  
o The investigation of ligands binding to thymidylate synthase in the active site – 
dUMP and its analogues, in the presence of cofactor methylenetetrahydrofolate. 
The underlying idea is to find competitive TS inhibitors that exhibit better long-
term behaviour than 5-fluorouracil. 
o Studies of thymidylate synthase dynamics, conformational changes and behaviour 
in the presence of various ligands in the active site. 
o The design of new thymidylate synthase inhibitors, both binding to the active site 
(dUMP analogues) and to other sites at the surface of the protein (allosteric 
inhibitors, e.g. peptidomimetics). 
3 Methods 
Drug discovery requires a vast investment of time and resources. Although clinical trials 
are undoubtedly the most expensive part of that process, significant costs are also 
associated with preclinical phases and the hit rates in conventional screenings are rather 
low: it is estimated that only five out of 40 000 compounds tested in animals reach 
clinical trials [Kapetanovic, 2008]. Therefore, approaches alternative to conventional 
screening are being sought in order to facilitate the drug development and optimise the 
resources in terms of time, manpower, and costs. In the past two decades, vast 
development of in silico tools applied to preclinical drug development was made 
possible due to the increase in computational power, software development, and 
constantly growing amount of publicly available data such as solved crystal structures 
of important protein targets. Computational approaches are currently used in virtual 
screening, hit detection (identification of drug candidates), hit-to-lead conversion, lead 
optimisation (reducing the side effects and improving ADMET properties of the 
selected compounds), and in the target assessment (target dynamics, binding 
selectivity/off-target binding). These are done primarily by molecular docking methods 
and molecular dynamics (MD) simulations.  
Molecular docking, in principle, predicts the optimal binding pose (geometry and 
orientation) and its energetics (and therefore binding affinity) of a drug candidate upon 
binding to its cognate receptor. It can thus be used to rank the list of drug candidates 
according to their predicted binding energy (virtual screening) in order to select the 
most promising candidates for further development, that is, possible modifications and 
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experimental testing. The use of molecular docking techniques typically leads to a 
relatively short list of predicted binding poses, amongst which a near-native binding 
mode is often observed [Ritchie, 2008].  
Recent results from the CAPRI (Critical Assessment of PRedicted Interactions, a 
community-wide experiment set up to monitor progress in the field of molecular 
docking) blind docking tests show constant improvement in the currently used docking 
algorithms, including automatic docking servers [Lensink and Wodak, 2013]. 
Numerous studies described in details the types of algorithms and scoring functions 
commonly used in molecular docking protocols, their accuracy, robustness, 
approximations used, and their advantages and limitations [Cheng et al., 2009, Li et al., 
2014 a and b]. In general, regardless of their type (force field-based, empirical, 
knowledge-based, hybrid, etc.), the scoring functions implemented tend to cover reliable 
models of electrostatics, van der Waals, and solvation effects, and therefore are very 
useful in drug design applications.  
Methods based on molecular dynamics (MD) simulations provide detailed insight into 
the nature of potential drug-target interactions by representing the interacting species as 
a conformational ensemble that follows the laws of statistical thermodynamics. As such, 
MD simulations are very valuable in the assessment of the dynamics of such complexes 
in short time scales (typically tens to thousands of nanoseconds, occasionally several 
microseconds). The analysis of MD trajectories allows for monitoring of the 
conformational changes induced by binding of a drug molecule to its molecular target, 
tracking changes in the hydrogen-bonding network, studying the role of the solvation 
effects in drug-target binding, and assessing the stability and energetics, including 
enthalpic as well as entropic contributions. Trajectories of MD simulations and their 
post-processing (e.g. MM-PBSA method, see Section 3.2.3) enables detailed and 
accurate analysis of binding of very closely related ligands and for rational direction of 
development of better, more tight-binding compounds.  
3.1 Molecular docking 
Molecular docking is a method of quickly predicting the location, orientation, and 
conformation (the binding pose) of one molecule (e.g. a small ligand – drug candidate) 
versus another (e.g. a protein). Fast, crude docking algorithm applied to a set of putative 
ligands may serve as a high-throughput tool of hit identification (see Section 1.1). It is 
also useful during lead optimisation stage, allowing for the testing of various 
modifications of the lead structure before synthesis.  
The aim of docking is basically to find a correct structure of the complex, e.g. of an 
enzyme (E) and inhibitor (I):  
[EI]aq ⇌ [E]aq + [I]aq 
The free energy of binding ∆G = –RTlnKA is related to binding affinity KA and 
inhibition constant Ki by the equation: 
[E][I]
]EI[1
==
−
iA KK  
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For the purposes of high-throughput docking and preliminary scoring of docked 
compounds, binding energy can be crudely estimated as a sum of Coulombic (Ecoul) and 
van der Waals (EvdW) interactions:  
∑∑
= =
=
E IN
i
N
j ij
ji
coul
r
qq
rE
1 1 04
)(
piε
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where ε is the well depth of the potential and σ is the collision diameter of the atoms i 
and j, respectively. 
The process of docking a ligand to a receptor involves:  
1. Posing – finding orientations and conformations, within a given degree of 
flexibility for each molecule, fitting into the active site of the receptor. 
A balance must be found between the number of degrees of freedom of the 
molecule – with the aim to find the right conformation – and the algorithm speed 
that would permit the evaluation of thousands of molecules in a short time. 
There are several methods of treating flexibility of both the receptor and the 
ligand. For example, the ligands may be divided into fragments that are docked 
into the active site and linked again; or a “rigid core” of the molecule may be 
docked first and flexible “side chains” added later, one molecular fragment at a 
time. A set of pre-generated conformations can also be used. Other approaches 
involve stochastic methods of conformational space exploration, or the use of 
molecular dynamics (MD) simulations. Because of the approximations used and 
the requirement for the docking algorithm to be fast, the receptor flexibility is 
usually somewhat compromised. Amino acid side chain rotamer libraries and 
protein ensemble grids are used along with the algorithms removing the less 
favourable conformations and steric clashes. The initial pose score can be 
calculated as an approximate measure of how the ligand fits into the binding 
pocket of the receptor. 
2. Ranking – evaluation (scoring) of the “best” predicted ligand poses in order to 
indicate which ligands are suitable for further investigation, usually by 
approximating the free energy of binding (the so-called binding score or the 
energy score). The simplest scoring method is to estimate binding energy as the 
sum of Coulombic and van der Waals components given above, and in some 
cases to normalise the resulting energy by dividing it by number of heavy atoms 
in the molecule – since the larger the molecule is, the more interactions it has 
with the receptor. Other scoring approaches may involve the use of force fields, 
empirical scoring functions, knowledge-based scoring functions, and other 
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schemes. Entropic and solvation terms may also be taken into account [Kitchen 
et al., 2004].  
After the best ligands for further development – lead compounds – have been selected, 
lead optimisation phase (see Section 1.1) may begin with the use of further docking 
procedures for combinatorially modified leads (Section 4.2.4), molecular dynamics 
simulations, and in vitro tests. 
3.2 Molecular dynamics 
3.2.1 Basic concepts of molecular dynamics 
The basic concept of molecular dynamics is to simulate time-dependent behaviour of a 
system, e.g. a protein, protein-ligand complex, or macromolecular complex. In general, 
atoms are treated as points in space with charges assigned and may or may not be 
connected with bonds. The movements of the atoms are described by numerically 
solving Newton’s equations of motion. 
The force field V describes electronic energy as a function of nuclei configuration R. 
The force field gradient gives the forces acting on the atoms. In classic molecular 
mechanics (MM) and molecular dynamics (MD), the force field is approximated by the 
following function:  
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The first term of the equation above describes chemical bonds within the harmonic 
model in relation to a certain reference length for a given pair of atoms r0; the second 
term describes bond angles in the same way in relation to a reference angle θ0; the third 
term pertains to torsional interactions; the fourth term describes Van der Waals forces 
between non-bonded atoms; and the last term gives Coulombic interactions between 
atomic charges that are assumed to be fixed. In the classic MM/MD models used in this 
work the bonds are “unbreakable” and no new bonds are created.  
Molecular mechanics is a method of finding a stable configuration of the nuclei (called 
equilibrium geometry) by minimising V(R) with respect to the nuclear coordinates. The 
resulting geometry, being a local minimum of potential energy, is usually close to the 
starting one, i.e. for a reasonable starting geometry no significant conformational 
changes occur.  
In a molecular dynamics simulation time is taken into account as well as the 
temperature and acceleration of the atoms.  
The method is based on Newton’s equation of motion Fi=mi ai, or:  
2
2
dt
rd
m
dr
dV i
i
i
=−  
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where V is the potential energy of the system. In order to obtain positions of the atoms ri 
after the time t, the equations of motion must be solved numerically. The integration 
algorithms are based on the Taylor series expansion:  
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The initial positions are assumed (e.g. according to experimental results or other 
simulations), and the initial velocities are assigned randomly according to Maxwell-
Boltzmann distribution for a given temperature. Then the positions and velocities of 
atoms after one time step are calculated e.g. using the Verlet algorithm, assuming linear 
change of velocity and acceleration during the time interval δt. In this way 
conformational space of the system can be explored [Piela, 2014]. 
A typical molecular dynamics simulation of a protein-ligand system is performed in 
constant pressure and temperature (NPT) conditions, and involves:  
• choosing initial coordinates of the system 
•  energy minimisation of the structure in order to remove any steric clashes and 
bad electrostatic contacts that might occur after the initial construction of the 
structure 
• adding solvent (if explicit solvent molecules are to be used) 
• adding counter-ions, in order to maintain the neutral charge of the whole 
system 
• heating phase: the simulations starts at low temperature that is gradually, 
during a short MD run, increased to the target temperature (e.g. 300 K) 
• equilibration phase: achieves the correct density and stabilises the properties of 
the system with respect to time 
• actual simulation – production runs, typically of nanosecond time scale, up to 
microseconds. Production runs may comprise of  a single trajectory or multiple 
ones (starting from the same, equilibrated structure, in order to improve the 
sampling and the statistics). 
During a MD run, the velocities of the atoms are regularly checked and scaled in order 
to maintain the desired temperature. Periodic boundary conditions are often used.  
The molecular dynamics simulations are useful in:  
• evaluation of conformational changes of the system (RMSD, principal 
component analysis) 
• calculating free energy and affinity (MM-PBSA) 
• assessment of the stability of the system 
• calculation of enthalpic and entropic energy components 
• comparison to experimental results (e.g. NMR, crystallography) 
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• generation of conformational ensembles (e.g. for molecular docking). 
 
3.2.2 Preparing the MD simulations 
Geometry optimisation 
In order to obtain correct energies and atomic charges, an accurate geometry of the 
molecule – that is, an energy minimum – is needed. In the case of relatively small 
molecules such as the ligands of thymidylate synthase, one can search the potential 
energy surface with quantum mechanical methods. In the work described here, 
geometry optimisation was performed using Berny algorithm implemented in Gaussian 
03/09 program suite and described in the Opt section of Gaussian 09 User’s Reference 
[G09 User’s Reference], at the HF/6-31G* level, sometimes with preliminary 
optimisation using DFT (B3LYP) to get better starting geometry for the more 
demanding ab initio computations. This procedure yields local minima, thus the starting 
structures resembling the ones present in X-ray data were used. 
Since a protein is too big a system for ab initio quantum mechanical geometry 
optimisation, starting structures of the complexes were optimised with molecular 
mechanics only, starting with X-ray structures for the protein and QM-optimised 
geometries for the ligands. The initial positions of the ligands versus the protein were 
assumed according to the geometries of analogous complexes (Section 4.2.1) or to the 
results of molecular docking (see Sections 3.1 and 4.2.2). 
Restrained Electrostatic Potential (RESP) method of determining atomic charges 
All molecular mechanics and molecular dynamics calculations rely on the concept of 
atomic charges. However, there is no such thing as “true” atomic charge, one can only 
speak of the distribution of electrons around the nuclei in the molecule. Some 
approximate construct must be used in order to derive atomic point charges that allow 
for accurate computer simulations for the system. 
Using ab initio calculations, one can derive atomic charges by fitting them so that 
electrostatic potential (ESP) calculated for a grid of points around the molecule is 
accurately reproduced. For this, Merz-Singh-Kollman scheme us used on the 
HF/6-31G* level. This method yields atomic charges that accurately reproduce 
multipole moments and intermolecular interactions. However, they are basis set 
dependent and conformation dependent. Moreover, the charges for “buried” atoms (less 
exposed to solvent, such as an sp3 carbon) are poorly determined, since the ESP points 
used to fit the charges lie outside the Van der Waals surface of the molecule. 
A hyperbolic restraint function is therefore used in the fitting, which reduces the 
fluctuation in charges of buried atoms without seriously impairing the quality of the 
overall fit to ESP. Moreover, the charges for equivalent atoms (i.e. atoms rapidly 
exchanging during molecular dynamics, e.g. hydrogen atoms of methyl groups) should 
be identical. In the case of methyl groups, a two-stage fit is used – the first stage is 
performed without forced symmetry and with weak restraints, and the second stage refit 
concerns only methyl groups, with forced symmetry and strong restraints.  
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The charges derived with the use of the RESP method are suitable for quantitative and 
qualitative description of a molecule. RESP charges are consistent with chemical 
intuition, exhibiting moderate fluctuations between related functional groups, and still 
reflecting the local chemical environment [Bayly et al., 1993]. The calculations of 
conformational energies, hydrogen bonds energies, and free energies of solvation made 
by Cornell et al. show that the two-stage RESP charges reproduce both intermolecular 
and intramolecular energies and structures quite accurately [Cornell et al., 1993]. 
Amber parameterisation 
In Amber and other similar programs for molecular mechanics / molecular dynamics 
calculations, force field parameters are specified in a file containing values of r0, θ0, and 
φ0 for any combination of atom types that is likely to appear in a given calculation. The 
assignment of an atom type depends on the hybridisation state of an atom (e.g. sp2 or 
sp3) and its chemical environments (e.g. sp2 nitrogen in amide groups). In the 
calculations described here, PARM99 and GAFF force field parameters were used, with 
modifications in the cases where less typical bond angles were present in the ligand 
molecule and thus the force field file lacked the corresponding angle and dihedral 
parameters. In these cases parameters for similar atom types were used.  
3.2.3 Analysis of the MD simulation 
Visualisation of the results 
The results of the molecular dynamics calculation can be viewed frame by frame as a 
film, or individual frames or averages can be analysed visually, in order to spot any 
irregularities, and to get an idea on whether, and to what degree, does the overall 
conformation of the system change. In this work, visualisation was performed and all 
the drawings depicting molecular conformations were made with the use of freeware 
molecular graphics programmes: UCSF Chimera [Pettersen et al., 2004], RasMol 
[Bernstein, 2000], VMD [Humphrey et al., 1996], and Molden [Schaftenaar and 
Noordik, 2000]. These programmes, along with XleaP (part of the Amber package), 
were also essential in preparing all structures for simulations and for visual inspection 
of the results obtained.  
RMSD 
The root-mean-square deviation (RMSd) is the measure of the average distance between 
the atoms (all of them, protein backbone only, or selected groups) of the superimposed 
structures. In the analysis of a molecular dynamics run the RMSd is a tool to estimate 
quantitatively the extent of conformational changes in time and the stability of the 
system.  
It is calculated according to the formula:  
∑
=
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where δ is the distance between N pairs of equivalent atoms.  
End-state free energy calculations: MM-PBSA 
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The binding free energy in a noncovalently bound receptor-ligand complex may be 
calculated by subtracting the free energies of the nonbound receptor (apo-protein) and 
ligand from the free energy of the complex: 
][
,,,, solvatedligandsolvatedreceptorsolvatedcomplexsolvatedbinding GGGG ∆+∆−∆=∆  
The terms ∆Gsolvated on the right-hand side of the above equation are estimated as: 
solutesolvationgassolvated TSGEG −∆+=∆  
where Egas denotes gas-phase energies, often calculated by molecular mechanics from 
the force field, ∆Gsolvation is the solvation free energy calculated using an implicit solvent 
model (e.g. Generalized Born), and ∆S – the entropic contribution – is estimated e. g. by 
normal mode analysis. In practice, in the end-state calculations these energies are 
estimated from the average values for an ensemble of representative structures: 
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where N is the number of analysed frames, i – the frame index. 
The ensembles can be extracted from a molecular dynamics or Monte Carlo run, either 
from a single trajectory for the complex, or from trajectories generated separately for 
each state [Miller et al., 2012]. 
 
4 Summary of the results 
4.1 Published paper 
The initial steps of thymidylate synthase reaction were investigated using QM/MM 
approach.  
It is assumed that the Asn177 (E. coli numbering scheme) residue stabilises, by 
hydrogen bonding, the partial negative charge on O4 of covalently bound dUMP (for 
the numbering of atoms see Figure 10). The “switch effect” hypothesis developed in 
this work is that the screening of this partial negative charge facilitates the formation of 
the C—S bond between C6 of dUMP and Cys146 of the enzyme. In other words, 
without the partial negative charge on O4 the dUMP-enzyme bond is not stable.  
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Figure 10 Schematic diagram of the TS-dUMP-MTF complex 
In order to verify this hypothesis, three models of TS ternary complexes with 
methylenetetrahydrofolate (MTF) with dUMP, FdUMP, or dUMP-OH, respectively, 
were created using the X-ray diffraction structure of E. coli TS complexed with dUMP 
and THF (PDB accession code 1KZI) as the starting point. Models of three different 
sizes were used; the largest one, comprising of residues in 10A sphere (within 10A from 
the S atom of Cys146), was investigated by combined quantum mechanical / molecular 
mechanics (QM/MM) routine using two-layer ONIOM-ME scheme. The internal part, 
containing residues within 5A sphere, was computed at the B3LYP/LANL2DZ level, 
and the external layer was studied by MM with Amber force field. The smaller model 
consisted only of the residues within the 5A sphere and was studied at the 
B3LYP/LANL2DZ level. For the transition state calculations a small model consisting 
only of uracil and selected atoms from its environment was used (Figure 11).  
 
Figure 11 The model of the transition state for the proton movement. H3O+ is mimicking the 
presence of Asn177 and the 6-mercaptopropane group represents Cys146 
All calculations were performed with the Gaussian03 software.  
It was concluded that the nucleophilic attack of Cys146 on dUMP appears to be 
concerted with the presence of a proton bound to O4 atom of dUMP, or a proton donor 
forming hydrogen bond with O4 atom. Moreover, this “proton switch” stabilises or 
destabilises the sulphur – carbon S(Cys146)—C6(dUMP) bond. The “switch effect” 
does not occur when there is sulphur or a –SH group in place of the O4 atom.  
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Additional calculations indicate that the “switch effect” occurs also in C5-substituted 
analogues of dUMP, i.e. FdUMP, dUMP-OH, dUMP-CH2OH, and dUMP-OCH3.  
This work was conducted in cooperation with M. Fusaro, A. Jarmuła, A. Leś, and W. 
Rode [Fusaro et al, 2010], and the full text can be found in Appendix 1. 
4.2 Non-published work  
4.2.1 Hydroxyl analogues of dUMP 
Analogues of the substrate 
In search of new inhibitors of thymidylate synthase, certain hydroxyl analogues of the 
substrate, where the 5H hydrogen atom of dUMP was substituted by –OH, –CH2OH and 
other related groups, were investigated experimentally by W. Rode’s team in the Nencki 
Institute of Experimental Biology [Dzik et al., 1997].  
The above mentioned experiments showed that both dUMP-OH and dUMP-CH2OH are 
competitive vs. dUMP inhibitors of thymidylate synthase. The dUMP-OH demonstrates 
some substrate-like activity in that mTHF is slowly converted into dihydrofolate, 
however, the products of this reaction remain unknown. The product analogue, 
dUMP-CH2OH, acts as a slowly binding inhibitor inactivating the enzyme in a time-
dependent matter [Dzik et al, 1997]. The computational simulations [Jarmuła et al., 
2000] suggested that the difference of behaviour between dUMP-OH and 
dUMP-CH2OH is related to different acidity of the respective substituents. In 
dUMP-OH and dUMP-OCH3, the C5-O5 bond is partially double due to the resonance 
with the pyrimidine ring. This is not the case with dUMP-CH2OH, where the bond 
between C7-O7 is strictly single. Hence, in dUMP-OH the O5 atom bears positive 
charge, promoting deprotonation of the 5-hydroxyl group. This computational result is 
supported by UV absorption spectra of 5-hydroxyuridine and 5-hydroxy-2’-
deoxyuridine.  
In addition to the above, the presence of an additional hydroxyl group in the chemical 
environment of the modified uracil ring should promote new hydrogen bonds in the 
active centre and impact the recognition of the analogue by the enzyme and the course 
of enzymatic reaction. For comparison, dUMP-OCH3, a ligand similar to 
dUMP-CH2OH, but without additional hydrogen bonding ability, was also taken into 
account. As reference, identical MD simulations for dUMP and the known TS inhibitor, 
FdUMP, were also performed. Figure 12 shows hydroxyl analogues of dUMP that were 
investigated along with dUMP and FdUMP. 
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Figure 12 Hydroxyl analogues of dUMP: dUMP-OH, dUMP-CH2OH, and dUMP-OCH3; dr-P 
denotes deoxyribose-phosphate group  
Modelling of the interactions in the active centre 
The crystal structure of thymidylate synthase used in the simulations was a modified 
1TSN PDB structure (E. coli thymidylate synthase bound to FdUMP and 
methylenetetrahydrofolate). The cofactor in this ternary complex is in its bent 
conformation with the imidazoline ring open, and is covalently bound to FdUMP, which 
in turn is bound to the enzyme by C6-Cys146S bond. This structure, representing a 
model of the first stage of the enzymatic reaction, was the starting point for all MD 
simulations with the five abovementioned TS ligands.  
The dynamics of TS active site upon binding to the studied ligands in the presence of 
the cofactor was investigated in line with the description of the active site in the paper 
[Finer-Moore et al., 2003] (Figure 13). 
MD protocol 
The geometries of the ligands and the cofactor were optimised with Gaussian 03 at 
HF/6-31G* level, then RESP protocol (see Section 3.2.2) was used to calculate charges. 
Then the structures were parameterised using modified parm99 (for the ligands) and 
GAFF (for the cofactor) force fields available in the Amber8 package [Amber8], and 
finally minimised by MM calculation made in Amber8. Then the ligands were inserted 
into the active site of the protein, aligned in the same position as FdUMP in the 1TSN 
structure. 
Then 20 ns molecular dynamics in periodic boundary conditions and in the presence of 
explicit TIP3P water in a 12A solvent box was performed with Amber8 sander 
programme, according to the following protocol: 50 ps of heating from 0 to 300 K, 50 
ps of equilibration (NPT ensemble), and then 20 nanoseconds of molecular dynamics 
simulation. The same simulation was performed for the enzyme without any ligands 
(apo-TS) and for the enzyme bound to the cofactor only, in order to compare the 
dynamics of the protein, and to find ligand- or cofactor-induced conformational changes 
within the protein. 
Post-MD processing  
The MD trajectories were then analysed with ptraj module available in AmberTools. 
Investigated were the binding energies, geometries of the active centre along with 
hydrogen bonds between the ligands and the enzyme, and protein tertiary structure 
features.  
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Figure 13 Active centre of TS: residues essential for catalysis (according to: [Finer-Moore et al., 
2003], amino acids numbered as in E. coli TS) 
The following distances between heavy atoms involved in protein – ligand binding, 
corresponding to hydrogen bonds shown in the above diagram of the active centre, were 
recorded during 20 ns molecular dynamics simulation: between C6 of X-dUMP and S 
of catalytic Cys146 (Figure 14 a); O2 of X-DUMP and amino-N of Gln165 (Figure 14 
b); O4 of X-dUMP and amide-N of Asn177 (Figure 14 c), O of phosphate group in X-
dUMP and hydroxyl-O of Ser 167 (Figure 14 d), O of phosphate group in X-dUMP and 
amino-N of Arg166 (Figure 14 e), and between ligands: C5 of dUMP and the 
methylenetetrahydrofolate (Figure 14 f). In the case of the phosphate group of dUMP 
(Figure 14 d and e), the phosphate oxygen atoms that remain the closest to the 
respective amino acids are shown (the rotation of phosphate group during the dynamics 
is visible on the charts as rapid changes of the distance from 2.7 to over 4.5 A). The 
distances along the dynamics are shown as simple moving averages, where the average 
distance from last 1000 data points (1 nanosecond) is shown so that the fluctuations are 
smoothed out and the charts are more readable. The X axis shows the simulation time 
(in picoseconds), the Y axis shows inter-atomic distances in angstroms.  
The following abbreviations are used on the charts:  
DMP = dUMP; FMP = FdUMP; MOD = dUMP-OCH3; OCD = dUMP-CH2OH;  
OHD = dUMP-OH 
From looking at the series of charts (Figure 14) it is apparent that among the ligands 
investigated, dUMP-OH (denoted as OHD, light blue line on the charts) is strongly 
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involved in the interaction with the enzyme via the hydrogen bonds network. Along 
with dUMP (denoted as DMP, red line), it also remains in the position suitable for 
binding the catalytic cysteine (which in E. coli is Cys146) (Figure 14 a). dUMP-OH 
also stays most strongly bound by ligand-binding amino acids Asn177, Ser167, and 
Arg166 (Figure 14 c, d and e, respectively). dUMP-OH also stays approximately in one 
place with respect to Gln165 (Figure 14 b).  
On the other hand, dUMP-CH2OH (denoted as OCD, purple line) seems to be relatively 
weakly bound by the active site, only its phosphate group stays in place with respect to 
Ser167 and Arg166 (Figure 14 d and e). Not surprisingly, dUMP-OCH3 (denoted as 
MOD, dark blue line), having a bulky substituent at C-5 that does not take part in 
hydrogen bonds, stays rather far from the catalytic cysteine and from Gln165, which 
normally stabilises the ligand on the other side of the pyrimidine ring.  
In general, these three investigated ligands behave similarly to the known inhibitor, 
FdUMP (denoted as FMP, green line) and to the substrate, dUMP (denoted as DMP, red 
line). The hydrogen bond network in the case of all five compounds remains in place, at 
least partially. As could be expected, FdUMP exhibits the weakest affinity to 
methylenetetrahydrofolate (Figure 14 f), while dUMP-OH, which might be stabilised by 
more hydrogen bonds in the active site, remains relatively close to it, keeping the 
alignment of the enzymatic reaction. 
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Figure 14 20 ns runs for five TS-ligand complexes, distances measured between: a) X-dUMP_C6 – Cys146_SG, b) 
X-dUMP_O2 – Gln165_NE2, c) X-dUMP_O4 – Asn177_ND2, d) phosphate oxygen of X-dUMP and Ser167_OG, 
e) phosphate oxygen of X-dUMP and Ser167_OG, f) X-dUMP_C5 and MTF_C11 
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MM-PBSA calculation – estimation of binding free energies 
For all the complexes, MM-PBSA calculations (see Section 3.2.3) were performed in 
order to estimate binding energies and compare them to the available experimental 
data.  
The results are presented in Table 1. 
Table 1 Free energies of binding for dUMP, FdUMP and hydroxyl analogues of dUMP. 
Experimental Ki from: [Jarmuła et al., 2000]; ∆GExp calculated according to the 
formula: ∆GExp = RTlnKi,Exp 
Ligand ΔGtotal (kJ/mol) Ki,Exp(microM) ΔGExp (kJ/mol) 
DMP -44.03 ± 8.38 3.2 -31.56 
FMP -86.99 ± 10.25 0.02 -44.22 
MOD -35.56 ± 9.01 3.7 -31.20 
OCD -38.77 ± 10.54 3.7 -31.20 
OHD -58.4 ±11.83  3.2 -31.56 
 
4.2.2 Virtual screening and docking 
Ligand selection and preparation 
In the present study 8060 ligands were selected for virtual screening in the “hit 
detection” part of the project. For virtual screening, 4890 experimental, purchasable, 
small-molecular compounds available in ZINC database [Irwin et al., 2012] along with 
1491 FDA-approved drugs and 82 FDA-approved nutriceuticals were chosen. In 
addition to this, 2 sets of natural products: AfroDB (954 compounds, [Ntie-Kang et al., 
2013]) and NuBBE (643 compounds, a database of natural products found in the 
environment of Brazil [Valli et al., 2013]) were selected and tested. 
Partial atomic charges on all tested ligands were assigned using the AM1-BCC 
methodology [Jakalian et al., 2002] and obtained from the ZINC database.  
Molecular docking protocol 
In all calculations targeting the catalytic pocket of the thymidylate synthase (TS), the 
crystal structure of human TS bound to dUMP and Raltitrexed (PDB code: 1HVY) was 
used as a starting structure of the target [Phan et al., 2001]. This structure is a 
homodimer, in its closed conformation, and represents the “bioactive” conformation of 
the enzyme. Prior to the docking procedure, it was modified by removing the covalent 
bond between the catalytic cysteine C195 and dUMP (which was present in both 
subunits), deleting ligands, adding hydrogen atoms, and relaxing side chains of all 
protein residues by MM energy minimisation, 5000 cycles. The binding site for the 
tested ligands has been selected on one of the monomers. Molecular docking was 
performed using the UCSF DOCK6.5 suite [Lang et al., 2009], with semi-rigid docking 
procedure and energy grid scoring in an implicit solvent. The grid spacing was 0.25 A, 
and the grid included 12 Å beyond the terminal sphere corresponding to the flanking 
heavy atoms of the Raltitrexed molecule, which was present in crystal structure. The 
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energy score was the sum of electrostatic and van der Waals contributions. In the course 
of the docking procedure, each ligand molecule was subjected to 1500 cycles of 
molecular-mechanical energy minimisation. The number of maximum ligand 
orientations was 2500. Partial flexibility of the protein during the docking was enabled. 
After the docking the cluster analysis of the obtained complexes was performed. 
Complexes with ligand poses more similar (in terms of RMSD on heavy atoms) than 
2 Å were assigned to the same cluster. The population of the clusters has been used as 
one of the criteria of analysing the results. The total number of best-scoring poses 
analysed was 25. 
The docking procedure has been calibrated using crystallised ligands as well as 443 
known TS inhibitors obtained from the ZINC database. The set of 386 non-binders was 
used as a negative control. The procedure successfully reproduced experimentally 
observed binding modes, and the energy scores for binders were significantly more 
favourable than for non-binders. These results gave the confidence in the applied 
methodology.  
The putative lead compounds, which were selected by molecular docking, are listed in 
Table 2 (hits from ZINC database), Table 3 (natural compounds), and Table 4 
(competitive inhibitors from the FDA-approved set), respectively.  
For the docking studies targeting the allosteric binding site, the crystal structure of 
human TS dimer bound to a short peptide LSCQLYQR (PDB code: 3N5E) has been 
chosen as a receptor. The putative ligand binding site has been assigned based on the 
positions of the heavy atoms of the peptide reported (Figure 15) [Cardinale et al., 2011]. 
Because of the protein-protein and flexible ligand-protein interactions, the 
conformational change of protein side chains and loops could occur upon binding of 
diverse ligands. Thus, 5 conformations of the binding site have been selected and 
considered independently in the docking studies, and the docking results have been 
refined using short MD simulations for best-scoring ligands (50 ps). The best scoring 
leads are presented in Table 5. 
Putative competitive (orthosteric) inhibitors 
Table 2 Potential orthosteric leads selected from the ZINC database. Starting structure 
1HVY, reference score for D16 (Tomudex): -79.22 (X-ray structure) or -78.07 
(structure from ZINC) 
ZINC ID Score No. of heavy 
atoms 
Benign functionality 
(ZINC) 
ZINC38408177 -72.51 35 No 
ZINC67541826 -69.71 28 Yes 
ZINC14120429 -66.23 27 Yes 
ZINC64775540 -63.91 33 Yes 
ZINC71703871 -61.74 24 Yes 
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ZINC ID Score No. of heavy 
atoms 
Benign functionality 
(ZINC) 
ZINC08655373 -78.84 35 Yes 
ZINC37584283 -71.38 21 Yes 
ZINC70311107 -68.13 21 Yes 
ZINC37584284 -66.87 21 Yes 
ZINC70309711 -65.45 19 Yes 
ZINC70311108 -64.23 19 Yes 
ZINC50195860 -62.40 20 Yes 
ZINC09778504 -61.38 35 Yes 
ZINC09778499 -61.13 35 Yes 
ZINC70309712 -60.02 19 Yes 
ZINC31948501 -60.01 22 Yes 
 
Table 3 Potential leads (orthosteric) selected from AfroDB and NuBBE databases of 
natural compounds  
ZINC ID Score No. of heavy 
atoms 
Benign 
functionality 
(ZINC) 
Name  
(if available) 
ZINC95485963 -60.54 38 Yes  
ZINC28462577 -63.66 40 No Ochnaflavone 
ZINC03871576 -53.17 20 Yes Apigenin 
ZINC84154073 -56.34 37 Yes  
ZINC03874317 -47.63 23 No Myricetin 
ZINC03869685 -46.45 22 No Quercetin 
ZINC84153817 -44.55 24 Yes  
ZINC03872070 -44.31 19 Yes  
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Table 4 Potential leads (orthosteric) selected from FDA-approved set of molecules 
ZINC ID Score No. of heavy 
atoms 
Benign 
functionality 
(ZINC) 
Name 
ZINC03927870 -93.55 24 No Fludarabine 
ZINC03830428 -75.13 35 No Cefonicide 
ZINC12503222 -74.27 20 No Famotidine 
ZINC03833880 -73.45 33 Yes Rosuvastatin 
ZINC01851132 -73.41 31 Yes Alimta (Pemetrexed)
(*)
 
ZINC03830442 -73.11 36 No Cefotetan 
ZINC01530639 -72.48 30 Yes Fluvastatin 
ZINC29319828 -71.38 30 No Eprosartan 
ZINC03871967 -71.00 27 No Ceftibuten 
ZINC01536934 -69.97 26 No Ridogrel
(**) 
(*)
 Pemetrexed is a known TS inhibitor used in clinical practice 
(**) Ridogrel is a dual action drug useful for the prevention of systemic thrombo-
embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial 
infarction. However, there currently are no clinical indications for preferential use of 
ridogrel over aspirin 
 
Putative allosteric inhibitors 
 
Figure 15 Allosteric binding site at the dimer interface of thymidylate synthase. Binding peptide 
LSCQLYQR shown in the middle. PDB code 3N5E [Cardinale et al., 2011] 
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Table 5 Potential leads (allosteric) obtained from ZINC database, peptide and peptoid 
set. All the molecules are annotated as having benign functionality 
No. ZINC ID No. of 
heavy 
atoms 
Score Remarks 
1 ZINC17911992 29 -77.44  Peptide. Start for peptoid 
development and for optimisation. 
Purchasable 
2 ZINC65299894 29 -75.18 Peptide 
3 ZINC67661339 29 -75.15 Peptide 
4 ZINC62554870 27 -74.99 Peptoid 
5 ZINC41398864 29 -74.98 Peptoid 
6 ZINC41398860 29 -74.74 Peptoid 
7 ZINC04866612 30 -74.42 Peptide 
8 ZINC40614900 27 -74.00 Peptide 
9 ZINC28330572 31 -73.99 Peptoid 
10 ZINC65683365 29 -73.78 Peptide 
11 ZINC69022072 28 -73.71 Peptoid. Purchasable 
12 ZINC41400402 29 -72.99 Peptoid 
13 ZINC69022087 27 -72.79 Peptide-peptoid mix. Purchasable 
14 ZINC36125115 27 -72.77 Peptoid. Purchasable 
15 ZINC71810038 28 -72.68 Peptoid. Purchasable 
16 ZINC41400074 29 -72.62 Peptoid 
17 ZINC71810050 28 -72.46 Peptoid. Purchasable 
18 ZINC62089977 28 -72.42 Peptoid  
19 ZINC08346744 31 -72.10 Peptide-peptoid mix. Purchasable 
20 ZINC35325177 29 -71.89 Peptide-peptoid mix. Purchasable 
21 ZINC62187452 26 -71.63 Peptoid 
22 ZINC22844848 28 -71.44 Peptide-peptoid mix. Purchasable 
23 ZINC66885030 28 -71.42 Peptoid. Purchasable 
24 ZINC24675306 29 -71.36 Peptide-peptoid mix. Purchasable 
25 ZINC71962264 31 -71.33 Peptide. Purchasable 
26 ZINC41400813 29 -71.15 Peptoid 
27 ZINC71810037 28 -71.13 Peptoid. Purchasable 
28 ZINC69022076 28 -70.98 Peptoid. Purchasable 
29 ZINC41400547 28 -70.83 Peptoid 
30 ZINC69021893 28 -70.80 Peptoid. Purchasable 
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The most promising compounds from Table 5 were then subjected to optimisation – see 
Table 6 and Figure 16 below, and Section 4.2.4 for further combinatorial optimisation 
with the use of peptoid library. 
 
Figure 16 Lead optimisation: initial modifications of the ZINC17911992 compound  
Table 6 Docking scores for modified derivatives of ZINC17911992 shown in Figure 16 
Name Score 
DR1 -79.18 
DR2 -81.02 
DR3 -81.64 
DR4 -81.26 
DR5 -84.51 
DR6 -84.39 
DR7 -87.76 
DR8 -90.41 
DR9 -82.29 
D10 -76.01 
D11 -82.25 
ZINC17911992 -77.44 
 
Table 6 shows that small modifications of the ligand can lead to significant increase in 
binding energy. Further optimisation of this lead compound, and two other ones, was 
therefore performed with the use of the library of peptoids (see Section 4.2.4). 
 
 39 
4.2.3 Drug repositioning  
The by far most expensive and longest part of drug design process is the stage of the 
clinical trials. However, not all the drugs that have passed this phase are in use, either 
because of their limited therapeutic effect, or for other reasons such as marketing 
decisions of the pharmaceutical companies. It is also not unknown to use old drugs in 
new therapies. Examples include miltefosine, a drug initially intended for breast cancer 
and not proven successful in this respect, but now used for treating a parasitic disease 
visceral leishmaniasis; or thalidomide, the infamous hypnotic drug with teratogenic 
properties that found its new use as an immunomodulator in a variety of diseases 
[Aronson, 2007]. The compounds that have passed clinical tests have well-known 
toxicological and pharmacokinetic properties, safety profiles, and some are already 
approved for use in humans.  
The ZINC database [Irwin et al., 2012] contains a set of molecules approved by the US 
Food and Drug Agency (FDA), and this subset was also screened in search for 
thymidylate synthase inhibitors, both competitive (Table 4) and allosteric.  
Losartan (Figure 17), an angiotensin II receptor antagonist drug used mainly in the 
treatment of high blood pressure, ranked well as a potential allosteric inhibitor of TS, 
docked to the binding site described by Cardinale et al. with docking score of -85.87 
and large cluster of 18 conformations.  
 
Figure 17 Chemical structure of losartan 
It was therefore selected as a candidate for development. The molecule was 
parameterised according to the MD protocol described in Section 4.2.1 for hydroxyl 
analogues of dUMP, RESP charges were calculated and GAFF force field parameters 
assigned, and a 50-ns MD simulation of hTS-losartan complex in explicit TIP3P water 
was performed. Free energy of binding ∆Gtotal was estimated with MM-PBSA method 
(see Section 3.2.3) to be -52.4 ± 4.3 kcal/mol, which indicated that losartan may have 
inhibitory properties with respect to thymidylate synthase. More simulations are needed 
in order to estimate the behaviour of TS-losartan complex in the presence of the 
substrates. 
In vitro experiments with the aim to estimate inhibition of human TS by losartan are 
currently being conducted by the team of W. Rode in the Nencki Institute of 
Experimental Biology.  
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4.2.4 Peptidomimetics 
The use of polypeptides as drugs, despite many desirable attributes, is limited since they 
are in vivo rapidly degraded by proteases and may induce immune response. It is 
therefore necessary to find different chemical scaffolding that would function as peptide 
chains – peptidomimetics – and allow for the design of drugs with a structure similar to 
polypeptides, but resistant to proteases. 
Peptoids – N-substituted glycine oligomers – are compounds with backbone similar to 
peptides, in which the side chain is shifted to the main chain nitrogen atom and the main 
chain carbon atom remains achiral (Figure 18). The monomers are linked by polyimide 
bonds and lack the amide hydrogen, thus preventing the formation of hydrogen bonds 
that in peptides stabilise the secondary structure. 
 
Figure 18 Primary structure of peptoid (illustration from [Nandel and Saini, 2010]) 
 
Figure 19 Examples of the structures of “N-amino acids” compared to amino acids 
Unlike peptides (with the exception of peptide bonds to proline), peptoids may 
isomerise between cis and trans configuration of the amide bond (Figure 20), however, 
the interchange between configurations seems to be slower than receptor-ligand 
binding. Our initial computer simulations indicate that the cis-trans rotation rarely 
occurs in 300 K (Figure 21). In di- and tripeptoids studied experimentally by Sui et al. 
with the use of NMR spectroscopy, the population of cis conformation was about 35%. 
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Thus, a peptoid composed of n monomers may exist in solution as an equilibrium 
mixture of 2n-1 configurational isomers [Sui et al., 2007]. 
 
Figure 20 Cis and trans configuration of peptoid (illustration from [Sui et al., 2007]) 
 
Figure 21 Molecular dynamics run (20 ns) in 900 (black), 600 (red) and 300 (green) K for the 
molecules with peptide bond and peptoid bond, Ca-C-N-Ca dihedral angle shown. Rotation around 
the peptoid bond occurs to a significant degree only in 900 K. 
Computer simulations made by Nandel and Saini show that polypeptoid models adopt 
degenerate helical structures stabilised by carbonyl interactions. Apart from the use in 
drug design, these structures may also be useful in the design of surfactant molecules 
[Nandel and Saini, 2010]. 
Peptoids with various side chains are relatively easy to synthesise and that, together 
with the properties described above, makes them attractive targets for drug design. For 
example, it might be possible to design and synthesise peptoid molecules on the basis of 
peptides that inhibit thymidylate synthase in vitro, described in [Cardinale et al., 2011].  
4.2.4.1 Library of peptoids 
The library of peptoids is a project carried out in cooperation with Dr. Agnieszka 
Bronowska (Heidelberg Institute for Theoretical Studies). The goal of this project was 
to create a library of N-substituted glycine units (“peptoids”), together with RESP 
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charges and PARM99 parameters, in the same way as amino acid units in Amber suite 
are constructed. These peptoid monomers can be connected to each other, which allows 
for easy “building” of putative ligands for docking and molecular dynamics studies. In 
this way, hypotheses on new peptidomimetic drugs can be easily tested in silico, leading 
to new, promising ligands that may be synthesised and tested experimentally.  
Analogues of all proteinogenic amino acids present in eukaryotes were constructed, 
with the exception of glycine, which has no side chain, and proline, which is itself a 
secondary amine. Cysteine was included in two forms: regular protonated cysteine and 
cysteine involved in disulphide bridges and other bonds. 
Nineteen structures of peptoid amino acid analogues were built with groups added to the 
ends: N-terminal COCH3 group and C-terminal NHCH3 group. The template structure is 
shown on Figure 22, where R denotes a side chain corresponding to the one present in 
the respective amino acid. All structures were in trans configuration. Additionally, 
calculations for cis-NAla and cis-NSer were performed in order to compare results and 
prove that the use of only one set of charges was justified. 
NHCH3R
COCH3
N C
O
 
Figure 22 Initial structure of peptoid monomers used for geometry and RESP charges calculation 
For all structures, geometry optimisation was performed with Gaussian09 suite 
[Gaussian09] at HF/6-31G* level, and charges fit to the electrostatic potential at the 
points selected according to the Merz-Singh-Kollman scheme were calculated. Then 
RESP charges were fitted with Antechamber programme (part of the Amber 11 suite 
[Amber11]), and Amber (PARM99 modified with frcmod.ff99SB) atom types were 
assigned so that the atom types corresponded to the ones known from the amino acids 
library.  
Finally, the COCH3 and NHCH3 groups were truncated. If the unit lacked Amber angle 
or dihedral parameters due to an atom configuration not found in PARM99 data set, 
these parameters were assigned according to GAFF data set for atoms of the relevant 
type. The Amber library files for each unit were edited with respect to connectivity so 
that amide-N and carbonyl-C atoms, where the COCH3 and NHCH3 groups previously 
were (as shown in Figure 22), were assigned “head” and “tail” attributes, respectively.  
Using these units, it is easy to build peptoid chains with Leap programme (part of the 
Amber 11 suite), ready for further simulations.  
The following naming convention for the new residues was adopted. All the units are 
named NTZ, where N denotes peptoid unit, T – trans configuration (C would be cis 
configuration), and Z is an one-letter symbol of the corresponding amino acid.  
Thus, charges and parameters were derived for the following residues: NTA, NTC, 
NTD, NTE, NTF, NTH, NTI, NTK, NTL, NTM, NTN, NTQ, NTR, NTS, NTT, NTV, 
NTW, NTX (disulphide bridge NCys), and NTY.  
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4.2.4.2 Further optimisation of the most promising compounds docked 
to the allosteric pocket of TS 
From the compounds in Table 5, two were initially selected for further optimisation 
with the use of the library of peptoids: best scoring ZINC17911992 (already mentioned 
in Section 4.2.2), and ZINC71810038, suggested as a leading compound suitable for 
further modifications by a medicinal chemist (Figure 23). 
 
Figure 23 Compounds subject to further optimisation with the use of peptoid library 
Derivatives of the ZINC71810038 molecule 
On the basis of this compound, according to the suggestions of medicinal chemistry 
experts (informal discussions with Prof. M. Auer and his co-workers), eighteen 
molecules were constructed of the formula B2Z, where Z denoted a corresponding 
amino acid side chain, and B2 – a bulky molecular group, derivative of ZINC71810038 
compound. An example with N-lysine side chain (B2K) is shown in Figure 24. 
 
Figure 24 The structure of B2K molecule. The N-lysine side chain is marked green 
The resulting docking scores are shown in Table 7. The suggested modifications 
improve the binding properties of the compound.  
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Table 7 Potential leads (allosteric) based on ZINC71810038 modified with amino acid 
side chains 
Name DOCK Score 
B2A -73.30 
B2C -75.78 
B2D -79.92 
B2E -79.62 
B2F -78.02 
B2H -73.41 
B2I -77.36 
B2K -88.91 
B2L -80.38 
B2M -80.43 
B2N -78.34 
B2Q -76.23 
B2R -80.06 
B2S -74.86 
B2T -76.81 
B2V -77.25 
B2W -84.44 
B2Y -82.62 
 
A combinatorial set of peptidomimetic ligands for thymidylate synthase: 
derivatives of ZINC17911992 molecule 
As the results of the modifications of ZINC17911992 molecule were promising (Table 
6), this approach was taken further and a series of over 300 combinatorially modified 
structures with short, two-peptoid chains was designed (Figure 25). An example of the 
series is shown in Figure 26. 
 
Figure 25 Scheme of the set. R1 and R2 denote amino acid side chains 
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Figure 26  Example of P–R1–R2–B series of ligands: PFSB; CH3(dark blue)–NPhe(blue)–
NSer(yellow)–B(red). B denotes the bulky “tail” from the ZINC17911992 molecule 
The series of 324 ligands was then docked to the allosteric pocket of thymidylate 
synthase, and the best 30 results are presented in Table 8. 
Table 8 Potential leads (allosteric) among combinatorially modified ligand series based 
on ZINC17911992. Best results are highlighted.  
Sequence Score Sequence Score 
PKTB -102.18 PKFB -109.63 
PKVB -109.21 PHKB -133.88 
PKSB -97.55 PKKB -127.85 
PKLB -111.44 PKDB -99.50 
PKAB -110.85 PEKB -97.93 
PKDB -111.51 PFKB -97.14 
PKRB -100.65 PIKB -97.91 
PKCB -100.61 PKQB -96.89 
PKNB -109.13 PFRB -96.66 
PKMB -104.04 PERB -95.53 
PKHB -100.31 PHRB -95.63 
PKYB -107.28 PDKB -95.98 
PKWB -99.62 PLKB -98.42 
PKEB -103.62 PLRB -95.02 
PKIB -95.68 PMKB -96.79 
 
The reference score for these compounds is the LSCQLYQR peptide (calculated as 
-107.93), docked to the same allosteric pocket, which is a TS inhibitor in vitro 
[Cardinale et al., 2012].  
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The best scoring ligands will be further investigated in molecular dynamics simulations 
with the use of the library of peptoids we created.  
5 Other work 
The author’s scientific interests involved also quantum chemical calculations with the 
aim to better understand and interpret experimental results. Several papers have been 
published in this regard, presented here in approximately chronological order and 
attached to the dissertation.  
5.1 DFT studies of interactions between nucleic acid bases 
To understand molecular aspects of genetic processes, it is important to gain data on the 
interaction energy between nucleic acids in different mutual arrangements, and on the 
barriers of transition from one arrangement to another. Experiments usually only yield 
information on equilibrium states; it is therefore necessary to use computational 
methods to predict geometries and interaction energies for the local minima on the 
potential energy surface of base pairs. In the work carried out with V.I Poltev, V.I 
Danilov, A. Leś et al. local minima for DNA fragments of various size – from base 
pairs to deoxydinucleoside monophosphate anions – were found with molecular 
mechanics calculations and then investigated thoroughly by DFT studies. It was 
concluded that the parallel arrangement of the bases in B-like single-stranded nucleic 
acid conformations is dictated by the sugar-phosphate backbone rather than by the 
“stacking” interaction between base rings. Moreover, the results indicate that the nearly 
parallel arrangement of the base rings is already present in the single DNA strand 
[Poltev et al., 2008; Poltev et al., 2009] (Full text in Appendices 2 and 3).  
5.2 Boron analogues of nucleosides 
Computational analysis of the regio- and chemoselectivity of N-vinylurea and its 
derivatives in the synthesis of novel 5,6-dihydroborauracil derivatives 
Boron analogues of biologically active compounds have interesting properties, 
supposedly associated with the electron deficiency of sp2 boron moiety that may bind to 
an enzyme, which would lead to the formation of a stable sp3 „boronate” complex and 
the inhibition of the enzyme. In addition to this, boron-containing compounds can be 
useful in boron-neutron capture therapy (BCNT). Borauracils, borathymines or 
boracytosines, and their derivatives, could play an important role in the search for new 
biologically active compounds, e.g. anticancer drugs. However, to date only a few 
boron analogues of nucleic acid bases are known. 
In the work of T. Ruman et al. (2009) the synthesis of novel boron compounds – 
5,6-saturated borauracil derivatives (4-bromo-5,6-dihydroborauracil, 4-hydroxy-5,6-
dihydroborauracil and 4-methoxy-5,6-dihydroborauracil) is presented along with the 
synthesis of other boron compounds from N-vinylurea.  
The computational part of this work concerned the selectivity of the substrates, 
N-vinylurea and its derivatives, in hydroboration reaction. The calculated natural 
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charges indicate that, in agreement with the experimental results, the partially negative 
hydrogen atom of the borane complex should attack the carbonyl carbon of N-vinylurea, 
which confirms the proposed mechanism of the reaction. The theoretical (DFT) 
calculations were performed in Gaussian03 suite at the B3LYP/aug-cc-pVTZ level. The 
electronic density distribution has been analysed with the use of the NBO 5.G module 
also implemented in Gaussian03 [Ruman et al., 2009a] (Full text in Appendix 4). 
Calculation of 1H NMR parameters of the hydroxyborohydride anion 
The team of T. Ruman et al. (Rzeszow University of Technology) described a fast, 
economic method of the synthesis of sodium and potassium salts of 
hydroxyborohydride (BH3OH)– anion. The 1H NMR spectrum of (BH3OH)– was 
recorded for the first time and NMR studies showed higher reactivity of 
hydroxyborohydride towards acetone carbonyl than borohydride.  
The calculations conducted by the author of the dissertation and Prof. A. Leś involved 
computations of spin-spin coupling constants 1J(B–H) for (BH3OH)–, (BH3OH)Na, 
BH4–, BH3, and B2H6 at the B3LYP/aug-cc-pVTZ level. Good agreement with 
experimental data confirmed the hypothesis that the (BH3OH)– anion was detected as an 
individual species in the solution. The new, high yield synthetic route of 
hydroxyborohydride salts makes them attractive as reagents [Ruman et al., 2007] (Full 
text in Appendix 5). 
5.3 Modification of stavudine 
DFT calculations of the geometric and electronic properties of the tetrahedral 
boric acid complexes – derivatives of stavudine 
Stavudine (2’,3’-didehydro-3’-deoxythymidine, Figure 27) is a synthetic analogue of 
thymidine approved for use in the European Union and USA for treatment of HIV 
infections in combination with other antiretroviral compounds.  
 
Figure 27 Stavudine 
The active form of the drug, stavudine 5’-triphosphate, is a competitive vs. dTTP 
inhibitor of HIV nucleoside reverse transcriptase that causes the termination of DNA 
polymerisation. In search of new antiretroviral compounds, two boron-containing 
analogues of stavudine 5’-phosphate were synthesised (Figure 28). In these compounds, 
in place of the phosphate group, the boron moiety forms complexes in which an 
additional electron pair donor coordinates to boron atom, and the resulting slightly 
distorted tetrahedral group mimics the geometric and electronic properties of the 
phosphate group. This could possibly improve the cell wall transfer properties and 
increase the bioavailability of stavudine. 
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Figure 28 Boron-containing derivatives of stavudine 
Compound 2 was synthesised by direct reaction of stavudine (also synthesised during 
this study) with large excess of pinacolborane (4,4,5,5-tetramethyl-
[1,3,2]dioxaborolane), and compound 3 was formed in the reaction of stavudine with 
borane-dimethylsulphide complex, followed by hydrolysis of the resulting hydride 
compound 5’–CH2–O–BH2. The 11B spectra of 2 and 3, recorded in non-coordinating 
solvent, show broad resonances at 22.4 and 17.8 ppm, respectively, in accordance to the 
previously known data. Addition of H2O into the NMR tube containing the compound 2 
resulted in an upfield shift of 11B resonance up to –11.2 ppm. This is caused by the 
formation of a stable eight-electron, tetrahedral adduct as a result of the coordination of 
an electron pair donor (such as water, thiol, amine, alcohol, hydroxyl anion, or 
carboxylate anion) to the positively polarised boron atom. Similar behaviour was also 
observed when H2O was added to 3. No significant changes were observed in the 1H 
NMR spectrum during H2O titration, which indicates the lack of side reactions. 
These tetrahedral boron moieties were considered to be potentially capable of 
mimicking the steric and electronic properties of the phosphate group. In order to test 
this hypothesis, DFT calculations were performed at B3LYP/LANL2DZ level with the 
use of Gaussian 03 suite. In the course of these calculations, three models of 
5’-CH2-O-X, representing stavudine and two adducts of the compound 3, were taken 
into account (Figure 29).  
 
Figure 29 The models of stavudine-5'-CH2-O-X (nucleoside group is truncated and replaced with 
methyl group); X=phosphate (left), –B(OH)3 (middle), and –B(OH)2:NH2CH3 (right); geometries 
after optimisation 
The geometries were optimised and Merz-Kollman ESP charges and molecular volume 
calculated. All models adopt tetrahedral geometry with similar bond lengths (slightly 
shorter in the case of borane moieties) and angles. The values of atomic charges and 
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molecular volumes are also close. The comparison between phosphate and borane 
moieties suggests that their local properties should lead to similar short- and long-range 
interactions with the environment [Ruman et al., 2010a] (Full text in Appendix 6).  
 
5.4 Non-enzymatic modifications of thymidylate synthase 
Thiophosphoramidates as agents for studies on 
phosphorylation/dephosphorylation of proteins  
The use of thiophosphate compounds offers insight into the processes of 
phosphorylation of amino acids. Compared to phosphates, thiophosphates have an 
additional centre of chirality on phosphorus, are more stable towards chemical and 
enzymatic hydrolysis, and are easier to detect by analytical methods. The preparation of 
thiophosphoramidate-modified biomolecules under mild conditions that preserve 
protein structure could be useful for studying the biological function of the 
corresponding phosphoramidates.  
The team of T. Ruman et al. performed the synthesis of 15N-thiophosphoramidates 
(potassium and diammonium salts), and tested their 15N and 31P NMR properties as well 
as potential to thiophosphorylate histidine, thymidine, glucose and 2-deoxyribose.  
 
Figure 30   15N-enriched potassium thiophosphoramidate 
A series of DFT calculations was conducted in order to estimate the 31P NMR chemical 
shifts of thiophosphoramidates by analysing electronic shielding of 
thiophosphoramidate and thiophosphate ions. The calculations were performed using 
Gaussian03 suite at the B3LYP/aug-cc-pVTZ level. The aim was to estimate trends 
rather than reproduce exact values of NMR parameters, which in the case of 31P NMR 
remains a long-term challenge. It was concluded that DFT methods can be useful in 
anticipating the NMR chemical shifts of newly synthesised thiophosphate compounds 
[Ruman et al., 2009b] (Full text in Appendix 7). 
Thiophosphorylation of free amino acids and enzyme thymidylate synthase 
Potassium and diammonium thiophosphoramidates in Tris- and ammonium carbonate 
based buffer solutions were used to thiophosphorylate free amino acids as well as 
recombinant human and C. elegans thymidylate synthase. This reaction environment 
proved to be non-destructive for protein function – the thiophosphorylation reaction 
lowered the enzyme activity by ~50% after 24 hours.  
A series of phosphorylated and thiophosphorylated amino acid derivatives was 
prepared, their 31P NMR spectra were recorded, and computational (DFT) estimations 
of chemical shifts were made in order to properly assign NMR resonances of the 
thiophosphorylated protein to particular thiophosphorylated amino acid side chains. The 
presence of thiophosphorylated Lys, Ser and His moieties was proven in this way. 
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Moreover, the 31P resonances of thiophosphorylated amino acids are shifted downfield 
by roughly 42 ppm on average, compared to the corresponding phosphate compounds, 
which allows for a rough estimate of chemical shift for a thiophosphate when this 
parameter for a corresponding phosphate is known.  
The DFT calculations (geometry optimisation and calculation of 31P NMR shielding 
constants) were again performed at the B3LYP/aug-cc-pVTZ level with Gaussian03 
suite. To save computational time, the structures of thiophosphorylated (TP) and 
phosphorylated (P) amino acids were truncated in the regions remote from the 
(thio)phosphate group (Figure 31). 
 
Figure 31 Models of phosphorylated (X=O) and thiophosphorylated (X=S) amino acids  
Due to the complexity of the interactions between the analysed compounds and buffer 
ingredients, and to the unreliability of concentration estimation of neutral, mono- and 
dianionic forms of phosphate in the solution, it is difficult to properly set a reference 
value for the calculation of 31P NMR chemical shift δP = σref – σx (σ being the isotropic 
shielding constant) with phosphoric acid as a reference compound. Moreover, as 
mentioned before, the calculations of shielding constants with the method used give a 
trend assessment rather than exact values. Thus, chemical shifts were first estimated as 
differences between the calculated isotropic shielding constants for neutral forms of P- 
or TP-amino acids and non-dissociated H3PO4. Then, after comparison with 
experimental results available for TP-His, TP-Lys, and TP-Ser, an additional factor of 
33.7 ppm was subtracted from all calculated chemical shifts. This way, values of 31P 
chemical shifts were suggested for TP-Arg and TP-Thr, for which experimental data 
were not available. In addition to this, the results for TP-Cys indicated the presence of 
both “thione” (P=S) and “thiol” (P-SH) tautomeric forms.  
The experimental and computational results outlined above enabled the identification of 
thiophosphorylated lysine, serine and histidine moieties in the thiophosphorylated 
recombinant thymidylate synthase. Methods presented in the paper can be useful in 
predicting 31P NMR chemical shifts of thiophosphorylated compounds [Ruman et al., 
2010b] (Full text in Appendix 8). 
Studies on tyrosine nitration of thymidylate synthase 
Nitration of protein tyrosine appears endogenously in diseases involving increased 
biosynthesis of NO, including cancer. This reaction may lead to the loss or gain of 
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activity of the protein. The effect of thymidylate synthase nitration was studied with 
respect to kinetic and physicochemical (NMR and MS) properties, on human, mouse 
and C. elegans recombinant TSes, nitrated in vitro. In order to interpret the obtained 
NMR resonances, model tripeptides of a general formula H2N-Gly-X-Gly-COOH were 
nitrated and analysed by NMR spectroscopy, with X=Phe, Tyr, Trp, Lys, Arg, His, Ser, 
Thr, Cys, and Gly. Theoretical calculations of 15N NMR chemical shifts for the models 
of the nitrated amino acids were also performed in the same way as described above for 
the calculations of 31P NMR parameters, using truncated models (see Fig. 3 and Table 1 
in Appendix 9), and the results were compared to experimental spectra.  
The nitration of TS did not seem to influence binding to dUMP, FdUMP or mTHF, as 
reflected by Km values, however, the enzyme catalytic potency was affected, with 2-fold 
decrease of Vmaxapp.  
The comparison of NMR parameters of nitrated thymidylate synthase with the NMR 
analysis of model tripeptides, as well as the results of MS experiments, allowed for the 
identification of nitrated tyrosine. The presence of other nitrated moieties could not be 
confirmed [Dąbrowska-Maś et al., 2012] (Full text in Appendix 9). 
 
6 Discussion, conclusions and future outlook 
Rationalisation of observed binding properties of a set of dUMP analogues to 
thymidylate synthase 
Three selected analogues of dUMP, substituted at C5 position with small functional 
groups: –OH, –CH2OH, and –OCH3, were investigated computationally. The dynamical 
behaviour of the ternary complexes comprising of thymidylate synthase monomeric 
unit, the cofactor methylenetetrahydrofolate in its active, open form, and the ligand, was 
analysed in the course of 20 ns molecular dynamics runs. For comparison and 
verification of the results, analogical calculations with dUMP and a known TS inhibitor, 
FdUMP, were also performed. The estimation of binding energies (enthalpic 
contribution) made with the use of MM-PBSA method (Table 1) agreed qualitatively 
with the experimental results given according to [Jarmuła et al., 2000]. Apart from the 
fluorouracil derivative, the most strongly bound and most ordered ligand in the active 
site is dUMP-OH. Figure 14 shows the impact of hydrogen bonds network on the 
ligand/protein binding capabilities. The more bulky and flexible substituent –CH2OH 
remains less ordered and the binding is weaker, as is in the case of –OCH3 substituent 
which has no additional hydrogen bonds. The obtained results of the molecular 
simulations strongly indicate that these factors – namely, the size of the substituent and 
its hydrogen bonding ability – affect heavily the binding properties of these ligands. 
Qualitative agreement between experimental and computational data gives confidence 
in the conclusions made of the simulation results. Therefore, these should be taken into 
account during the design of new, C5-substituted uracil analogues intended as inhibitors 
of thymidylate synthase or agents for enzyme-catalysed therapies. 
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Allosteric inhibition of TS as an alternative to overcome drug resistance  
In addition to causing some adverse effects, the known orthosteric, i.e. active site 
inhibitors of thymidylate synthase, may induce drug resistance. Human thymidylate 
synthase is believed to be self-regulated by binding with its own mRNA when the 
ligands are not bound. It is postulated that due to conformational change upon ligand 
binding the TS loses this self-regulation capacity, which in turn leads to the 
overexpression of the protein (see Section 1.2.5). Moreover, the efficiency of TS 
degradation decreases when the ligands remain bound. As an alternative to competitive 
inhibitors, allosteric thymidylate synthase inhibitors that bind to another site, e.g. at the 
dimer interface, are investigated. These compounds preferably would prevent the 
ligands from entering the active site of the protein without disrupting self-regulation. 
A putative allosteric binding site at the TS dimer interface was found by Cardinale et al. 
(2011). The available X-ray structures showing ligands binding to this site include a TS-
peptide complex described in [Cardinale et al., 2011], PDB access code 3N5E, and a 
TS-purpurogallin complex (Celeste and Lebioda, unpublished work, PDB access code 
4GD7). 
In the course of this work a plethora of ligands binding to the above described site was 
investigated computationally in order to select promising candidates for further 
optimisation and experimental studies. The compounds under study included existing 
drugs, prodrugs and naturally occurring compounds from databases such as ZINC and 
Afro-DB, and newly designed compounds (peptidomimetics). 
Peptoids as allosteric TS inhibitors 
Peptoids (see Section 4.2.4) were brought into drug discovery projects in the early 
1990s and they remain a developing class of peptidomimetics since then. While 
peptides and their binding to therapeutically-relevant protein targets are well-studied in 
the framework of medicinal chemistry and drug design, the development of peptide-
based therapeutics is hindered by their poor absorption, in vivo degradation due to 
proteolytic digestion, rapid clearance, and their potential for aggregation, misfolding, 
and immunogenicity. Unlike peptides, peptoids are resistant to denaturation due to their 
lack of backbone H-bonds, and are very straightforward to synthesise, with readily 
available (and cheap) precursors and lack of chirality in the backbone. Yet their side 
chains may – if required – resemble very closely those of peptides and proteins. Thus, 
peptoids have demonstrated usefulness for medicinal chemistry as protein mimics and 
as potential replacements for small-molecule drugs. 
In the recent years, several applications of short peptoids as potent antimicrobial and 
anticancer agents have been reported. For instance, Chongsiriwatana et al. (2011) 
published the synthesis and evaluation of peptoid analogue of antimicrobial lipopeptides 
with alkyl chains, consisting of only 5 peptoid monomers, with selective, broad-
spectrum antimicrobial activity, and as potent as the antimicrobial peptide pexiganan, 
which is a 22-residue long analogue of magainin-2 [Chongsiriwatana et al. (2011)]. 
Earlier, Mas-Moruno et al. (2007) reported the design of libraries of small peptoids with 
antiproliferative activity against representative human neoplastic cell lines. These were 
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synthesized and successfully assayed for their biological activity [Mas-Moruno et al., 
2007]. These peptoids were found cytotoxic and were reported to be the smallest 
peptidomimetics with such activity. Due to their properties, these compounds did not 
suffer from diketopiperazines (DKP) formation, a problematic side reaction typically 
observed in peptide synthesis. Moreover, these peptoids were conveniently synthesized 
on a solid surface (BAL resin). 
Therefore, the idea of using peptoids as allosteric inhibitors of TS is very appealing.  
The screening of compounds from ZINC database also revealed several peptoid 
compounds that can be a basis for optimisation and design of novel drugs (see Table 5 
and Section 4.2.4). 
Virtual screening of FDA-approved drugs and peptoid ligands present in ZINC 
database 
Molecular docking studies conducted in order to find new candidates for TS inhibitors, 
both orthosteric and allosteric, involved over eight thousand compounds (see Section 
4.2.2), among which were around fifteen hundred FDA-approved drugs and 
nutriceuticals, and a similar number of natural products from AfroDB and NuBBE 
databases. The docking procedure was calibrated with the use of known TS inhibitors 
and non-binding compounds, and in the case of compounds targeting the allosteric site, 
the reference structure was the complex of human TS bound to a short peptide, 
described by Cardinale et al. (2011).  
This extensive screening resulted in many hits (see Tables in Section 4.2.2), some of 
which were further optimised (results shown e.g. in Table 6 and Section 4.2.4, Table 8) 
and yielded promising leads for more thorough molecular dynamics studies and 
experiment.  
Drug repositioning is also an important part of the drug design process. A promising hit 
from FDA-approved set, losartan – a drug used in the treatment high blood pressure – 
was investigated more thoroughly as a putative allosteric inhibitor of thymidylate 
synthase, by molecular dynamics simulations (see Section 4.2.3).  
Peptoids as building blocks for rational drug design 
While molecular simulations of peptides and proteins are standard and all molecular 
simulation packages have implemented tools to perform those, relatively few tools 
suitable for simulations of peptoids and peptoid-protein systems are available. 
A set of model peptoid structures, studied by Butterfoss et al. using QM methods, as 
well as three experimentally determined peptoids, were simulated using Amber force 
fields [Butterfoss et al., 2009, Voelz et al., 2011]. Their results showed that Amber 
force fields, when used with a GBSA implicit solvation model, successfully reproduced 
the peptoid torsional landscape as well as the major conformers of known peptoid 
structures. 
Very recently, Mirijanian et al. published an atomistic force field for peptoids 
implemented in the CHARMM22 package [Mirijanian et al., 2014]. In their work, the 
key parameters for peptoids were adjusted to match both experimental data and 
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quantum mechanical calculations for two model peptoid systems – namely, disarcosine 
and dimethylacetamide. 
Despite these encouraging reports, none of the published works to date reported on the 
development of a set of standard, residue-like building peptoid blocks, suitable for 
setting up the molecular simulations, in a manner similar to peptides, proteins, and 
nucleic acids.  
The results presented in this dissertation cover this need and herein the collection of 
ready-to-use peptoid residues, with charges fitted and atom parameters assigned, is 
reported. These additional parameters have been developed for Amber package 
(AMBER11 version and beyond) and can be used standalone as well as in peptoid-
peptide and peptoid-protein systems.  
The test MD simulations performed in explicit (TIP3P) as well as implicit (GB) solvents 
correctly predicted the structure of cyclic peptoid octamers: 8-sarcosine and 
cyclosporine A (in a complex with cyclophilin B) to an accuracy of 1.2 Å backbone 
RMSD. 
Overall, these results show that currently available molecular modelling techniques can 
successfully perform de novo structure prediction of short peptoids and reliably study 
the dynamics and binding of peptoid ligands to their cognate protein receptors. 
Moreover, the results reported herein provide a potentially valuable tool for the rational 
design of drug-like peptoids with desired structural and dynamic properties. 
“Combinatorial” improvement of the leads selected from ZINC database  
Around 300 compounds with peptoid bonds found in the ZINC database were docked to 
the dimer interface to select potential allosteric inhibitors of thymidylate synthase. 
Several leads for synthesis and further development were selected (Table 5 in Section 
4.2.2). Two selected compounds were then optimised combinatorially by adding amino 
acid side chains to peptoid units (Section 4.2.4.2). This optimisation procedure led to 
significant improvement of docking scores for several derivatives of the original 
compounds (Table 8). In order to assess computationally the actual inhibitory potential 
of the selected derivatives, molecular dynamics simulations are required. Setting up of 
these simulations will be easy with the use of the library of peptoids that was developed 
in the course of this work (Section 4.2.4.1). This set of parameters for Amber (and other 
molecular dynamics packages where Amber force fields are used) comprises of 19 
peptoid analogues of amino acids that can be used as “building blocks” for quick 
construction and parameterisation of peptidomimetic structures for the purposes of 
molecular dynamics simulations, in the same way as peptide chains are constructed in 
Amber.  
Molecular dynamics simulations set up with the use of the above mentioned library of 
peptoids will be performed for complexes of TS with several peptoid ligands selected 
through combinatorial improvement and molecular docking procedure described in 
Section 4.2.4. 
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Quantum mechanical studies  
The development of modern computational tools – e.g. numerical methods such as 
linear scaling algorithms, or semiempirical methods – made feasible the studies of even 
large systems at the quantum mechanics level. The ab initio QM methods also have 
numerous applications in the field of studying biological molecules. In this work they 
were essential for setting up molecular dynamics simulations (determination of atomic 
charges, see Sections 3.2.2 and 4.2.1), and in studying reaction mechanisms in small 
models as well as in a QM/MM setting, where the active centre of the enzyme is 
subjected to QM calculations and the surrounding protein is studied with semi-empirical 
or MM methods (Section 4.1). Moreover, QM calculations are useful in predicting 
NMR parameters of newly synthesised compounds and therefore in the identification of 
the product of a reaction such as thiophosphorylation or nitration of the protein (Section 
5.4). In this case, the use of a relatively quick DFT method (B3LYP/aug-cc-pVTZ) 
applied to the truncated models of molecules under study allowed for a qualitative 
assessment of NMR parameters of the products of a reaction and contributed to the 
identification of these products.  
Most experimental methods, with the exception of X-ray analysis, do not yield 
information on the geometry of the reagents and on interaction energies of the 
individual components of the system. Quantum mechanical calculations, in particular 
DFT methods, may fill these gaps in the understanding of processes in biological 
systems. In the course of this work the geometry as well as the potential short-range 
interactions (atomic charges, molecular volume) of novel boron-containing derivatives 
of stavudine was studied computationally (Section 5.3), complementing experimental 
results.  
QM methods are also essential in the theoretical studies on nucleic acids. They enable 
an assessment of the interactions between nucleic acid bases in DNA, giving 
information on local minima of geometry, mutual arrangements of the bases, and on the 
stability of the DNA strands (Section 5.1). 
Conclusion 
Computational methods of chemistry, from ab initio QM calculations to large-scale 
molecular dynamics simulations and high-throughput molecular docking protocols, 
found their use in studying biochemical processes and rational drug design. In this 
dissertation an overview of some of these uses is presented in relation to the enzyme 
thymidylate synthase and the search of therapies for TS-related cancers. Molecular 
docking studies can help in finding drug candidates for further development; the library 
of peptoids is intended to facilitate the development of novel peptidomimetic 
compounds with therapeutic potential; molecular dynamics simulations are needed to 
investigate the studied compounds thoroughly and establish the dynamics, binding 
properties and mutual arrangements of the components of the system; and ab initio 
quantum mechanical calculations allow for investigating the processes of interest at the 
atomic level and contribute to the interpretation of the experimental data.  
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Hypothesis of a proton switch in QM/MM modelling of interaction of dUMP analogues
with thymidylate synthase
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Quantum mechanical, molecular mechanics and molecular dynamics (MD) methods were used to investigate initial steps of
20-deoxyuridine-50-monophosphate (dUMP) methylation catalysed by the thymidylate synthase (TS) enzyme. The amino
acid residues surrounding the active site within a 10 A˚ radius sphere were modelled with the combined quantum mechanical
(B3LYP/LANL2DZ) and molecular mechanics ONIOM double-layer method. The results indicated the initial nucleophilic
attack of Cys146 on dUMP to be concerted with formation of a hydrogen bond to the oxygen O4 of dUMP. Moreover, the
proton in the vicinity of the O4 atom appears to act as a ‘proton switch’: if a proton is present near O4, it stabilises the
S(Cys146)ZC6(dUMP) sulphur–carbon bond, but if it is absent, the sulphur–carbon bond does not form. If the O4 oxygen
is replaced by sulphur atom, the ‘switch effect’ does not occur. The suggested correlation between the strength of hydrogen
bond involving O4 oxygen and the ability of dUMP to form bonds at C6 corresponds well to the crystal structures of
TS complexes available in the Protein Data Bank. In the vast majority of crystal structures, the presence of the
S(Cys146)ZC6(dUMP) bond was coupled with the presence of hydrogen bond between the dUMP O4 atom and the
conserved Asn177. The ‘proton switch’ hypothesis is supported also by the results of MD studies of TS binary complexes,
suggesting that average distance separating S(Cys146) and C6(dUMP) becomes distinctly shorter in the presence of
hydrogen bonding between Asn177 and O4.
Keywords: thymidylate synthase; dUMP; methylenetetrahydrofolate; density functional theory
1. Introduction
Thymidylate synthase (TS, EC 2.1.1.45) is an enzyme
catalysing the C(5) methylation of 20-deoxyuridine-50-
monophosphate (dUMP) to 20-deoxythymidine-50-mono-
phosphate with concerted conversion of the cofactor,
methylenetetrahydrofolate (MTF), to dihydrofolate [1].
This reaction is the sole pathway of de novo thymine
synthesis in a cell and is a target in chemotherapy [2–5], in
particular therapy involving fluoro-pyrimidine drugs [6,7].
Basic structure of the ternary complex TS–dUMP–MTF
is presented in Figure 1.
The reaction of TS catalysis is initiated by the
nucleophilic addition of the active site cysteine (CYS 146)
to the pyrimidine C(6) atom of dUMP. It is believed that
at this stage the negative charge of cysteine residue is
delocalised, probably towards the C(4)vO of dUMP,
forming the corresponding enolate anion at the C(4)ZO(4)
moiety. It is believed that due to resonance between
C(4)vO(4), C(4)ZC(5) and C(5)vC(6) bonds, the C(5)
atom becomes negative enough to allow for a consecutive
attack of the methylene residue which takes the form of an
iminium cation created through the opening of imidazol-
idine ring of the cofactor [8].
A strong TS inhibitor, 5-fluoro-dUMP (FdUMP), is the
active form of 5-fluorouracil and 5-fluoro-20-deoxyuridine –
drugs used in antitumour chemotherapy. The inhibition
mechanism involves time-dependent formation of a ternary,
covalently bound complex of the enzyme with FdUMP and
N5,10-MTF. As the complex is formed, the reaction stops,
resulting in a slowly reversible inactivation of the enzyme.
The substitution of the C(4)vO group in FdUMP
pyrimidine ring by either C(4)vNZOH group (in N4-
hydroxy-5-fluoro-20-deoxycytidine-50-monophosphate; N4-
OH-FdCMP) or C(4)vS group (in 4-thio-FdUMP)
preserves high inhibitory potency, but alters selectivity of
inhibition [9–11].
It is assumed that dUMP pyrimidine C(4)vO and non-
dissociated N(3)ZH groups are vital for the specific
binding of pyrimidine moiety by the enzyme through
active site asparagine residue (Asn177) and an ordered
water molecule [12,13]. The assumption is that the
asparagine residue stabilises, by hydrogen bonding, the
partial negative charge on O4 of covalently bound dUMP
[14]. This suggests an explanation of TS active site
discrimination between dUMP and dCMP. As it is shown,
strong mechanism-based inactivation by FdUMP or 4-
thio-FdUMP of TS depends on the fact that N(3)ZH group
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remains non-dissociated [15], hence it appears that the
active site Asn177 is involved in the interaction. The same
is probably true for N4ZOHZFdCMP [8].
In order to learn more about the mechanism of
interactions of dUMP and its 5-substituted analogues
[FdUMP and 5-OH-dUMP (dUMP-OH)] with TS, and
the role of 4-thio substitution in those interactions, the
combined quantum mechanical and molecular mechanics
modelling study was attempted and relevant data from
molecular dynamics (MD) simulations of the structures of
binary TS complexes with various other dUMP analogues,
substituted at the C5 position in the base and/or in the C20
position in the sugar, are presented. Findings from the
computational work were compared with crystal struc-
tures of TS complexes available in the Protein Data
Bank (PDB).
The numbering of residues of Escherichia coli TS
is used in this work. The corresponding numbering of
Lactobacillus casei TS is occasionally provided in
parentheses.
The ‘switch effect’ hypothesis developed here can be
summarised as follows: screening of the partial negative
charge of O4 originating from the Cys146 attack on dUMP
facilitates the formation of C6ZS carbon–sulphur bond
(so-to-say: no screening, no bond).
2. Method
2.1 Models of the active site
The active site of an enzyme contains the catalytic and
binding sites. The structure and chemical properties of the
active site allow for the recognition and binding of the
substrate.
In other words, the active site is usually a small pocket
at the surface of the enzyme, which contains residues
responsible for the substrate specificity and catalytic
residues that often act as proton donors or acceptors or are
responsible for binding of a cofactor.
The X-ray diffraction structure of the monomer A of
E. coli thymidylate synthase (ECTS) complexed with
dUMP and MTF (PDB accession code 1KZI [16]) was
used as the starting point for the calculations.
The hydrogen at C5 of dUMP was replaced either with
fluorine, giving FdUMP, or with the hydroxyl group,
giving dUMP-OH. The water molecules were removed
from the X-ray structure.
Several models of different size that simulated the
active site were considered. The small model, denoted as
5A model, was prepared by removing atoms farther than
5 A˚ from the S atom of CYS 146 residue, with the
exception of atoms involved in non-peptidic bonds, which
were included in the model. For the larger systems,
denoted as 10A model, a similar procedure with the cut-off
radius of 10 A˚ was adopted.
The residues included in our active site are consistent
with the ones referred to in the literature [17]. In the
5A model of the active site, the following residues were
included: TYR 94, LEU 143, ALA 144, PRO 145, CYS
146, HIS 147, ARG 166 and dUMP-X. The MTF cofactor
was not included, as it is farther than 5 A˚ from the S atom
of CYS 146. Moreover, to avoid unnatural expansion of
the system, the border main chain atoms were frozen
during the following optimisation at the experimental
positions [18] (see Figure 2).
The 10A model contained the following residues: LEU
90, GLY 91, PRO 92, VAL 93, TYR 94, ALA 132, TRP
133, ASN 134,VAL 135, GLY 136, GLU 137, LEU 138,
ASP 139, LYS 140, MET 141, ALA 142, LEU 143, ALA
144, PRO 145, CYS 146, HIS 147, ALA 148, PHE 149,
LEU 163, TYR 164, GLN 165, ARG 166, SER 167, CYS
168, ASP 169, VAL 170, PHE 171, LEU 172, GLY 173,
Figure 1. Schematic diagram of the TS – dUMP – MTF
complex.
Figure 2. Schematic view of the 5A model. Fourteen atoms (C,
N and O) indicated by cyan-coloured marks were frozen during
the calculations to take the presence of the surrounding
enzymatic environment into account (colour online).
M. Fusaro et al.1060
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LEU 174, PRO 175, PHE 176, ASN 177, ILE 178, ALA
179, SER 180, TYR 181, TRP 201, THR 202, GLY
203, GLY 204, ASP 205, THR 206, HIS 207, LEU 208,
TYR 209, dUMP-X and MTF. In this case, also to avoid
unnatural expansion of the system, the main chain atoms of
the polypeptide were frozen in their experimental crystal-
lographic positions, as in the work of Torrent et al. [18].
The dangling bonds in the models were saturated with
hydrogen atoms.
The amino acid residues were modelled with the
GaussView 3.07 [19] in their standard protonation states,
adopting total charges of þ1 (ARG, HIS and LYS), 21
(ASP and GLN) or 0 (all remaining amino acids).
The MTF cofactor had total charge of þ1 and the
phosphate residue had total charge of 22 (ZPO4
22; 5A
model) or 21 (ZHPO4
2; 10A model).
In the 10A and 5A models, a covalent bond exists
between the S(Cys146) and C6 (dUMP) [16], and a proton
is bonded to O4 atom of dUMP.
The resulting total charge of all models was neutral,
since that allows for indirect simulation of the presence of
counterions in the real systems. All models were prepared
with the Chimera molecular visualisation program [20]
and GaussView software [19].
In order to investigate the factors involved in the first
step of the enzymatic reaction [17], i.e. the Michael
addition of CYS 146 to the dUMP residue, a small S model
was also created from a fragment of the 5A model, i.e. the
coordinates of the atoms present in this small model are
extracted from 1KZI PDB structure [16] (Figure 3). The S
model simulates the approach of protonated residue
(modelled as H3O
þ) towards the O4 oxygen of dUMP
bound to Cys146 (modelled as 1-methyl uracil-6-
mercaptopropane anion). The hydrogen atoms were
added to saturate bonds and two carbon atoms were
frozen during geometry optimisation to avoid unnatural
expansion of the system.
2.2 Calculations
For the 5A and S models, the initial geometries based on
literature data appropriately adapted were optimised with
constraints using the quantum mechanical density func-
tional theory with the B3LYP functional and the
LANL2DZ [21] atomic basis set. The 5A models consist
of 157 or 158 atoms (the latter in the case of dUMP-OH).
In order to incorporate protein environment effects to a
larger extent, 10A models of the active site were also
investigated. These models were subjected to the
combined quantum mechanical/molecular mechanics
(QM/MM) routine with mechanical embedding (two-
layer ONIOM-ME) [22]. The internal part of the model
(containing the same residues as in the 5A model) was
investigated using the B3LYP/LANL2DZ method [18]
(the QM-layer), whereas molecular mechanics method,
employing the Amber force field [23], was applied for
studying the external part (the MM-layer). In total,
149(150) and 737 atoms were included in the QM and MM
layers, respectively.
All calculations were performed with the Gaussian 03
software [24]. The initial (before optimisation) and final
(after optimisation) geometries were compared using the
Tinker program [25].
3. Results
3.1 Active site geometry
The total QM/MM energies of the 5A and 10A models, as
well as the mass-weighted, all-heavy-atom root mean
square deviations (RMSD) between the initial and final
geometries, are presented in Table 1.
Table 1 shows that the energy differences between the
modelled systems depend almost entirely on the QM,
while very little on the MM, parts; the former differing
strongly from each other, while the latter agreeing very
closely.
The RMSD between initial and final geometries of the
10A models are less affected during the optimisations than
the corresponding RMSD in the 5A models due to more
rigorous constraints imposed (freezing of main chain
atoms in the 10A models vs. only border atoms in the 5A
models).
Figure 3. The S model of protonated residue approaching
dUMP bond to CYS 146. The geometry corresponds to the
transition state for proton movement. The atoms indicated by
cyan-coloured marks, C, N and O of water, were frozen during
the calculations.
Molecular Simulation 1061
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It was observed that during the geometry optimisation,
when the proton connected to the oxygen O4 atom was
removed (Figure 5), the distance separating the S (CYS 146)
and C6 (dUMP-X) atoms lengthened considerably with
respect to the initially assumed configuration (Figure 4).
This result suggests that the formation of the S(Cys146)Z
C6(dUMP) bond is correlated with the presence of a
hydrogen atom (or the formation of a strong hydrogen bond)
at the O4 position of dUMP. Additional computational
experiments showed that the SZC6 bond does not break if
the O4 atom of dUMP is replaced with a sulphur atom or a
thiol group. The SZC6 bond persists independently on the
presence or absence of hydrogen bond at S4.
We can hypothesise that the hydrogen atom bound to
the O4 atom of dUMP acts as a ‘proton switch’ stabilising
the S(CYS 146)ZC6 bond during the reaction. However,
if the O4 atom is replaced with vS or ZSH, the ‘switch
effect’ is absent (presumably due to different charge
distributions on the sulphur vs. oxygen atoms). The latter
effect seems to contribute to the previously observed
influence of the 4-thio substitution in FdUMP, consisting
in a different specificity of slow-binding inhibition by
4-thio-FdUMP (of TSs from various sources) as compared
to the specificity of inhibition by FdUMP [10].
Additional calculations showed that the ‘switch effect’
occurs also in C(5)-substituted analogues of dUMP, i.e.
when the hydrogen at the C5 position of dUMP is replaced
by one of the following functional groups: ZOH, ZF,
ZOCH3 orZCH2OH. The ionisation state of the phosphate
group (ZPO224 , ZHPO
2
4 or ZH2PO4) and consequently
the total charge of the system (neutral system with proton
bonded to the O4 atom and the phosphate group doubly
ionised) have not influenced the ‘switch effect’.
A transition state quantum mechanical calculation was
performed, using the small S model, to show whether
the presence of a proton close to the oxygen atom O4 can
stabilise the S(CYS 146)ZC6 bond, see Figure 3. The
transition structure with only one imaginary frequency
corresponding to the proton transfer from O4 atom to the
water molecule was found at the O–H distance of 2.36 A˚.
Our simplified model corresponding to the vacuum rather
than to biochemical systems does not contain either
solvent or enzyme environment, hence the overestimation
of calculated energy barrier of around 80 kcal/mol. A real
barrier, however, must be considerably smaller as the
proton transfer is driven by electrostatic forces which are
screened by the molecular residues of the environment.
Figure 4. The final optimised structure of 5A model. The O4
atom of dUMP is protonated (zero total charge). The bond of
CYS 146 S atom remains stable (1.8 A˚ as compared to 1.7 A˚ in
1KZI PDB file) during the geometry optimisation.
Figure 5. The final optimised structure of 5A model. The O4
atom of dUMP is not protonated. The bond of Cys146 S atom
with C6 is not stable (.6 A˚) during the geometry optimisation
unless there is a proton connected to the O4 atom as shown in
Figure 5. This is consistent with the reaction pathway described
in [16]. The total charge of the model shown in the picture is zero.
Table 1. QM and MM energies and all-heavy-atom RMSD from the initial geometries in the 5A and 10A models.
5A model 10A model
System Energy (Hartree) QM RMSD (A˚) Energy (Hartree) QM/MM RMSD (A˚)
dUMP 24048.1034 0.64 23896.0053/91.9172 0.47
5-OH-dUMP 24123.2206 0.86 23971.2453/92.4893 0.48
FdUMP 24147.3318 0.62 23995.2899/92.0936 0.47
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Due to the presence of environment, the effective
Coulombic forces are inversely proportional to the relative
dielectric constant 1, which amounts to about 4 in the
catalytic site interior in TS [4]. As a consequence, the
forecast barrier should be reduced correspondingly.
Moreover, experimental research shows [19] that the
abstraction of the O4 proton in fact does take place.
Therefore, the proton transfer can occur following the
mechanism suggested here as the proton switch effect.
The present simulation also indicates that the proton
approaching dUMP residue bound to Cys146 can be an
essential factor modulating the first step of the enzymatic
reaction catalysed by TS.
3.2 Molecular dynamics
In the crystal structure of the ECTS–dUMP complex
(PDB code 1BID) [26], the dUMP molecule is located
away from Cys146 in such a way that the Michael addition
to the pyrimidine C6 cannot occur. A distance of 3.16 A˚
observed in this structure can be perceived as a reference
distance between the Cys146 S atom and the dUMP C6
atom in the absence of the cofactor. For the reaction to
start, the cofactor binding must occur, upon which the
active site closes and Cys146 is brought closer to dUMP,
rendering the Michael addition feasible. An important
factor that ensures a proper alignment of the cofactor at the
time of binding is the orientation of the dUMP molecule,
the correctness of which depends to a significant extent
upon the presence of a double hydrogen bonding between
the N3–H (donor) and O4 (acceptor) groups of dUMP and
the active site asparagine (Asn177) [27–29].
Recently, MD simulations of the series of binary
complexes between ECTS and 5- and/or 20-substituted
dUMP analogues were carried out in order to determine
the effect of substitution on the conformation of the active
site [30,31]. Considering our ‘proton switch’ hypothesis,
particular attention should be paid to the variation of the
C6–S distance in relation to the level of protonation of the
O4 atom, the latter estimated in terms of preservation – or
the lack thereof – of hydrogen bond between O4 and
Asn177 as observed in the MD results.
3.3 Average structures from MD simulations
Average structures from the MD simulations can be
divided into two groups depending on how much they
conform to the active site organisation present in the
crystal structure of the ECTS–dUMP complex. In general,
a single C5-substitution in dUMP has a little (most of the
substituents) to moderate (ZC2H5 group) effect on the
organisation of the active site [31], resulting in its strong
preservation (first group). A similar effect takes place in
the case of a double fluorine substitution, if one of the
substituents lies at C5 such as in the 20,5-diF-dUMP
molecule [32]. The second group consists of the structures
of three complexes, TS–5-C3H7-dUMP, TS–2
0-F-ara-
dUMP (fluorine in the ‘up’ configuration) and TS–20,200-
diF-dUMP, wherein the substitution at dUMP C5 and/or
C20 results in the reorganisation of the active site [30,31]
which leads to a considerable change in the positions
with respect to each other of the catalytic CYS 146 and the
pyrimidine ring of an analogue of dUMP, and in turn to an
elongation of the molecular distance between S(CYS 146)
and C6(dUMP). While the S–C6 distance in the structures
from the first group fluctuates very little, ranging from 3.27
to 3.40 A˚, it rapidly increases in the structures from the
second group, from 3.75 A˚ in TS–20-F-ara-dUMP to
4.36 A˚ in TS–20,200-diF-dUMP and to 5.65 A˚ in TS–5-
C3H7-dUMP (Table 2). Apart from the S–C6 distance
elongation, changes to the active site organisation manifest
themselves in the TS–20-F-ara-dUMP and TS–20,200-diF-
dUMP structures in a displacement of the molecule of
dUMP analogue from the position held by dUMP in the
crystal structure of the TS–dUMP complex, which results
in the uracil N3–H (TS–20,200-diF-dUMP) and O4 (TS–20-
F-ara-dUMP and TS–20,200-diF-dUMP) losing hydrogen
bonding with Asn177 (Table 2). While in the TS–20,200-
diF-dUMP structure, but not in TS–20-F-ara-dUMP, the
O4 atom gains a compensating hydrogen contact with the
Table 2. Distances separating C6(dUMP) and S(CYS 146) atoms and the presence (þ) or absence (2 ) of hydrogen bonding in the
average structures of binary complexes, as predicted by the results of MD simulations.
Hydrogen contacts of
Asn177 with
Complexes from Complex C(6)–S(CYS 146) distance (A˚) N3ZH O4
First group TS–5-Xa-dUMPb 3.27–3.40 þ þ
TS–20,5-diF-dUMPc 3.39 þ þ
Second group TS–20-F-ara-dUMPc 3.75 þ 2
TS–20,200-diF-dUMPc 4.36 2 2
TS–5-C3H7-dUMP
a 5.65 þ þ
a X ¼ ZF, ZCl, ZBr, ZI, ZCHO, ZCH3, ZC2H5, or CH2OH. b Data from Ref. [26]. c Data from Ref. [27].
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hydroxyl of Tyr94; dislocation of the molecule of 20,200-
diF-dUMP prevents its C6 atom from maintaining an
approachable distance to Cys146.
The structure of the TS–5-C3H7-dUMP complex has a
special active site arrangement among the members of the
second group [28]. In this structure, the large size of the
propyl moiety resulted in the pyrimidine ring twisting and
adopting the syn orientation relative to the sugar moiety
(different from the usual anti conformation present in the
rest of simulated structures as well as in the ECTS–dUMP
crystal structure) in order to dispose the propyl between
the indole rings of the two tryptophanes, Trp80 and Trp83,
pushing them further away from each other as compared
to their ‘normal’ positions. This rearrangement strongly
dislocated the position of CYS 146, but did not disturb the
hydrogen bonding of the uracil O4 and N3–H groups with
Asn177 (Table 2).
An additional argument supporting the hypothesis of
‘switch effect’ on the C(4)vO residue comes from the
analysis of the Asn177–O4 distance during MD simulation
of the TS dimer complexed with dUMP/FdUMP and the
cofactor. The results are presented in Figure 6 (TS with
dUMP and cofactor) and Figure 7 (TS with FdUMP and
cofactor). The variation of the Asn177–O4 distance in
both systems clearly shows high flexibility of proton
location in the vicinity of the O4 oxygen. Thus, it may be
inferred that the proton can move from Asn177 towards
dUMP/FdUMP and temporarily forms a hydrogen bond.
In general, the results of MD remain in line with the
‘proton switch’ hypothesis by showing the S(CYS 146)Z
C6(dUMP analogue) molecular distance to become longer
and thus less approachable (in view of the chances for the
formation of covalent bond) upon the lack of hydrogen
bonding between the O4 atom of dUMP and Asn177
residue of ECTS, whereas shorter and more approachable
upon the presence thereof. However, the results suggest
that the hydrogen bond at O4 can be a necessary but not
sufficient condition for a successful CYS 146 approach to
the C6 atom. The active site organisation similar to the one
observed in the crystal structure of the native TS–dUMP
complex seems a prerequisite for the latter to take effect.
3.4 Crystal structures from PDB
Inspection of crystal structures of TS complexes stored
in the PDB data bank shows that the presence of the
S(Cys146)ZC6(dUMP) covalent bond is correlated, in
vast majority of cases, with the hydrogen bonding at the
O4 atom. In most cases, one H-bond donated to O4 comes
from Asn177, an essential amino acid residue aiding
in recognising and orienting the molecule of dUMP.
Additional hydrogen contact of O4 with Wat 1, a
conserved water molecule participating in a water-
mediated hydrogen bond network coordinated by gluta-
mate 58, is usually also present. Only two structures were
found, in which the H-bond between O4 and Asn177 is
not present; the electron densities as well as distance and
angular conditions, however, suggest the presence of
the SZC6 bond. Both these structures are TS mutants:
E58(60)Q from L. casei (LCTS) in complex with dUMP
and a cofactor analogue CB3717 (PDB accession code
1VZE) [32], and N177A from E. coli (ECTS) in an
analogous complex with dUMP and CB3717 (PDB
accession code 1BQ1) [33]. In the structure of the
LCTS–dUMP–CB3717 complex, dUMP shifted farther
from its original position, with the O4 atom loosing the
Figure 7. Distances (A˚) between H atom of Asn177 (denoted as
Asn441 in monomer B) and O4 atom of dUMP (denoted here
as O6) for both monomers of TS, registered during 3 ns MD
simulation of TS–FdUMP–MTF ternary complex. Red, monomer
A; green, monomer B (colour online).
Figure 6. Distances (A˚) between H atom of Asn177 (denoted as
Asn441 in monomer B) and O4 atom of dUMP (denoted here as
O3) for both monomers of TS, registered during 3 ns MD
simulation of TS–dUMP–MTF ternary complex. Red, monomer
A; green, monomer B (colour online).
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hydrogen bonding with Asn177(229) and Wat 1, while
forming a hydrogen bridge through another water
molecule (Wat C) with Tyr94(146). In the structure of
the ECTS–dUMP–CB3717 complex, on the other hand,
asparagine 177 was mutated into a smaller residue of
alanine, partly freeing a space occupied in the wild-type
enzyme by the side chain of Asn177 and resulting in the
side chain of His147 relocating into that space and forming
a compensating hydrogen bond with O4. Another H-bond,
linking O4 with the Wat C molecule, was also present.
Thus, in view of the crystal structures of TS
complexes, hydrogen bonding to dUMP O4 in the form
of direct bonding from the enzyme (Asn177) and/or an
indirect bond, mediated by water, appears as a key factor
for the presence of a covalent linkage between C6(dUMP)
and S(CYS 146).
4. Conclusions
The nucleophilic attack of CYS 146 on the C6 carbon atom
of dUMP appears to be concerted with the bonding of a
proton to the oxygen O4 atom of dUMP or with the
presence of a proton donor forming hydrogen bond with
the O4 atom. Moreover, the proton bound to the O4 atom
seems to act as a ‘proton switch’ which stabilises or
destabilises the sulphur–carbon S(Cys146)ZC6(dUMP)
bond. The ‘switch effect’ does not occur when the O4 atom
is replaced with a thione or thiol sulphur.
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DFT Study of B-like Conformations of 
Deoxydinucleoside Monophosphates Containing 
Gua and/or Cyt and their Complexes with Na+ Cation
http://www.jbsdonline.com
Abstract
B-like minimum energy conformations of deoxydinucleoside monophosphate anions (dD-
MPs) containing Gua and/or Cyt and their Na+ complexes have been studied by the DFT 
PW91PW91/DZVP method.  The optimized geometry of the dDMPs is in close agreement 
with experimental observations and the obtained minimum energy conformations are con-
sistent with purine-purine, purine-pyrimidine, and pyrimidine-purine arrangements in crys-
tals of B-DNA duplexes.  All the studied systems are characterized by pyramidalization of 
the amino groups, which participate in the formation of unusual hydrogen bond between 
the carbonyl oxygen of the second base in the dGpdC, dCpdG dDMPs, and their Na+ com-
plexes.  In all the obtained structures the bases assume a nearly parallel disposition to each 
other and this effect is independent on the degree of their spatial superposition.  From this 
it is concluded that the parallel disposition of the bases in the B-like single-stranded con-
formations is dictated by the sugar-phosphate backbone.  Correspondingly, the base-base 
interactions attain a secondary role in the formation of these spatial structures.  The forma-
tion of a weak C6-H6…O5ʹ hydrogen bond between cytosine and the phosphate oxygen is 
reported, in agreement with experimental observations.
Key words: dDMP; Dinucleoside; Deoxydinucleoside; Gua; Cyt; DFT; and Conformation.
Introduction
Computer simulation of nucleic acids is an indispensable tool for understanding 
molecular mechanisms of genetic processes.  In spite of the enormous success 
achieved in this field by using modern molecular mechanical methods [see, e.g., 
Ref. (1)], studying novel and underlying structural effects in these systems [see, 
e.g., Ref. (2-4)] requires the use of sophisticated quantum mechanical methods.  In 
the end, the knowledge gained from such studies will be a valuable aid in develop-
ing more accurate force fields.
During the last decade, several density functional theory (DFT) and correlated ab 
initio calculations were published on nucleic acid bases, their pair combinations, 
nucleosides and nucleotides [see Ref. (2, 3, 5-7) and references therein].  De-
spite their usefulness these publications were focused on relatively small building 
blocks of DNA and RNA.  But in order to develop predictive theoretical models 
of DNA it is necessary to go to larger fragments of nucleic acids.  Due to the ex-
ponential growth of computational cost with the number of atoms in the system 
such computations still represent a challenge.  This paper represents a step toward 
the goal of studying larger systems and presents the results of DFT computations 
of minimum energy conformations of deoxydinucleoside monophospate anions 
(dDMPs) and their complexes with a Na+ cation.  In the present study, energy 
minimum B-conformations of dDMPs anions and their Na+ complexes containing 
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guanine and/or cytosine nucleosides are considered, which are the largest struc-
tural units of DNA so far studied by using correlated quantum mechanical (QM) 
methods.  A part of the results was presented at the 15th Albany Conversation on 
Biomolecular Stereodynamics (8).
Methods
To study dDMPs and their Na+ complexes we used the DGauss program (9).  The 
intrinsic feature of this program is reducing four-center Coulomb integrals to 
three-center ones by introducing the so-called fitting basis set.  In this approxima-
tion, the Coulomb energy contains only three-center terms, making feasible QM 
study of relatively large systems.  We used split-valence double zeta basis set 
(DZV), which is specifically optimized for DFT calculations (9, 10) as opposed to 
the commonly used basis sets, such as Pople’s 6-31G(d) (11), that are optimized 
for Hartree-Fock calculations.  DZV uses a double zeta basis for the chemically 
important valence region, while using a single function to represent the less mo-
bile core orbitals.  The calculations performed in this work employed the DZVP 
basis set augmented with polarization functions (10).
Energy values and molecular properties were calculated using the original gra-
dient-corrected exchange-correlation functional developed by Perdew and Wang 
(12).  It appears that the functional PW91PW91, based on the results of Kurita 
for dimers of rare gases (13), describes van der Waals forces better than com-
monly used functionals of Becke type (14).  According to Kurita et al. (13), the 
Becke-type DFT functionals completely fail to describe the binding states, while 
the Perdew-Wang exchange-correlation functional provided a qualitatively correct 
trend in energy and geometry of the rare gas dimers.  This conclusion is addition-
ally supported by the recent DFT study of stacking complexes of DNA bases (15) 
where the PW91PW91 functional provided an improved description of these com-
plexes in comparison with BLYP, BP86, OLYP, B3LYP, and X3LYP ones.  In addi-
tion to that, the results of our study (see below) demonstrate that the properties of 
the systems considered are governed mainly by properties of the sugar-phosphate 
backbone rather than by base stacking.
To test the sensitivity of the obtained results to the choice of a particular DFT 
functionals, the basis sets, and to the density fitting, additional minimizations of 
selected structures were performed using the 6-31G(d,p) basis set (11), and the 
B3LYP functional (16-18) as implemented in the GAMESS program (19) and 
in the GAUSSIAN 03 program package (20).  The structures obtained had the 
conformational parameters only slightly deviating from those of the initial ones, 
thus confirming that the conclusions of this work are invariant of the details in 
the DFT method.
Starting B-like geometries of dDMPs were generated using the HyperChem pro-
gram version 7.01 (HyperCube, Inc.).  Due to limitations in the HyperChem soft-
ware the sugar rings were constructed with C3ʹ-exo (not C2ʹ-endo) puckering, char-
acterized by a pseudorotation phase angle P = 192º.  The possibility of biasing the 
computational results toward a particular initial puckering form is ruled out by a 
wide variety of different phase angles obtained after geometry optimization.  This 
proves that the computational results are not particularly sensitive to initial sugar 
ring puckering in the region around the C2ʹ-endo conformation.  Neutral dDMPs 
were obtained by placing sodium cations at equidistant positions to the anionic oxy-
gens (at O…Na distance of 2.2 Å) in the O1P-P-O2P plane.  The generated struc-
tures were subjected to all-atom geometry optimization and the geometric charac-
teristics of the optimized minimum energy conformations including bond lengths, 
valence and torsion angles as well as hydrogen-bond characteristics and distances 
from Na+ ion to anion oxygens were analyzed.  The program PROSIT (21) was used 
for the analysis of sugar-ring puckering and glycosidic torsions.
χ
d1
e
ξ
a
b
g
d2
χ
Figure 1:  Designation of the torsion angles of the 
sugar-phosphate backbone of the dDMPs and their Na+ 
complexes.
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Results and Discussion
General Features of Minimum Energy Conformations.  
Sugar-phosphate Geometry and Na+ Ion Positions
In the energy minimized structures the dDMPs and their Na+ complexes adopt 
distorted B-like conformations with the torsion angles of the backbone and the 
mutual positions of the bases being characteristic of B-family DNA conforma-
tions.  The computed bond lengths and valence angles are within the limits of the 
experimentally observed values (22, 23) with the exception of those of the anionic 
phosphate group, which will be discussed further.  The Na+ ion is located at an 
equidistant position of 2.26 Å from the anionic O1P and O2P oxygen atoms stay-
ing practically in the O1P-P-O2P plane.
The analysis of the computational data on the sugar-phosphate backbone is pre-
sented in Table I along with standard deviations from experimental data on dinu-
cleoside monophosphates (DMP) and trinucleoside diphosphates (TDP) (23).  Each 
of the torsion angles stays in the limits of one of the regions observed for DMPs 
and TDPs in crystals (23), namely, -sc (-gauche) for α and ζ, ap (trans) for β and 
ε, +sc (+gauche) for γ; δ values are characteristic for C2ʹ-endo sugar puckering 
and clustered around 140º.  The largest deviations from the experimental values 
are observed for the dGpdG anion.  The RMS deviations from experiment for the 
calculated structures are smaller for the Na+ complexes than those for the anions. 
This is quite reasonable because crystals carry net zero charge.
Geometry of Phosphate Group
Among all structural elements of the dDMPs the phosphate group shows the larg-
est geometrical differences between the computed and experimental data (Table 
II).  For the anionic dDMPs the P-O3ʹ and P-O5ʹ bonds are longer by 0.1 Å than 
the experimental value of 1.60 Å; the computed O1P-P-O2P angles overestimate 
the experimental value of 119º by 8º; and the O3ʹ-P-O5ʹ angles are predicted to be 
smaller by 4º than the corresponding experimental value of 104º.  The formation 
of a complex with Na+ considerably improves the agreement with the experimental 
data giving 1.65 Å, 115º and 104º, respectively, for the corresponding geometric 
parameters.  This is consistent with the notion that the neutralized dDMPs represent 
better models of the crystals than the anionic dDMPs.
From the analysis one may see that the experimental value for the O1P-P-O2P 
(O=P=O) angle is located between the calculated values for anionic and Na+ com-
Table I 
Torsion Angles of the Sugar-Phosphate Backbone (definitions are in Figure 1) and 
Average Values of the Angles between the Base Planes ( ) for the Calculated 
Conformations of dDMPs and their Na+ Complexes. 
dDMP 1 2
dCpdC 138.2 181.8 263.5 292.1 197.6 55.3 139.2 8.5 
dCpdCNa+ 138.9 181.7 261.2 295.0 183.3 59.2 132.1 4.9 
dGpdG 140.9 155.4 277.6 274.5 245.6 57.2 148.3 18.2 
dGpdGNa+ 141.7 173.9 259.2 298.0 190.7 54.5 141.8 14.1 
dCpdG 138.5 177.7 268.1 290.1 203.6 49.9 144.0 18.5 
dCpdGNa+ 138.1 179.7 265.2 296.9 184.7 53.1 134.9 21.2 
dGpdC 128.4 176.3 264.2 290.3 214.0 52.7 144.0 9.4 
dGpdCNa+ 136.8 182.0 260.6 298.8 183.6 55.3 134.6 11.9 
SDa 8.7 41.2 20.8 1.4 31.7 1.3 1.3  
SDb 6.3 34.7 27.6 11.9 2.1 3.0 9.4  
Exp.c 145.2 214.0 289.2 285.3 183.5 52.5 145.2  
Exp. SDc 4.9 8.6 4.8 9.8 13.0 5.7 4.9  
aStandard deviation for computed anionic dDMPs; bStandard deviation for computed 
sodium complexes; cExperimental data from Ref. (22). 
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plexes.  While this may be considered as merely a reasonable agreement between 
experiment and theory, and reserving room for possible limitations in the selected 
level of theory (24), it may also be viewed as the consequence of intermolecular 
interactions with water molecules in the crystals, which shifts Na+ away from its 
position corresponding to the energy minima for the dDMP-Na+ complexes, thus 
making a real system partially resembling the dDMP anion.  The character of the 
differences upon going from the anionic to the sodium complex of the dDMPs is 
also reproduced by the B3LYP/6-31G(d,p) method.
To clarify the influence of the level of theory on the geometry of the phosphate 
group we performed calculations of dimethylphosphate (DP) in anionic form and 
in a complex with sodium using the MP2 method (25, 26).  The comparison of the 
computation results on bond distances and valence angles pertaining to the phos-
phate group is presented in Table II.  The MP2 results basically repeat the pattern in 
the geometrical properties of neutralized and anionic forms of the phosphate group 
discussed above, confirming the suitability of the DFT level.  Surprisingly the better 
agreement with experiment is obtained with somewhat moderate 6-31+G(d) basis 
set (27) (possibly due to fortuitous error cancellation) and with the aug-cc-pVTZ 
one, the most extended basis set used here (28, 29).  In order to improve the agree-
ment for the anions further, higher level calculations are warranted [see, e.g., cal-
culations for anions of uracil dimers and trimers Ref. (30)].  However, good agree-
ment observed for the Na+ complexes justifies the selected methodology.
Sugar Ring Puckering and Sugar-base Orientation
Analysis of the sugar ring geometry is performed using the terminology of phase 
angle, P, and puckering amplitude, υmax, proposed by Altona and Sundaralingam (31). 
All the sugars of dDMP-Na+ complexes have pseudorotational phase angles P laying 
in between 150º and 177º, i.e., they pertain to C2ʹ-endo conformations, with the sugar 
puckering amplitude being in the region between 31.2º and 35.3º.  The sugar pucker-
ing of anionic dDMP varies in somewhat broader region with P being in the range 
from 136º to 206º, corresponding to C1ʹ-exo, C2ʹ-endo, or C3ʹ-exo sugar types.  Nu-
merical characteristics of sugar rings and glycosyl torsion angles of dDMPs, dDMP-
Na+ complexes, and individual deoxynucleosides are listed in Table III.
Sugar ring bond lengths, valence angles, and endo-cyclic torsions of the calcu-
lated conformations are close to the averaged crystal structure values (22).  De-
tailed comparison of the calculated endo-cyclic bond angles with crystal data is 
provided in Table IV.
The mutual orientations of the sugar and base rings correspond to the anti region 
of the glycosyl torsion angle χ (O4ʹ-C1ʹ-N9-C4 for guanine and O4ʹ-C1ʹ-N1-C2 
Table II 
Phosphate Group Geometry at Various Levels of Theory. 
Level of theory System P=O P-Oa O=P=Ob O3’-P-O5’ 
B3LYP/6-31+G(d) neutralized DP 1.523 1.632 113.7 103.7 
B3LYP/6-31+G(d) anionic DP 1.504 1.683 125.5 99.5 
MP2/6-31+G(d) neutralized DP 1.527 1.635 114.9 102.9 
MP2/6-31+G(d) anionic DP 1.509 1.684 125.9 98.9 
MP2/aug-cc-pVDZ neutralized DP 1.547 1.657 115.3 102.5 
MP2/aug-cc-pVDZ anionic DP 1.529 1.706 126.8 98.5 
MP2/aug-cc-pVTZ neutralized DP 1.515 1.618 115.3 103.1 
MP2/aug-cc-pVTZ anionic DP 1.498 1.663 125.5 99.4 
DGauss/DZVP neutralized dDMPs 1.53 1.65 115 104 
DGauss/DZVP anionic dDMPs 1.51 1.71 127 100 
Experiment c DMP & TDP 1.485 1.60 119 104 
aAverage values of the O3’-P and O5’-P distances; bSame as O1P-P-O2P; cRef. (22); The 
geometry of DP is minimized at the gauche-gauche geometry of the methoxy groups. 
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for cytosine containing nucleosides), which is in the range between 170º and 280º. 
Again, anionic dDMPs are characterized by a larger deviation of their glycosyl tor-
sions in comparison with the data of the corresponding Na+ complexes (see Table 
II).  The glycosyl bond of the dDMPs deviates from the base ring plane by a few 
degrees, the exact value being dependent on the base sequence.  The maximal de-
viations (up to 7º) happen in the structures characterized by inter-base hydrogen 
bonds, which will be discussed further.
An interesting feature of most of the obtained structures is a short contact (up to 
3.3 Å) between O5ʹ and cytosine C6, which can be viewed as a weak C6-H6…O5ʹ 
hydrogen bond.  A similarly short C…O distance was mentioned in the first X-ray 
diffraction resolved nucleoside, cytidine, as early as in 1950 (32).  The crystal struc-
ture of the sodium salt of GpC (33) demonstrates similar short C6…O5ʹ distance 
of 3.29 Å.  In some crystals this distance can be as short as 3.12 Å, e.g., in 5ʹ-O-
(Guanosine-2ʹ-O-phosphonomethyl)-cytidine tetradecahydrate (34).  The obtained 
computational results can be considered as additional evidence of the importance 
of C-H…O weak H-bonds for nucleic acid structure.  The computations clearly 
demonstrate that such H-bonds are not the result of crystal packing forces, but they 
are intrinsic features of these biomolecules.
The Geometry of Bases and Base-base Interactions
Good agreement between the computational and experimental data is obtained for 
the geometry of the bases.  The majority of endo cyclic bond lengths and bond 
Table III 
Characteristics of the Sugar Ring Conformations and Glycosyl Torsion Angles of the 
dDMPs and dDMP-Na+ obtained by PW91PW91/DZVP methoda.
dDMP-Na+  PMDd Nucleoside 
sequence puckering P max  puckering P max
dCpdC C2’-endo C2’-endo 
168
150
31.2 
33.0 
-127 
-135 
C2’-endo 
C2’-endo 
166
167
30.5 
31.4 
-124 
-127 
dGpdG C2’-endo C2’-endo 
177
173
31.8 
31.3 
-109 
-99 
C2’-endo 
C3’-exo 
167
206
37.1 
30.1 
-124 
-77 
dCpdG C2’-endo C2’-endo 
167
152
30.6 
34.6 
-128 
-103 
C2’-endo 
C2’-endo 
167
177
31.3 
32.1 
-124 
-93 
dGpdC C2’-endo C2’-endo 
161
153
31.3 
34.0 
-122 
-108 
C1’-exo 
C3’-exo 
136
185
40.8 
30.3 
-139 
-99 
dGb C3’-exo 190 28.4 -98 
dCb C2’-endo 164 30.0 -128 
aP, pseudorotational  phase angle of a sugar ring; max, puckering amplitude; ,
glycoside torsion (O4’-C1’-N9-C4 for guanine and O4’-C1’-N1-C2 for cytosine 
containing nucleosides); the first row for each dDMP corresponds to nucleoside at the 
5’-end; bexperimental data, Ref. (22). 
Table IV 
Endo cyclic Bond Angles of the Sugar Rings of the dDMPs and dDMP-Na+ complexes. 
dDMP-Na+  PMDd Nucleoside 
sequence C1’ C2’ C3’ C4’ O4’ C1’ C2’ C3’ C4’ O4’ 
dCpdC 106.0 105.1 
103.8 
103.3 
102.7 
103.0 
107.4 
107.7 
110.3 
109.6 
106.6 
106.0 
103.7 
103.4 
102.6 
103.1 
107.5 
106.9 
110.0 
110.5 
dGpdG 106.2 106.4 
103.4 
103.4 
102.8 
102.8 
106.5 
107.0 
110.8 
110.5 
106.0 
107.7 
102.0 
104.2 
101.6 
103.1 
107.0 
105.7 
109.0 
110.0 
dCpdG 105.9 105.1 
103.8 
102.5 
103.0 
102.9 
107.3 
107.4 
110.5 
109.8 
106.4 
106.7 
103.9 
102.8 
102.3 
102.7 
107.9 
106.5 
109.6 
110.6 
dGpdC 105.7 105.3 
103.8 
102.6 
103.0 
103.2 
107.3 
107.2 
110.3 
109.9 
104.5 
106.8 
102.1 
103.5 
102.8 
103.4 
107.5 
106.1 
106.3 
110.8 
C2’-endoa 105.9 102.5 103.1 106.0 110.1      
C3’-endoa 106.8 102.4 102.2 104.5 110.3      
aAveraged crystal data [Ref. (22)] for the C2’-endo and C3’-endo conformations; the first row for each 
dDMP corresponds to the nucleoside at the 5’-end. 
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angles of the bases in the optimized structures differ from the averaged characteris-
tics for monomer crystals (23) by 0.01-0.05 Å and 1-3º, respectively.  Differences 
between the values of the same bond lengths in different structures are about or 
less than 0.01 Å, and those for valence angles differ by less than 1º.  Similar results 
were obtained by using the B3LYP/6-31G(d,p) method.  The base rings, which are 
normally expected to be planar, are slightly distorted according to our results, which 
can be seen in the endo cyclic torsions deviating from planarity by up to 5º.  These 
effects are accompanied by significant pyramidalization of the amino groups with 
A B
Figure 2:  The minimum energy conformation of the 
dCpdG-Na+ complex.  Two orthogonal projections 
(panel A and panel B) illustrate the mutual disposition 
of the bases and inter-base H-bonding.  Atoms closer to 
the observer are richer in color.
A B
Figure 3:  The minimum energy conformation of the 
dGpdC-Na+ complex illustrating ring-on-ring stacking 
and N2-H21…O2 inter-base H-bonding.
A B
Figure 4:  The minimum energy conformation of the 
dGpdG-Na+ complex.  The base-base ring-on-ring 
stacking resembles that of the purine-purine sequence 
in crystals of DNA duplexes.
A B
Figure 5:  The minimum energy conformation of the dCp-
dC-Na+ complex showing no base-base superposition. 
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particular details of the geometry depending on their interactions with other moi-
eties of the dDMPs (see further discussion).  It is well known that DFT methods in 
general tend to underestimate the level of pyramidalization of the amino group (24), 
because these effects are characterized by small energy differences.  The present 
calculations revealing pyramidalization of the amino group lead us to believe that 
the energetic effect of the pyramidalization is sufficiently strong for it to be captured 
by DFT.  Among the factors facilitating pyramidalization of the amino group is the 
novel H-bond type interaction observed between the stacked bases.  As the calcula-
tions reveal, the dDMPs and their Na+ complexes simultaneously containing Gua 
and Cyt in one molecule are characterized by formation of hydrogen bonds between 
these bases due to the pyramidalization of the amino groups.  Such H-bonds can be 
observed between the amino group of the 5ʹ-end base and the carbonyl oxygen of the 
3ʹ-end base, namely, in the dCpdG and the dCpdG-Na+ (N4-H41…O6, Figure 2), 
and in the dGpdC and the dGpdC-Na+ complexes (N2-H21…O2, Figure 3).  Geom-
etry characteristics of these H-bonds are listed in Table V.  Remarkably, in the case 
of equivalent bases (dGpdG and dCpdC) the hydrogen atoms of the pyramidalized 
amino groups of both bases deviate in the same directions from their base planes (see 
Figures 4 and 5) leading to favorable dipole-dipole interactions of these groups.
As seen from Figures 2-5 the base rings of the dDMPs are located in a nearly par-
allel disposition.  The plane-plane angle between the stacked bases is in the range 
of 4.9 to 30.8 degrees.  The largest deviation from ideal parallel orientation of the 
base rings is observed for the dGpdG anion (see Table I).  This anion shows also 
the largest structural deviation of the conformational parameters from the experi-
mental data, deviating considerably in this aspect from the other studied structures. 
Overall, the nearly parallel base – base arrangement takes place in all dDMP struc-
tures.  According to the common wisdom such geometrical preference of the bases 
is usually attributed to favorable base-base dispersion interactions also known as 
“stacking interactions”.  If such dispersion interactions are indeed important for 
the studied systems, then the level of the parallel disposition of the bases would be 
directly proportional to the degree of their spatial overlap.  However, the analysis 
of the optimized structures of the bases points out that the parallel disposition of the 
bases is independent on the degree of the ring-on-ring overlap.  Indeed, even in the 
least overlapping case of dCpdC anion and its Na+ complex (see Figure 5) the base 
planes are ideally parallel to each other.  Similarly, no significant influence is made 
on the parallel disposition of the bases by the presence or absence of the inter-base 
H-bonding.  This suggests that the major contribution to the stability of the B-like 
single-stranded conformation comes from the sugar-phosphate backbone and only a 
minor contribution can be attributed to base-base stacking interactions.
Another characteristic feature of the dDMPs is related to the sequence of the bases. 
The dDMP anions with G at the 5ʹ end and their Na+ complexes demonstrate exten-
sive base ring-on-ring overlap (Figure 3 and 4), while the dDMP anions with C at 
the 5ʹ end and their Na+ complexes have practically no base ring overlap (Figures 
2 and 5).  This observation is in excellent agreement with the Pur-Pur, Pur-Pyr, and 
Pyr-Pur arrangement in crystals of B-DNA duplexes (35).  The difference in mutual 
base arrangements of the two dDMPs with the same base content, but different base 
sequence, e.g., dGpdC and dCpdG, resembles that for the Pur-Pyr and Pyr-Pur steps 
of B-DNA duplexes in crystals (35).  Namely, the first step demonstrates substantial 
ring-on-ring overlap (Figure 3).  Base stacking can be seen in crystal structures of 
Table V 
Base-base hydrogen bonds in the dDMP and dDMP-Na+ complexes. 
dDMP H-bond X-H…Y 
H…Y distance 
(Å) 
X…Y distance 
(Å) 
X-H…Y 
angle (º) 
dGpdC N2-H21…O2 2.26 3.10 139 
dGpdCNa+ N2-H21…O2 2.17 3.09 147 
dCpdG N4-H41…O6 2.18 3.05 141 
dCpdG Na+ N4-H41…O6 2.21 3.07 140 
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sodium (33) and ammonium (36) salts of ribodinucleoside monophosphate GpC 
as well.  At the same time there is no visible ring overlap in dCpdG where the 
exocyclic pyrimidine O2 is placed over the purine five-atom ring [Figure 2, see for 
comparison Figure 2 in Ref. (35)], presumably stabilizing the present geometry.  A 
similar situation in the spatial disposition of the bases can be seen in dCpdG crystals 
(37).  Considerable superposition of the two bases for dGpdG (Figure 4) and negli-
gible inter-base overlap for dCpdC (Figure 5) are similar to the base-base arrange-
ment taking place in the Pur-Pur and Pyr-Pyr steps of B-DNA duplexes (35).
Conclusions
The DFT geometry optimization studies of deoxydinucleoside monophosphate an-
ions containing Gua and/or Cyt and their Na+ complexes demonstrate existence of 
an important conformational minimum where the sugar ring puckering and sugar-
phosphate backbone torsion angles resemble those of B-family DNA duplexes.  All 
the sugar rings of the sodium complexes pertain to the C2ʹ-endo type, while the 
sugars of the anions exhibit C1ʹ-exo and C3ʹ-exo puckerings as well.  The het-
erocyclic rings of the bases retain a nearly planar configuration while the amino 
groups become non-planar, and their conformations depend on nucleoside content 
and sequence.  The dGpdC, dCpdG dDMPs and their Na+ complexes demonstrate 
formation of unusual hydrogen bonds between the carbonyl oxygen of one base and 
the pyramidalized amino group from the other base.  The conformations obtained 
after geometry optimization show an almost parallel orientation of the bases with 
the interplane angle between the bases varying in the range from 4.9 to 30.8 de-
grees.  It is found that the base-base superposition is independent on the extent of 
the inter-base overlap.  From this it is concluded that the sugar-phosphate backbone 
contributes most to the stability of B-like single-stranded conformations and that 
base-base interactions play only a secondary role in the formation of these spatial 
structures.  The dDMPs with the 5ʹ end G and their Na+ complexes demonstrate 
extensive stacking overlap of the base rings, while in the dDMPs with the 5ʹ end C 
and their Na+ complexes the inter-base overlap is practically absent.  This observa-
tion correlates well with purine-purine, purine-pyrimidine, and pyrimidine-purine 
arrangements in crystals of B-DNA duplexes.  The significant structural feature of 
the dDMPs is the formation of the cytosine base – phosphate oxygen (C6-H6…O5ʹ) 
hydrogen bond, which is consistent with experimental observations.
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a b s t r a c t
DFT studies of desoxydinucleoside monophosphate complexes with Na-ions (dDMPs), using DGAUSS and
ADF software reveal that the characteristic B-type conformation of DNA duplexes is initially predisposed
in single strand in the form of a local minimum. Such predisposition may be important for biological
functioning of DNA by facilitating an addition of new nucleotide in the processes of DNA duplication
and restoration of double helix after unwinding. The computational results demonstrate the important
contribution of intra-strand interactions to conformational stability and sequence-dependent variability
of B-DNA duplexes. The main characteristics of the ‘‘canonical” BI conformations, such as the regions of
torsion angles of sugar-phosphate backbone, C20-endo or very close to C20-endo sugar puckerings, and
nearly parallel base-ring arrangements are already present in the single strand and are universal for all
16 dDMPs. The dihedral angle between the bases does not depend on the extent of their overlap, which
suggests the major contribution of sugar-phosphate backbone to formation of these minima. The study
reveals characteristic sequence dependence of the base arrangements. Namely, an extensive base-ring
overlap takes place for all purine–purine and purine–pyrimidine sequences, and negligible ring overlap
is observed in all pyrimidine–purine and pyrimidine–pyrimidine sequences. These arrangements closely
resemble the geometrical characteristics of BI DNA in duplex crystals. Preliminary results of search for
other energy minima related to helical DNA structures revealed the existence of BII-like minima for some
dDMPs.
 2009 Elsevier B.V. All rights reserved.
1. Introduction
Study of the role of nucleic acids building blocks in confor-
mational stability and conformational preferences of DNA with
specific base sequences is an important step toward under-
standing the molecular mechanisms of genetic processes. Exper-
imental studies revealed various patterns of three-dimensional
structure of DNA, including well-known A-, B-, and Z- double
helices, which differ in sugar-phosphate torsional angles and
mutual base arrangements as presented in the Nucleic Acid
Data Bank [1]). The conformational preferences of DNA duplex
fragments can be studied by experimental, e.g. X-ray and
NMR, and theoretical methods, including molecular mechanics
and quantum mechanics computations. Conventionally, the con-
formational stability of the double helix is attributed to inter-
strand hydrogen-bond interactions of complimentary bases and
to inter- and intra-strand stacking interactions. Interactions of
the duplex with surrounding media, including water molecules
and counterions, further modulate the duplex conformation in-
side the region of its possible geometric variations. The confor-
mational preferences of nucleotide sequences have been derived
from X-ray diffraction studies of DNA duplex fragments contain-
ing from 6 to 14 nucleotide pairs, followed by theoretical con-
siderations and computer simulations. Hundreds such studies
are collected in Nucleic Acid Data Bank [1] and analyzed in a
recent paper [2].
Contrary to duplexes the spectrum of conformational possibili-
ties of single chain fragments is more difficult to address by exper-
imental methods. The question, in what degree the single-strand
conformational preferences determine the duplex conformation,
are hardly possible to address by experimental studies. To large ex-
tent the conformation of single-strand fragments is determined by
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their interactions with other components of the crystal or solution,
thus, one need to involve first principle theoretical methods to
derive unperturbed conformational characteristics of the single-
strand chains. To evaluate the contribution of intra-strand interac-
tions to variation of duplex structures we performed quantum
mechanical (QM) calculations of minimal fragments of DNA chains
using density functional theory (DFT) methods. The latter provide a
reasonable compromise between accuracy and resource demand
among available computational methods. In general, ab initio
methods, e.g. MP2 and CCSD provide more accurate results but
they are computationally too expensive to be used for such large
systems.
Deoxydinucleoside monophosphate is the minimal fragment
of DNA single strand which consists of two nucleotides situated
along the chain. Correspondingly, dDMP determines the confor-
mation of the single strand via inter-strand interaction of the
nucleotides. Due to the computational cost, larger units and par-
ticularly the systems of practical interest can only be approached
using molecular mechanics. The success of such computation vi-
tally depends on refinement of the force fields and on their abil-
ity to quantitatively reproduce the detailed conformational
aspects of the minimal fragments. The need for such refinement
of molecular mechanics force fields has recently become appar-
ent from computations of DNA subunits and duplex fragments
(see e.g. long molecular dynamics simulations of tetranucleotide
repeating sequences [3,4]). These ‘‘simple” fragments have extre-
mely complicated conformational profile due to the existence of
many degrees of freedom, including six sugar-phosphate tor-
sions, glycoside torsions, and highly flexible deoxyribose ring.
As it was mentioned by Svozil et al. [5] quantum-mechanical
computations of a simple fragment of sugar-phosphate backbone
having no connected bases is already not trivial because of com-
plexity of its conformational space.
In the light of these observations we restricted ourselves to con-
sideration of B-family like structures of deoxydinucleoside mono-
phosphates applying special emphasis on dependence of their
three-dimensional structure on nucleotide sequence.
In our previous work [6] we considered four deoxydinucleoside
monophosphates and their sodium-complexes containing guanine
and cytosine bases. We obtained energy minima corresponding to
‘‘canonical” B conformations of DNA duplexes and recognized the
principal contribution of sugar-phosphate backbone to parallel
arrangement of bases, which is sequence dependent. The neutral-
ized deoxydinucleoside monophosphates–Na+ complexes (dDMPs)
found to be better models of the minimal DNA fragments in crys-
tals and solutions in comparison to their anionic counterparts, as
their calculated geometries were closer to experimental data [6]
than those of anionic systems. In this study we extended our pre-
vious calculations to include all possible 16 dDMPs. Using different
computational methods, we confirmed the general conclusions de-
rived in our previous study and found new regularities in the
dependence of dDMPs configuration on the base sequence. Among
these findings is the observation of another conformational energy
minimum for B-family duplexes, namely BII conformation. It has
some sugar-phosphate torsions located in regions different from
those for the canonical BI conformation [2].
2. Methods
The systematic study of all naturally occurring 16 dDMP–Na+
complexes was performed using the DGAUSS program [7]. We con-
sidered this program due to its remarkable performance and
acceptable accuracy as described earlier [6]. DGAUSS uses the
so-called fitting basis set for fast approximation of the Coulomb
energy, facilitating QM study of relatively large systems. We used
split-valence double zeta basis set augmented with polarization
function (DZVP), which is specifically optimized for DFT calcula-
tions [7,8]. The original gradient-corrected exchange-correlation
functional developed by Perdew and Wang PW91PW91 [9] is used
in this work. This functional is among few which describe van der
Waals interactions in dimers of rare gases [10,11] and hydrocar-
bons [10], as well as in hydrogen-bonded complexes of simple
molecules including water–water and water–formamide dimers
[10]. Tsuzuki and Lüthi came to a conclusion that despite of the dif-
ficulties the PW91 functional has with dispersion interactions, it
may be a viable alternative to the ab initio methods [10]. More re-
cent studies demonstrate that PW91 functional reasonably repro-
duces correlated ab initio results for hydrogen-bonded [12,13]
and stacking [14] complexes of DNA bases. In addition, the results
of our study (see below) demonstrate that the conformational
characteristics of the considered systems are governed mainly by
properties of the sugar-phosphate backbone rather than by base
stacking. Good agreement with ab initio MP2 results obtained for
separate bases (see Section 3.3) is an additional argument in favor
of the selected functional.
In our previous work [6], to test the sensitivity of the obtained
results to the choice of a particular DFT functional, basis sets, and
density fitting, additional minimization of selected structures was
performed using the 6-31G(d,p) basis set [15], and the B3LYP func-
tional [16] as implemented in the GAMESS program [17] and in the
GAUSSIAN 03 program package [18]. The resulting structures had
their conformational parameters only slightly deviating from the
initial ones contorting to a few degrees in torsion and valence an-
gles, and no more than 0.02 Å in bond lengths, thereby supporting
the main conclusions made in that work. Similar to that the con-
clusions of the present work were validated by using ADF (Amster-
dam Density Functional) program [19] and triple zeta basis set.
Basically the agreement with experimental data only improves
upon improvement in the DFT functional and basis set. The ADF
package [19] uses Slater functions and accurate and tunable
numerical integration scheme, in which the grid is automatically,
adapted to the available basis functions. A density fit and linear
scaling techniques reduce the cost of the Coulomb potential evalu-
ation. The use of this software with PW91 functional and TZP (tri-
ple zeta with polarization functions) basis set enabled us to
reproduce experimental phosphate group geometry somewhat
better than that in our previous computations; however the main
conformational features of dDMPs obtained via DGAUSS program
were conserved.
Starting BI-like geometries of dDMPs for the first optimizations
of each of the dDMPs were generated using the HyperChem pro-
gram version 7.01 (HyperCube, Inc.). Due to the limitations in this
version of the HyperChem software the sugar rings were con-
structed with C30-exo instead of C20-endo puckering, characterized
by a pseudorotation phase angle P = 192. In our previous work [6]
we ruled out the possibility of biasing the computational results
toward the initial sugar puckering form. In the present work we
reoptimized the structures of dDMPs containing Guanine or Cyto-
sine bases starting from their last optimized geometries. In addi-
tion to that, for some of the dDMPs, the optimizations were
started from experimental geometries obtained from Nucleic Acid
Data Bank [1]. The initial BII-like configurations were obtained
from the experimental duplex fragments with BII characteristic
sets of torsion angles. Sodium cations of the dDMPs were placed
at equidistant positions to the anionic oxygens of phosphate group
(at O. . .Na distance of 2.2 Å) in the O1P–P–O2P plane. The gener-
ated structures were subjected to all-atom geometry optimization
and the geometric characteristics of the optimized minimum
energy conformations including bond lengths, valence and torsion
angles as well as hydrogen-bond characteristics (for the structures
with H bonds) and distances from Na+ ion to anion oxygens were
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analyzed. The program PROSIT [20] was used for the analysis of su-
gar-ring puckering and glycosidic torsions.
3. Results and discussion
3.1. General features of B-like minimum energy conformations.
Geometry of sugar-phosphate backbone
Following our previous work the present calculations confirm
our supposition that for all dDMPs there exist energy minima cor-
responding to B-family conformations of DNA duplexes. The tor-
sion angles of sugar-phosphate backbone, sugar-ring puckering,
and mutual positions of the bases of these minima are characteris-
tic for BI-conformations of DNA fragments in crystals. The bond
lengths and valence angles of all the optimized structures are with-
in the limits of the experimentally observed values [21,22] with
the exception of some values for the phosphate group. The latter
differences can be partially attributed to the differences in sur-
rounding of anionic groups of the model dDMPs relative to the
crystals or solutions as discussed in our previous paper [6].
The calculated values of sugar-phosphate torsions of the BI min-
ima for all the 16 dDMPs are listed in Table 1 along with experi-
mental mean values for dinucleoside monophosphate (DMP), and
trinucleoside diphosphate (TMP) crystals [22], and averaged values
for BI-conformation steps of olygonucleotide duplexes [2]. For
some of the sequences characterized by the most pronounced devi-
ation of one of conformational characteristics from other
sequences, we performed additional optimizations starting from
several different initial geometries generated by displacing some
of the torsions from the values of previously optimized structures.
These displacements were limited in magnitude to a few degrees
for the structures to remain within the BI-conformation region.
The differences found between the previous conformations and
the corresponding new optimized structures were at the range of
0.1–0.4 kcal/mol for total energy and 1–4 for torsions. It points
to the existence of a wide region of BI conformations in the
multi-dimensional space of conformational variables. The confor-
mational characteristics listed in the paper correspond to the low-
est energy values.
The use of ADF software with the PW91 functional and TZP ba-
sis set minimally changed the values of torsion angles. Some of
these changes are less than 1 with the maximal deviation up to
9; the averaged values for 7 torsions mentioned in Table 1 vary
from 1 to 4 depending on the base sequence. Despite the individ-
ual differences all the torsions are preserved in the regions charac-
teristic for BI family of duplex conformations.
To simplify the analysis of the results and comparison between
different sequences, we subdivided the 16 dDMPs to four groups
corresponding to base sequences, purine–purine (PUR–PUR),
pyrimidine–pyrimidine (PYR–PYR), purine–pyrimidine (PUR–
PYR), and pyrimidine–purine (PYR–PUR) sequences. Each of the
analyzed torsion angles stayed in the limits of one of the regions
observed for DMPs and TDPs in crystals [22], close to averaged
BI-values [2], namely, sc (gauche) for a and n, ap (trans) for b
and e, +sc (+gauche) for c; d values are characteristic for C20-endo
sugar puckering. Variation in a dihedral angles is very small along
the series of base sequences, being within 3.9 from the experi-
mental value; c dihedrals vary from 53.1 to 58, and d1 torsions
vary in 8.2 interval (Table 1). It is remarkable to see very small
variations in some torsions within one dDMP group, e.g. c values
are preserved within 1.5 for PUR–PUR and 1.2 for PYR–PYR se-
quences; e values vary in 1.3 interval for PYR–PYR and PUR–PYR
sequences. One may see remarkable systematic changes in some
torsions upon going from one dDMP group of base sequences to an-
other, e.g. all the values of d1 angle for PUR–PUR sequences are
greater than those for PYR–PYR group, and the values of d1 torsions
for all the PYR–PYR sequences are greater than those for PUR–PYR
or PYR–PUR groups. Notable are the n dihedral values in PYR–PUR
sequences, which are somewhat greater than those for other
dDMPs. The systematic variations of torsion angles with base se-
quence result in specific patterns of mutual base arrangements,
which will be discussed below.
3.2. Sugar-ring puckering and sugar-base mutual orientation
Sugar ring bond lengths and valence angles for all the calculated
dDMP structures are close to those in the averaged crystal data
[21,22]. DGAUSS results on sugar-ring puckering of BI conforma-
tions are presented in Table 2 along with their numerical charac-
teristics in terms of pseudorotation concept of Altona and
Sundaralingam [23]. Computational results on pseudorotation
phase angle P, obtained using ADF program package differ from
DGAUSS results collected in Table 2 by less than 10. The sugar-
ring puckering of all the deoxyriboses pertain to C20-endo type or
very close to it. Rather small but systematic differences between
50-end and 30-end nucleoside sugars can be seen from Table 2.
The pseudorotation phase angle P for the first sugar varies from
161 to 181, while for the second one this value varies from
141 to 172. One of 16 dDMPs displays C30-exo puckering of
C50-end sugar with P values close to those for C20-endo region,
and 4 dDMPs have C10-exo conformations of the 30-end sugars with
P value being few degrees smaller than those of C20-endo sugar
conformations. For the dDMPs with sugar puckering close to C20-
endo border, we performed additional calculations starting from
the structures generated with C20-endo sugars to confirm that
the small deviations of sugar puckering are real features rather
than a results of limited energy minimization. For all the dDMPs
the P value of 50-end sugar is greater than that for 30-end nucleo-
side. Puckering amplitudes fall in the most populated region for
monomer crystals, namely from 28.6 to 37.3.
The mutual orientations of the sugar and base rings correspond
to the anti region of the glycosyl torsion angle v (O40–C10–N9–C4
Table 1
Torsion angles of the sugar-phosphate backbone (definitions are in Fig. 1) and average
values of the angles between the base planes (u) for the calculated BI conformations
of dDMP–Na+ complexes.
dDMPs d1 e f a b c d2 u
Purine–Purine
dApdA 141.7 175.4 263.5 295.3 191.9 54.9 137.9 3.1
dGpdG 141.7 173.9 259.2 298.0 190.7 54.5 141.8 14.1
dAdpG 142.5 178.0 261.6 297.4 189.6 52.3 137.9 6.1
dGdpA 143.8 178.5 263.3 295.8 191.6 52.7 140.6 8.0
Pyrimidine–Pyrimidine
dCpdC 139.1 180.7 262.2 294.3 185.8 57.9 133.6 4.8
dTpdC 139.7 181.5 262.1 294.2 184.7 58.5 132.9 3.6
dCpdT 138.9 182.0 263.3 295.9 184.4 58.0 130.2 11.8
dTpdT 139.1 181.5 264.2 295.4 185.5 56.6 129.9 11.2
Purine–Pyrimidine
dApdC 136.5 183.1 259.8 297.5 181.2 56.8 132.2 18.1
dApdT 137.1 181.9 263.7 296.1 181.6 57.5 129.6 8.2
dGpdT 138.4 182.3 262.9 297.0 181.5 55.2 130.3 8.7
dGpdC 136.8 182.0 260.6 298.8 183.6 55.3 134.6 11.9
Pyrimidine–Purine
dCpdA 136.1 178.9 267.9 295.6 183.9 53.9 134.4 22.8
dTpdG 135.8 182.4 266.5 296.3 181.1 54.1 131.8 18.7
dCpdG 138.1 179.7 265.2 296.9 184.7 53.1 134.9 21.2
dTpdA 135.2 182.4 265.7 297.4 179.5 55.5 129.7 20.2
Exp.a 145.2 214.0 289.2 285.3 183.5 52.5 145.2
Exp. SDa 4.9 8.6 4.8 9.8 13.0 5.7 4.9
BIb 132.8 181.7 263.2 299.0 179.3 48.4 132.8
a Experimental data from Ref. [22].
b Averaged values for BI conformations from Ref. [2].
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for purine and O40–C10–N1–C2 for pyrimidine containing nucleo-
sides). This angle varies in the range between 225 and 252 for
pyrimidines in agreement with experimental finding of
229.8 ± 18.4; for purines this angle varies between 238 and 261
in agreementwith experimental value of 237 ± 24.3 [22]. The angle
v is more variable in 30-end nucleoside as compared to 50-end one.
The glycosyl bonds of the most of the nucleosides deviate slightly
from the base-ring plane, and for some dDMP the deviation can
be up to 8, the exact value being dependent on the base sequence.
In the previous paper [6] we mentioned a short contact (up to
3.3 Å) between O50 and cytosine C6, which can be viewed as a weak
C6–H6. . .O50 hydrogen-bond. A similarly short C. . .O distance was
mentioned in the first X-ray diffraction resolved nucleoside, cyti-
dine, as early as in 1950 [24]. Analysis of the more representative
set of optimized structures confirms the presence of the short
C6. . .O50 contact in pyrimidine nucleosides and similar C8. . .O50
contact in purine ones. Our computations clearly demonstrate that
such weak H-bond is an intrinsic feature of the nucleic acid sub-
units. Naturally, because these distances correspond to 50-end
nucleoside they cannot be considered as a structural characteristic
of inter-nucleoside region on the polynucleotide chain.
3.3. Geometry of the bases and the patterns of mutual base
arrangements
Good agreement between computational and experimental data
is obtained for the geometry of purine and pyrimidine rings. The
majority of endo cyclic bond lengths and bond angles in the opti-
mized structures differ from the averaged characteristics for
monomer crystals [21] by 0.004–0.015 ÅA
0
and 1–3, respectively.
Even closer agreement is observed when our DFT calculations are
compared against the more accurate MP2 ab initio calculations of
bases [25]. Differences between the values of bond lengths in dif-
ferent structures are about or less than 0.01 Å, and those for va-
lence angles are less than 1o. According to our calculations the
base rings of all the dDMPs are slightly distorted from planarity,
which can be seen in deviation of some endo cyclic torsions from
expected values for planar structure by up to 6. The extent of
nonplanarity of the base rings varies from one nucleotide
sequence to another. The purine and pyrimidine rings in the opti-
mized structures of the separate bases are practically planar with
all the intra-ring torsions being within the ±1 limit.
A significant pyramidalization of the amino groups is observed
in all the optimized structures despite the general tendency of DFT
methods to underestimate the level of pyramidalization [26]. The
degree of pyramidalization of the amino groups depends on base
sequence in dDMP. It is interesting to note that our calculations
of separate bases reproduce well the geometry characteristics of
pyramidalized amino groups obtained by so far most accurate cal-
culations performed at the MP2 level with a large basis set. These
characteristics demonstrate substantially more pronounced non-
planarity of guanine amino group in comparison with adenine
and cytosine ones. The sum of three valence angles of amino group
calculated by DGAUSS program equals to 352.3, 354.0, and 339.9
for cytosine, adenine, and guanine, respectively. These values cal-
culated by ab initio MP2/aug-cc-pVQZ method are 355.4, 355.2,
and 342.0 [25], and those obtained from ab initio MP2/6-
31G(2df,p) level of calculations are 351.9, 352.9, and 339.6,
respectively [27]. The close agreement with MP2 results was ob-
tained for torsion angles of amino group. For example we can men-
tion the torsion angle describing out of plane displacement of one
of amino group hydrogens, namely (N of the ring)–(C of the ring)–
(amino N)–(H participating in Watson–Crick pairing). The values
calculated by DGAUSS program for Cyt, Ade, and Gua are 14.5,
13.1, and 39.7, respectively. They agree well with the values of
10.0, 12.9, and 36.5 obtained via MP2/aug-cc-pVQZ method [25],
as well as with 12.6, 16.5, and 39.2 obtained from MP2/6-
31G(2df,p) calculations [27]. All the dDMPs have more pronounced
amino group pyramidalization as compared to that of the separate
bases. The sum of three valence angles of amino group is confined
to the region from 332.9 to 347.9, from 336.7 to 354.6, and from
331.0 to 339.8 for Cyt, Ade, and Gua bases of dDMPs respectively.
The torsion angle mentioned above varies from 13.3 to 24.3, from
16.1 to 23.1, and from 14.7 to 51.1 for Cyt, Ade, and Gua,
respectively. Such pyramidalization of amino group enables the
formation of N–H. . .O hydrogen-bonds between the amino group
of the 50-end base and the carbonyl oxygen of the 30-end base.
Two base rings in optimized structures of all the dDMPs are lo-
cated in nearly parallel disposition, and the plane-plane angle
between the rings of the stacked bases varies from 3o to 23o (see
Table 2
Characteristics of the sugar ring conformations and glycosyl torsion angles of the dDMP–Na+ complexes obtained by PW91PW91/DZVP method.
dDMP–Na+ 50-end nucleoside 30-end nucleoside
Puckering P tmax v Puckering P tmax v
Purine–Purine
dApdA C20-endo 176 31.7 115 C20-endo 167 30.3 104
dGpdG C20-endo 177 31.8 109 C20-endo 173 31.3 99
dApdG C20-endo 177 31.9 116 C20-endo 168 30.1 105
dGpdA C30-exo 181 31.6 116 C20-endo 172 31.6 100.0
Pyrimidine–Pyrimidine
dCpdC C20-endo 168 31.2 127 C20-endo 150 33.0 135
dTpdC C20-endo 168 31.5 126 C20-endo 150 34.0 133
dCpdT C20-endo 167 31.2 133 C10-exo 143 37.1 126
dTpdT C20-endo 169 30.9 127 C10-exo 142 37.2 126
Purine–Pyrimidine
dApdC C20-endo 160 31.6 121 C20-endo 148 34.1 110
dApdT C20-endo 164 30.8 120 C10-exo 143 37.9 109
dGpdT C20-endo 169 29.9 120 C20-endo 145 34.4 112
dGpdC C20-endo 161 31.3 122 C20-endo 153 34.0 108
Pyrimidine–Purine
dCpdA C20-endo 166 28.6 129 C20-endo 148 36.9 105
dTpdG C20-endo 167 28.2 128 C20-endo 145 35.1 109
dCpdG C20-endo 168 30.6 128 C20-endo 152 34.6 103
dTpdA C20-endo 164 28.7 130 C10-exo 141 36.6 108
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Table 1). Such base–base arrangement is usually attributed to
dispersion interactions between the planar purine and pyrimidine
rings. Contrarily to that our results demonstrate, that these inter-
actions do not play the crucial role in the case of the dDMPs. In-
deed, as follows from the calculations, the angle between base
planes does not depend on the base overlap; nearly parallel plane
arrangement occurs for the structures, which have practically no
base overlap (dTpdC and dCpdC) and also for the structures with
extensive base overlap (dApdA and dGpdA). From this we conclude
that the existence of BI-like local energy minima is not determined
by the base–base stacking interactions but the major contribution
to the stability of the B-like single-stranded fragments comes from
the conformational properties of the sugar-phosphate backbone.
The analysis of mutual base positions in the optimized
structures of four dDMPs containing Gua and Cyt enabled us to
previously conclude that base overlap depends on nucleotide
sequence, namely, extensive overlap in Gua-Gua and Gua-Cyt se-
quences but minor overlap in Cyt-Cyt and Cyt-Gua sequences [6].
This observation is in excellent agreement with the base disposi-
tion patterns extracted from crystallographic structures of B-DNA
duplexes [28]. Based on these data we conclude that the mutual
position of the bases in minimal fragments of single DNA strands
predisposes the PUR–PUR, PUR–PYR, PYR–PUR, and PYR–PYR base
arrangements in DNA duplexes. The calculations for all the 16
dDMPs demonstrate that PUR–PUR and PUR–PYR base sequences
have extended overlap of pyrimidine rings of the bases. An exam-
ple of such structure, the optimized dApdT conformation in com-
parison with dApdT step of the d(CpGpCpGpApApTpTpCpGpCpG)
duplex [29] is displayed in Fig. 2. Our optimization of this dDMP
was initiated from the standard sequence-independent B confor-
mation fragment. However during the calculation the studied
structure closely converged to the experimental structure pattern
of PUR–PYR sequence of the above DNA fragment (see also
Fig. 2d of [28] demonstrating the dApdT fragment from another
X-ray structure [30]). Interestingly all dDMPs with PYR–PUR and
PYR–PYR base sequence have small to almost negligible overlap
of the bases. This can be seen on the example of dCpdA, with the
optimization started from the sequence-independent structure.
The resulting structure is displayed in Fig. 3 in comparison with
the corresponding step of the d(CpGpCpApApTpTpGpCpG) duplex
[31] (see also Fig. 2a of [28] demonstrating the dCpdA fragment
from another X-ray structure [32]). This result enables us to
extrapolate the important role of local interactions in the single
chain going to the global sequence dependence of double helix,
or more specifically, one can speak about the conformational pref-
erences of sugar-phosphate backbone of single chain contributing
to the conformational preferences of the fragments of DNA du-
plexes. The existence of such minima for single chain fragments
may be important for biological functioning of DNA facilitating
an addition of new nucleotide in the processes of its replication
and restoration of double helix after unwinding.
3.4. Perspectives of the investigation. Other minima of DMPs related to
the duplex structures, BII-like conformations
The DFT calculations for all the 16 dDMPs have confirmed our
supposition about existence of B-like local energy minimum in sin-
gle-chain DNA fragment. Surely, the use of more accurate QM
Fig. 1. Designation of the torsion angles of the sugar-phosphate backbone of the
dDMPs.
Fig. 2. The minimum energy conformation of the dApdT–Na+ complex (left), and dApdT step of d(CpGpCpGpApApTpTpCpGpCpG) duplex in the crystal [22] (right). Extensive
base–base overlap and nearly the same mutual base positions can be observed. Atoms closer to the observer are richer in color.
V.I. Poltev et al. / Journal of Molecular Structure: THEOCHEM 912 (2009) 53–59 57
methods and the consideration of larger fragments could result in
uncovering additional structural details leading to discovery of
new regularities determining the stability of three-dimensional
structure of DNA. But the main conclusions about the conforma-
tional predisposition of single-chain strands to B-type DNA helix
formation are unlikely to be changed. Other questions arise in rela-
tion to these calculations and DNA structure. The first set of the
problems can be formulated as follows: ‘‘Is this situation with sin-
gle-chain interactions is unique to the canonical B form?” What
about other DNA conformations revealed in the crystals of duplex
fragments, e.g. A form, BII conformations, and mixed A/B or B/A
forms of dinucleotide steps? Is it possible to predict from compu-
tations of dDMPs the preferences of various steps to the specific
conformation or the contributions of other interactions become
predominant? To answer these questions we started to search for
other minima of dDMPs related to helical structures. Such a study
is an order of magnitude more extensive and time-consuming one
as compared to those presented here. Nevertheless, some prelimin-
ary results and further suggestions can already be mentioned. As
for A form, preliminary calculations confirm our expectation of
such local minima. These minima are deeper than those for B form
(e.g. for dCpdC A form is more favorable than B form by about
5 kcal/mol). We detected the minima corresponding to BII confor-
mation for three dDMPs, namely to dCpdG, dCpdA, and dGpdG,
starting the optimization from the geometry of these steps directly
extracted from the X-ray structures. The torsion angles of sugar-
phosphate backbone and inter-base angles are listed in the Table
3 together with averaged values of torsions for BII structure [2].
These results definitely confirm the conclusion [2] that BII is a dis-
tinct B-form with differences in the values of three backbone tor-
sions, namely n being in trans region, high value of e and low
value of b in comparison to BI conformations. We have showed,
at least for some base sequences, that BII form corresponds to a lo-
cal energy minimum on dDMP potential energy surface, and that
the BII conformation is not a result of interactions with other mol-
ecules in the crystals. The conformation of dCpdG corresponding to
BII-minimum of energy together with such conformation in duplex
crystal [33] is shown in Fig. 4. The conclusion about the predis-
posed contribution of intra-chain interactions to a particular du-
plex conformation depending on specific base sequence will be
further studied by computation of various energy minima on the
potential energy surface of dDMPs. Such study is currently in
progress.
Fig. 3. The minimum energy conformation of the dCpdA–Na+ complex (left), and dCpdA step of d(CpGpCpApApTpTpGpCpG) duplex in the crystal [24] (right).
Table 3
Torsion angles of the sugar-phosphate backbone and average values of the angles
between the base planes (u) for the calculated BII conformations of dDMP–Na+
complexes.
dDMP–Na+ d1 e f a b c d2 u
dCpdA 130.7 228.4 194.6 300.5 155.1 49.3 142.5 10.6
dCpdG 128.8 242.8 171.3 295.8 136.7 50.9 139.0 6.45
dGpdG 138.7 224.2 193.1 299.5 146.8 47.9 129.7 4.9
BIIa 143.0 251.1 168.0 292.6 143.1 46.0 143.0
a Averaged values for BII conformations from Ref. [2].
Fig. 4. The minimum energy conformation of the dCpdG–Na+ complex corresponding to BII conformation (left), and the same step of d(CpTpCpTpCpGpApGpApG) duplex in
the crystal [26] (right).
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a b s t r a c t
Novel boron compounds – 5,6-saturated borauracil derivatives (4-bromo-5,6-dihydroborauracil, 4-
hydroxy-5,6-dihydroborauracil and 4-methoxy-5,6-dihydroborauracil) are presented along with other
boron compounds obtained from N-vinylurea: N-substituted b-boronic amino acid – 2-{[(dihydroxybor-
ano-amino)(dihydroxyboranooxy)methyl]-amino}ethylboronic acid and substituted methoxy-borane O-
[(1-amino-1-N-vinylamino)methyl]dihydroxyboronate.
 2009 Elsevier Inc. All rights reserved.
1. Introduction
Hydroboration, an important reaction in synthetic organic
chemistry, is accomplished with various hydroborating agents,
including borane-tetrahydrofuran, borane-pyridine, borane-di-
methyl sulfide, 9-BBN, and thexylborane complexes. Those re-
agents are commercially available and offer many options for
selective hydroboration [1–5].
Little is known about the hydroboration of olefinic ureas com-
pared to other olefinic systems; the published data have been re-
viewed by Soloway et al. [6,7]. Only a few boronic acids
containing urea-derived moieties are known and the intermediates
formed during the respective reactions were not described.
In this paper we present novel boron compounds 1–6. Com-
pounds 1 and 2, i.e. a substituted methoxyborane (O-[(1-amino-
1-N-vinylamino)methyl]dihydroxyboronate), and N-substituted
b-boronic amino acid, respectively (Fig. 1), could be used as build-
ing blocks for pharmaceuticals or as cross-linking agents in poly-
mer chemistry.
The most important aspect of this work are novel boron ana-
logues of 5,6-dihydrouracil (5,6-dihydroborauracils, 4–6 see
Fig. 2). There are only few boron analogues of nucleic acid bases,
with Zhuo group’s benzoborauracils as the most important work
of the last 20 years [8]. It should be noted that borauracils, bora-
thymines or boracytosines and their derivatives should be key
compounds in the search for e.g. new anticancer compounds. Bor-
on analogues of biologically active compounds have very interest-
ing properties. The mechanism of action that is unique for those
compounds is believed to be the nucleophilic attack of an enzyme
on to the electron deficient sp2 boron, resulting in the tetrahedral
sp3 hybridized boron ‘‘ate” complex. The boron analogue–enzyme
‘‘ate” complex is highly stable resulting in effective inhibition of
the enzyme [9–11]. Additionally, boron-containing compounds
can be considered potentially active in boron–neutron capture
therapy (BNCT) [12].
2. Results and discussion
2.1. Hydroboration of N-vinylurea
Of particular interest is the fact that O-[(1-amino-1-N-vinylami-
no)methyl]dihydroxyboronate (1) was synthesized in the present
study by an almost identical method to that used by Soloway’s
group [12]. Instead of the expected hydroboration product (borane
to C@C double bond addition product), compound 1 is the product
of addition at the carbonyl group of the vinylurea (Fig. 1). While
our synthetic approach allowed the substrates, N-vinylurea and
borane complex (BH3  THF), to be used in strictly equimolar quan-
tities, the same reaction would have been difficult to perform using
gaseous diborane as reported [6,7,13].
A proposed intermediate compound 10 resulting from addition
of borane to the carbonyl group of N-vinylurea undergoes hydroly-
sis to give 1. The vinyl moiety of N-vinylurea was not affected dur-
ing the reaction according to NMR spectroscopy. Carbonyl group
reduction by diborane gas and borane complexes have been
0045-2068/$ - see front matter  2009 Elsevier Inc. All rights reserved.
doi:10.1016/j.bioorg.2009.03.003
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studied widely by both experimental and computational ap-
proaches [14–16]. The reduction of urea moiety should not be sur-
prising as boranes also are known to perform reduction of wide
range of amides. The typical reduction of amide is performed in
mild conditions (66 C, atmospheric pressure). Reduction with bor-
anes in these conditions can lead even to amines [17]. The pro-
posed reaction mechanism suggests that the methine hydrogen
atom originates from the borane complex, with the remaining
BH2 moiety being attached to the oxygen atom. The final
dihydroxyboron structural fragment then results from hydrolysis.
The presented experimental data shows that hydroboration of
the unsaturated vinyl moiety also resulted in the formation of pro-
posed intermediate 20, which could be easily hydrolyzed to
dihydroxyboron derivative 2. When the borane to N-vinylurea mo-
lar ratio wasP1.8, addition of borane to the carbonyl moiety took
place, followed by hydroboration of the olefinic fragment and sub-
stitution of hydrogen on the peripheral –NH2 group (Fig. 1), giving
20, which hydrolyzed to compound 2. Using borane to vinylurea
molar ratios ranging from 1.8 to 2.8 resulted in formation of com-
pounds 1 and 2 in different proportions. Compound 2was obtained
as the major product when the borane to vinylurea molar ratio was
P3.1. No products containing two dihydroxyboron moieties were
detected. Surprisingly, our synthetic route to 1 is very similar to
that previously described, leading to b-ureidoethylboronic acid
by direct C@C bond hydroboration, thus having an unreacted car-
bonyl moiety of boronic acid [6,7]. It should be noted that newly
formed O-linked boric acid esters (1 and 2) could react with water
and also with simple alcohols and due to this reactivity the solu-
tions of those compounds for NMR spectra were prepared in apro-
tic solvents.
2.2. Computational analysis of the regio- and chemoselectivity of N-
vinylurea and its derivatives
The alkene and alkyne hydroboration reaction mechanism is
well known.[17] Steric effects are responsible for the regioselectiv-
ity, especially when using bulky borane reagents, however, for the
majority of olefins, the most significant factors are electronic ef-
fects. Attack of the electrophilic reagent, e.g. BH3, causes significant
redistribution of the electron density in the target molecule, and as
a consequence affects its reactivity. In the present work we consid-
ered a simplified mechanism for the hydroboration of N-vinylurea
by borane-tetrahydrofuran reagent.
The atomic charges calculations show that the sum of the natu-
ral charges of the olefinic moiety (C-1, C-2, and adjacent hydro-
gens) in N-vinylurea is more positive (+0.153 a.u.) than in
intermediate 10 (+0.098 a.u.), indicating that N-vinylurea should re-
act with the borane complex more slowly than 10. This can be ratio-
nalized by the lack of a carbonyl-related strong resonance effect in
1 and 10 which is known for amides and also occurs in urea deriv-
atives. The calculated natural charge on the C-4 carbonyl atom, is
+0.771 a.u., and this is the highest positive partial charge found
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for N-vinylurea. Therefore, it is reasonable to expect that the par-
tially negative hydrogen atom of the borane complex (for compar-
ison, the natural charge of the H atom in BH3 is 0.107 a.u.) should
attack the carbonyl carbon [18–20]. This suggestion agrees with
the experimental results. In summary, compounds 2 and 20 can
be obtained from N-vinylurea via hydroboration of compound 10
which is a borane-carbonyl addition product (vide supra).
2.3. Synthesis of 5,6-dihydroborauracils
The knowledge of small borane (BH3 and its complexes) reactiv-
ity towards carbonyl and amide groups suggested the use of the
bulky dibromoborane complex for the reaction with vinylurea.
Experimental data proved that dibromoborane–dimethylsulfide
complex does not react with carbonyl group as it was observed
for BH3:SMe2 complex. The possible explanation for this phenom-
enon is lower reactivity of BHBr2 reagent caused by both much
higher steric repulsion and a strong electron withdrawing effect
from two bromine atoms. Moreover, tetrahydrofuran could easily
form BHBr2:THF complex with even higher steric hindrance. The
BHBr2 complex hydroboration step (Fig. 2) was conducted at much
higher temperature (66 C) than in the case of BH3 complex (0 C)
and unfortunately it resulted in slow loss of dibromoborane. This
negative effect was neutralized by multiple additions of dibrom-
oborane complex every hour of reaction time.
The obtained linear product 3 (Fig. 2) is similar to the one ob-
tained by Soloway group having BBr2 instead of BH2 group [12].
The work mentioned suggested possibility of formation of six-
membered complex where carbonyl oxygen coordinates to boron
atom. Such a possibility also exists for compound 3 with coordina-
tion of carbonyl oxygen or, more likely, peripheral nitrogen atom
(Fig. 2). The same group obtained also a linear boronic acid
(HO)2BCH2CH2NHCONH2 but failed to convert it into cyclic product
with covalent B–N bond [13].
The reaction of 3 with potassium hydroxide gave cyclic six-
membered product 4-bromo-5,6-dihydroborauracil (4). To the best
of our knowledge, 4 is the first boron-containing 5,6-saturated ana-
logue of uracil. The formation of covalent B–N bond was confirmed
by our analytical data, but unfortunately, we were unable to pre-
pare X-ray diffraction quality monocrystal. The 11B NMR chemical
shift of compound 4 (54.5 ppm) confirmed that boron atom is
covalently connected to carbon, nitrogen and bromine atoms
[21–23]. The exceptionally interesting aspect is the possibility of
coordination to boron atom of chiral electron pair donors (e.g. lac-
tate, amino acids, etc.) that should result in formation of diastereo-
isomeric products. Another dihydrouracils – 4-O-methoxy-5,6-
dihydroborauracil (5) and 4-hydroxy-5,6-dihydroborauracil (6)
were prepared by methanolysis (5) or hydrolysis (6) of 4. The 11B
chemical shifts of 5 (23.7 ppm) and 6 (24.9 ppm) are in accord with
literature data [8,21–23]. There was also observed the formation of
tetrahedral bis-methanol adduct of 5 (5:CD3OD) with 11B chemical
shift of 1.6 ppm, similar to those described by Zhuo et al. [8]. The
problem of determining the atom bound to boron was previously
discussed by Zhuo et al. [8]. The authors proved that hydroxyboron
compound (B–OH cyclic product) of benzoborauracils contains B–
N bond in solid state or in non-coordinating solvent, while the
titration with methanol gave bismethanol adduct that may contain
B–O (carbonyl oxygen coordinating to boron) form in equilibrium
with B–N form in solution. The removal of methanol gave starting
B–N form as judged from 11B NMR spectra [8]. Our observations are
very similar to that of Zhuo et al. Solution of compound 6 in non-
coordinating solvent contains mainly B–N form with 11B chemical
shifts value of 24.9 ppm (for 6), a value that differs significantly
from literature data for alkylboronic acids and their esters ((R–
B(OH)2 and R–B(OR)2, respectively, R@alkyl) where chemical shifts
that are always in 30–34 ppm range [24–28]. It should be noted
that methanol (or other alcohol of small steric hindrance) solution
could contain some amount of B–O form, the quantitative analysis
of B–O/B–N equilibrium is difficult due to process rate that is fast
in NMR-scale in analyzed conditions (0–20 C).
3. Conclusions
The synthesis, reactivity and spectroscopic properties of novel
boron compounds are presented. The intermediate compound 10
is the product of addition of the borane complex at the carbonyl
group of N-vinylurea giving O-[(1-amino-1-N-vinylami-
no)methyl]dihydroxyboronate (1) after hydrolysis. No reaction in
the vinyl moiety of N-vinylurea was apparent under conditions
used. Borane to N-vinylurea molar ratios higher than 1.8 resulted
in addition of borane to the carbonyl moiety, followed by hydrob-
oration of the olefinic fragment and substitution of a hydrogen
from the peripheral–NH2 group. Borane to vinylurea molar ratios
ranging from 1.8 to 2.8 resulted in the formation of compounds 1
and 2 in different proportions. The calculated natural charge on
the C-4 carbonyl atom of +0.771 a.u. is the highest positive partial
charge found for N-vinylurea. Therefore, the partially negative
hydrogen atom from the borane complex may be expected to at-
tack the carbonyl carbon, in accord with the experimental results.
Reactionof dibromoborane complexwithN-vinylurea conducted
in higher temperature (66 C) resulted in synthesis of C@C double
bond hydroboration product 3, formally a boronic acid bromide.
Its reaction with potassium hydroxide in aprotic solvent resulted
in heterocyclic product 4, a first 5,6-dihydroborauracil derivative.
Its hydrolysis gave B–OH moiety at 4-position of saturated ring
(6), and reaction with methanol resulted in formation of another
cyclic compound containing B–OMe structural fragment (5).
4. Experimental
4.1. Materials and methods
1H NMR spectra were obtained with Bruker Avance spectrome-
ter operating in the quadrature mode at 500 MHz. All 11B spectra
were performed using 5 mm pure quartz NMR tube. The residual
peaks of deuterated solvents were used as internal standards. Ele-
mental analysiswas performedusing Carlo Erba Elemental Analyser
EA 1108. GC–MS analysis was carried out on Agilent Technologies
6890 N apparatus with 5973-Network mass detector. FTIR spectra
was recorded on Perkin Elmer Paragon 1000 apparatus. The N-
vinylurea was prepared using known method [29]. All other re-
agents and deuterated solvents of the highest commercially avail-
able grade were purchased from Aldrich and used without further
purification (with exception for acetone-d6 which was dried with
anhydrous sodium sulfate). Rubber septa joints were purchased
from Aldrich. All procedures, including preparation of samples for
the NMR measurements, were carried out under nitrogen.
The theoretical calculations have been performed with the den-
sity functional theory and the B3LYP functional with the aug-cc-
pVTZ basis set implemented in the Gaussian G03 (rev. C.02) suite
of programs [30]. The optimal geometries were obtained with de-
fault methods achieving the stationary point controlled by four
convergence criteria. The electronic density distribution has been
analyzed with the use of the NBO 5.G module implemented also
in the Gaussian G03.
4.2. Preparation of O-[(1-amino-1-N-vinylamino)methyl]-
dihydroxyboronate (1)
1 M Borane–tetrahydrofuran complex in THF (1 g of borane–
THF complex, 11.6 mmol) was placed in a dry, 100 ml round-
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bottom flask purged with dry nitrogen. The flask was then im-
mersed in an ice bath. N-vinylurea [29] (1 g in 5 ml of dry THF,
11.6 mmol) was added dropwise over a period of 30 min and the
reaction was allowed to run for another 30 min, with the reaction
temperature rising to 5 C. Distilled and deoxygenated water
(630 lL, 35 mmol) was added dropwise. Following completion of
hydrogen evolution, all volatile products were removed under re-
duced pressure. Finally, the resulting solid was dried under high
vacuum. Compound 1 was obtained in 96% yield (ca. 1.46 g). MS
(electrospray ionization, m/z): 131 + 132 (100%). Elemental Anal.
Calcd for C3H9BN2O3: C, 27.31; H, 6.83; N, 21.24. Found: C, 27.21;
H, 6.86; N, 21.22. FTIR (KBr, cm1) 3320 (mN–H, s, br); 3223 (mB–
O–H, s, br); 2104 (mC@CH, w); 1663 (mN–H, m); 1617 (mC@C, m);
1560 (mC–O, m); 1345 (mB–O, m); 1026 (mC–N, m); 750–760
(mN–H, w). 1H NMR (acetone-d6, ppm): 7.67–7.78 (m, Hvinyl, 3H);
5.77 (s, OH, 1H), 3.64 (m, CH, 1H), 1.72 (m, NH, 1H); 1.46 (m,
NH2, 2H). 13C NMR (acetone-d6, ppm): 83.2 (CHsatur.); 115.8,
165.0 (Cvinyl). 11B NMR (acetone-d6, ppm): 19.21.
4.3. Preparation of 2-{[(dihydroxyboranoamino) (dihydroxybor-
anooxy)methyl]amino}ethylboronic acid (2) (Fig. 1)
1 M Borane–tetrahydrofuran complex in THF (3.1 g of borane-
THF complex, 36.1 mmol) was placed in a dry, 100 ml round-bot-
tom flask purged with dry nitrogen. The flask was then immersed
in an ice bath. N-vinylurea [29] (1 g, 11.6 mmol, in 5 ml of dry THF)
was added dropwise over a period of 30 min, and the reaction was
run for another 90 min, with the reaction temperature rising to
10 C. Distilled and deoxygenated water (2 ml, 0.108 mol) was
added dropwise. Following completion of hydrogen evolution, all
the volatile products were removed under reduced pressure and
the resulting solid was dried under high vacuum. Compound 2
was obtained in 85% yield (ca. 2.2 g). MS (electrospray ionization,
m/z): 219–222 (100%). Elemental Anal. Calcd for C3H13BN2O7: C,
16.26; H, 5.87; N, 12.65. Found: C, 16.22; H, 5.90; N, 12.57. 1H
NMR (acetone-d6, ppm): 7.0, 7.27, 5.30 (br., OH, 2H + 2H + 2H)
3.30 (m, CH, 1H); 3.13 (m, CH2–N, 2H); 2.18 (m, NH–CH2, 1H);
2.14 (d, NH–B, 1H) 1.06 (tr., B–CH2, 2H). 11B NMR (acetone-d6,
ppm): 20.24; 19.70, 13.02. Compounds 1 and 2 were also ob-
tained by analogous reactions of N-vinylurea with 1 M toluene
solution of borane–dimethylsulfide complex, in yields of 92% and
79%, respectively.
4.4. Preparation of 3 and 4
Dibromoborane–dimethylsulfide complex (1.5 g of dibromobo-
rane–Me2S complex, 6.4 mmol) was placed in a 100 ml round-bot-
tom flask containing 20 ml of anhydrous THF. The flask was then
immersed in a silicon oil bath. N-vinylurea [29] (550 mg in 5 ml
of dry THF) was added dropwise to the reaction flask at THF reflux
conditions over a period of 10 min and the reaction was allowed to
run for another 30 min. Other portions of dibromoborane–dimeth-
ylsulfide complex (1.5 g) were added every 1 h to the refluxing
mixture (total amount of BHBr2:SMe2 complex used in the reaction
was 15 g). All volatile products were removed under reduced pres-
sure. Finally, the resulting solid was dried under high vacuum.
Compound 3 was obtained in 85% yield as judged from NMR spec-
tra. Reaction product was dissolved in anhydrous THF (20 ml) con-
taining 3.6 g of dry KOH and refluxed for 48 h. Resulting product
was vacuum dried. Compound 4 was washed out with two por-
tions of chloroform (2  10 ml). Yield: 880 mg (78% total yield).
Analytical data for 4: MS (electrospray ionization, m/z): 176–177
(100%). Elemental Anal. Calcd for C3H6BBrN2O: C, 20.38; H, 3.42:
N, 15.84. Found: C, 20.30; H, 3.46; N, 15.81. 1H NMR (acetone-d6,
ppm): 5.80–5.56 (br, NH, 2H); 3.35 (m, N–CH2, 2H), 1.18 (m,
B–CH2, 2H). 13C NMR (acetone-d6, ppm): 155.2 (C@O); 35.1 (N–
CH2), 15.6 (B–CH2). 11B NMR (acetone-d6, ppm): 54.5.
4.5. Preparation of 5
To the solution of 4 in anhydrous tetrahydrofurane (200 mg in
10 ml of THF) anhydrous methanol was added (50 ml). Reaction
mixture was stirred in room temperature for 1 h and vacuum dried
(60 C, 48 h at 0.01 Pa). Compound 5 was obtained in almost quan-
titative yield (approx. 0.14 g). Analytical data for 5: MS (electro-
spray ionization, m/z): 127–128 (100%). Elemental Anal. Calcd for
C4H9BN2O2: C, 37.55; H, 7.09; N, 21.90. Found: C, 37.48; H, 7.11;
N, 21.84. 1H NMR (acetone-d6, ppm): 5.61–5.72 (br, NH, 2H);
3.61 (s, OMe, 3H), 3.38 (m, N–CH2, 2H), 1.28 (m, B–CH2, 2H). 13C
NMR (acetone-d6, ppm): 157.2 (C@O); 53.1 (OMe); 35.2 (N–CH2),
17.0 (B–CH2). 11B NMR (acetone-d6, ppm): 23.7. 11B NMR (metha-
nol-d4, ppm): 1.6.
4.6. Preparation of 6
To the solution of 4 in anhydrous tetrahydrofurane (300 mg in
10 ml of THF) deoxygenated water was added (10 ml). Reaction
mixture was stirred in room temperature for 1 h and vacuum
dried. Compound 6 was obtained in almost quantitative yield (ap-
prox. 0.19 g). Analytical data for 6: MS (electrospray ionization, m/
z): 113–114 (100%). Elemental Anal. Calcd for C3H7BN2O2: C, 31.6;
H, 6.19; N, 24.59. Found C, 31.54; H, 6.23; N, 24.52. 1H NMR (ace-
tone-d6, ppm): 8.43 (br, B–OH, 1H); 5.68–5.81 (br, NH, 2H); 3.42
(m, N–CH2, 2H), 1.31 (m, B–CH2, 2H). 13C NMR (acetone-d6,
ppm): 156.2 (C@O); 35.0 (N–CH2), 17.5 (B–CH2). 11B NMR (ace-
tone-d6, ppm): 24.9. 1H NMR (D2O, ppm): 3.48 (m, N–CH2, 2H),
1.34 (m, B–CH2, 2H).
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Abstract
Hydroxyborohydride (sodium and potassium salts) were prepared by a one-pot method and the 1H NMR spectrum of sodium
hydroxyborohydride was recorded for the first time. Based on an NMR experiment, hydroxyborohydride was found to be more reactive
toward acetone carbonyl than borohydride. The calculated 11B- and 10B–H coupling constants are in very good agreement with exper-
imental data, and support the hypothesis about the detection of the (BH3OH)
 anion as an individual species in solution.
 2007 Elsevier B.V. All rights reserved.
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Introduction
Both organic and inorganic boron compounds have
been widely used in synthetic chemistry, their development
being fast [1,2], particularly in the last fifteen years, e.g.:
Suzuki reagents [3,4], Soderquist reagents [5–7], borylli-
thium [1] and many others [8–16]. The most popular inor-
ganic boron reagents used in chemical synthesis are
borohydride salts that are especially suitable for reduction
of carbonyl species.
The hydroxyborohydride ion (BH3OH)
 is a very useful
reducing agent, used usually for the reduction of carbonyl
compounds with limited solubility in organic solvents of
low polarity [17]. Reduction of carbonyl compounds by
BH4 (borohydride), compared to (BH3OH)
 (hydroxy-
borohydride), shows usually higher reaction rates, and
occurs at significantly lower temperatures [18].
Hydroxyborohydride ion is formed during hydrolysis of
the borohydride ion BH4 under neutral or acidic condi-
tions. Very few approaches have been described, including
those utilizing flow reactors, to synthesize hydroxyborohy-
dride salts. Surprisingly, the reaction was, in most cases,
carried out in aqueous solutions [19–21].
A new, fast, one-pot method of sodium/potassium
hydroxyborohydride preparation is presented, along with
the 1H NMR spectrum of hydroxyborohydride, recorded
for the first time. Additionally, NMR studies demonstrated
higher reactivity of hydroxyborohydride than borohydride
toward acetone carbonyl.
Experimental
Methods and materials
1H NMR spectra were obtained with Bruker Avance
spectrometer operating in the quadrature mode at
500 MHz. The residual peaks of deuterated solvents were
used as internal standards. Elemental analysis was per-
formed using Carlo Erba Elemental Analyser EA 1108.
GC–MS analysis was carried out on Agilent Technologies
6890N apparatus with 5973-Network mass detector. All
1387-7003/$ - see front matter  2007 Elsevier B.V. All rights reserved.
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reagents and deuterated solvents of the highest commer-
cially available grade were purchased from Aldrich, and
used without further purification. Rubber septa joints were
purchased from Aldrich. All procedures, including prepa-
ration of samples for the NMRmeasurements, were carried
out under nitrogen.
Theoretical calculations were performed with the
B3LYP/aug-cc-pVTZ method and, in a few cases, also with
the PW91PW91/aug-cc-pVTZ method. The optimal geom-
etries were obtained and confirmed with positive harmonic
frequencies. All calculations were performed with the
Gaussian G03 (Rev. C.02) suite of programs [22–30]. The
pictures of calculated structures were made with the Mol-
den program and are presented in Supplementary materials
[31].
Synthesis of sodium hydroxyborohydride
Sodium borohydride (0.462 g, 12.2 mmol) was placed in
a dry, 100 ml round-bottom flask, containing 20 ml anhy-
drous tetrahydrofurane and a magnetic stirring bar, fitted
with rubber septa, and immersed in a water bath at room
temperature. Deoxygenated water (0.22 ml, 12.2 mmol)
was added dropwise. The progress of the reaction was asso-
ciated by hydrogen sodium borohydride particles being dis-
solved, and the solution becoming slightly turbid.
Following completion of hydrogen evolution, all volatile
products were removed under reduced pressure. Finally,
the solid was dried under high vacuum. Sodium hydroxy-
borohydride was obtained in 96% yield (ca. 0.63 g). GC–
MS studies gave uncertain results due to high reactivity
of the hydroxyborohydride ion, m/z = 54 (100%). Elemen-
tal analysis: H 7.51% (calculated 7.43%). 1H NMR
((CD3)2CO, ppm): 2.96 (OH, broad, 1H); 0.46, 0.29,
0.13, 0.03 (BH, quartet, 3H total); 0.37, 0.32, 0.26,
0.21, 0.16, 0.10, 0.05 (BH, septet, 3H total). More
detailed analysis of the spectrum is presented in ‘‘Results
and discussion’’.
Synthesis of potassium hydroxyborohydride
The procedure was the same as that used for sodium
hydroxyborohydride, except that potassium borohydride
(0.501 g, 9.3 mmol) was a substrate and the resulting yield
was 95%. Elemental analysis: H 5.65% (calculated 5.72%).
The 1H NMR spectrum of potassium hydroxyborohydride
was identical to the one recorded for sodium
hydroxyborohydride.
Reaction of sodium hydroxyborohydride or sodium
borohydride with acetone-d6
Either sodium hydroxyborohydride (10 mg) or sodium
borohydride (10 mg) was placed under nitrogen in an
NMR tube sealed with a rubber Septa (at 273 K). Ace-
tone-d6 (0.5 ml; cooled to 273 K) was injected into the
tube, the mixture vigorously shaken and 1H NMR spec-
trum immediately recorded. Following 6 h incubation at
300 K, another spectrum was recorded.
The spectrum after 6 h reaction with hydroxyborohy-
dride: 1H NMR ((CD3)2CO): 3.92 (CH, s, 1H), 3.00 (OH,
broad, 1H); 0.42, 0.26, 0.10, 0.07, (BH, quartet, 2H
total); 0.34, 0.28, 0.23, 0.17, 0.12, 0.07, 0.01
(BH, septet, 2H total).
The spectrum after 6 h reaction with borohydride: No
reaction between acetone-d6 and sodium borohydride
was observed under such conditions: 1H NMR
((CD3)2CO): 0.48, 0.32, 0.16, 0.00, ðBH4 , quartet);
0.40, 0.35, 0.29, 0.24, 0.19, 0.13, 0.08 ðBH4 ,
septet). 1JH11B = 80.0 Hz,
1JH10B = 27.0 Hz.
Results and discussion
Synthesis of hydroxyborohydride salts
There are very few known methods for synthesis of
hydroxyborohydrides. All of them are based on the hydro-
lysis of borohydrides in aqueous solutions. Therefore, the
resulting products include compounds from every step of
borohydride hydrolysis, beside the final boric acid [19]. In
contrast, the present synthetic route, carried out in an
aprotic solvent, resulted in sodium and potassium hydroxy-
borohydrides in much higher yields.
The analysis of 1H NMR spectrum of hydroxyborohydrides
The 1H NMR spectra of hydroxyborohydride salts have
not been previously published, probably due to synthetic
problems and high reactivity towards atmospheric oxygen
and moisture. The 1H NMR spectrum of sodium hydroxy-
borohydride in acetone-d6 (Fig. 1) is similar to that
recorded for sodium borohydride, showing similar B–H
coupling region (approx. 0.5 to 0.0 ppm).
The most unusual and interesting part of this spectrum
is the 0.5 to 0.1 ppm region containing BH resonances.
3.50 3.00 2.50 2.00 1.50 1.00 0.50 0.00 -0.50
δ [ppm]
Fig. 1. 1H NMR spectrum of sodium hydroxyborohydride in acetone-d6.
The insert shows the 0.5 to 0.1 ppm region.
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Natural boron contains two ‘‘NMR-active’’ isotopes: 10B
(with nuclear spin I and natural abundance of 3 and
19.9%, respectively) and 11B (3/2 and 80.1%, respectively).
The four peaks of larger intensity are due to heteronuclear
coupling between 11B and boron-attached hydrogen atoms.
On the other hand, seven peaks with smaller intensity are
the effect of coupling between 10B and hydrogen atoms.
The 1H NMR spectrum of hydroxyborohydrides signifi-
cantly differs from those recorded for borohydrides. The
experiments conducted in identical conditions show notice-
able chemical shift differences, allowing precise assign-
ments. The measured coupling constants 1JH11B were
close to those found for borohydride anion (81.0 Hz) and
the second isotope 1JH10B (approx. 27.2 Hz). A similar
value of 1JH11B (82 Hz) was also found in a low quality
11B NMR spectrum, presented in 1964 by Gardiner and
Collat [19], and this result was also confirmed by our
NMR experiments. The integration of 11B- and 10B-cou-
pled hydrogen atom resonances is in agreement with the
isotope composition of natural boron, and shows their rel-
ative intensities to be 4:1.
The reactivity of hydroxyborohydride ion
To our knowledge differences in reactivity between
borohydride and hydroxyborohydride ions toward car-
bonyl compounds have been described only in a few cases
[20,21]. The presented comparison of reducing power of
both ions toward acetone-d6, under conditions of a large
excess of the latter, was performed in an NMR-monitored
experiment. The deuterated reagent was chosen due to the
relative simplicity of the products spectra. With hardly
any available data published on the subject, the mecha-
nism of reduction of acetone-d6 by hydroxyborohydride
ions may be expected to be similar to that observed for
borohydride ions. Such a mechanism is also supported
by the 1H NMR spectrum recorded after 6 h reaction,
containing an additional slightly broadened resonance at
3.92 ppm (half width 5.7 Hz), belonging to hydrogen
atom bound to the secondary carbon of the isopropox-
ide-d6 moiety. The proton responsible for this signal
seems to belong neither to hydroxyborohydride anion
nor to acetone and the broadening of its resonance may
be explained as due to coupling with deuterium atoms
in the product isopropyloxy-d6 moiety. Thus the proton,
to which the resonance was assigned, had to be trans-
ferred to the carbonyl carbon atom of acetone-d6 from
the (BH3OH)
 molecule.
Calculation of optimal geometry and coupling constants
Several model systems have been chosen for comparison
and for assessment of trends rather than attempting to
reproduce absolute values of NMR parameters. Such a
strategy stems from the fact that the calculation of spin–
spin coupling constants is extremely sensitive to the choice
of the molecular basis sets [32].
The results of 1J(11B–H) spin–spin coupling constants
are presented in the Table 1. It can be seen that the val-
ues of J(11B–H) are close for BH4 and (BH3OH)
, but
the values for (BH3OH)Na are different. In the latter case
there is one value of (11B–H) at about 120 Hz, which
does not correspond to the experimental spectrum. It
seems reasonable to assume that the experimental value
of J(B–H) should correspond to the averaged theoretical
value because of rotation of the OH group. For example,
taking a weighted average, we obtain a value of
(2 Æ 79.7 + 84.6)/3 = 81.3 Hz (PW91PW91), which corre-
sponds quite well to the experimental value of 80.0 Hz.
When the OH group is forced to be located on the
three-fold axis of symmetry, i.e. when the B–O–H angle
is fixed at 180, the value of J(11B–H) increases slightly,
about 6 Hz with respect to the value for a bent OH
group. Such a hypothetical C3v structure having three
equivalent B–H bonds becomes, in fact, a transition
structure, being energetically unfavorable by some
20 kcal/mol above the equilibrium geometry. Thus, in
the theoretical modeling of the (BH3OH)
 species one
cannot assume equivalent B–H bonds. The use of the
B3LYP functional leads to an overestimation of J(11B–
H) compared to the PW91PW91 (about 10%), which
indicates that the use of the PW91PW91 functional
should give J values closer to the experimental. The esti-
mated 1J(11B–H) coupling constants for BH3 (135.1 Hz)
differ considerably from the values for (BH3OH)
 and,
therefore, the presence of BH3 species cannot explain
the experimental spectrum. To assess the accuracy of
the present estimations of 1J coupling constants, the
B2H6 system was studied and compared to the literature
values obtained by other, more accurate, methods [33]. It
is seen that the present B3LYP/aug-cc- pVTZ values
differ by about 10–20% from the EOM–CCSD ab initio
estimations. Such a moderate accuracy is probably
sufficient for drawing conclusions as to the relative values
of 1J(B–H) coupling constants in structurally related
species such as BH3, BH

4 , (BH3OH)
 and (BH3OH)Na.
The presented theoretical calculations support the
hypothesis about the detection of the (BH3OH)
 anion
as an individual species in the solvent. If the complex
with solvent molecules (acetone) were formed, we
would probably not obtain this degree of
correspondence of experimental and theoretical values
of J(11B–H). The theoretical results suggest that the
OH group can be located in different positions relative
to the BH3 pyramid. It is likely that the position of the
hydroxyl group is averaged in solution, which renders
impossible a direct comparison of theoretical and
experimental J-values.
We investigated also the hypothetical complex
(BH3OH)
    Na+ and the corresponding J(11B–H) val-
ues. The presence of the Na+ ion influences significantly
the value of the coupling of one of the protons, yielding
J(11B–H) of about 120 Hz, which is not observed in the
experimental spectrum. This suggests that the Na+ ion
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can be coordinated by the acetone molecules rather than by
the (BH3OH)
 anion. One can hypothesize that the Na+
ion is solvated strongly by the acetone molecules, which
reduces the possibility of direct interaction with the
(BH3OH)
 ion. The detailed structure of the acetone solu-
tion with the presence of (BH3OH)Na would, however,
require much more advanced simulations.
Conclusions
The present high yield synthetic route providing
hydroxyborohydride salts is fast and economic, making
hydroxyborohydrides quite attractive reagents. The first
1H NMR spectrum of hydroxyborohydride shows a very
unusual pattern of resonances from heteronuclear
coupling of the boron-hydride moiety. An NMR spectros-
copy-monitored experiment demonstrated stronger reduc-
ing properties of hydroxyborohydride than borohydride
toward acetone carbonyl. The calculated 11B- and 10B–H
coupling constants are in a very good agreement with
experimental data, and confirm the hypothesis about the
detection of the (BH3OH)
 anion as an individual species
in solution.
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a b s t r a c t
Preparation and spectroscopic properties of novel boron-containing derivatives of anti-HIV agent stavu-
dine are presented, The new compounds, (50-O-(4,4,5,5-tetramethyl-1,3,2-dioxaboronate)-20-30-didehy-
dro-20-30-dideoxythymidine and 50-O-(dihydroxyboronate)-20-30-didehydro-20-30-dideoxythymidine),
were prepared by direct reaction between stavudine and reagents containing BAH moieties – pinacolbo-
rane and borane–dimethylsulfide complexes, respectively. The boron coordination equilibrium of those
compounds was analyzed by water titration monitored by NMR. Results of the DFT calculations and
NMR experiments pointed to structural and electronic similarity of tetrahedral boron complexes to phos-
phate group.
 2009 Elsevier Inc. All rights reserved.
1. Introduction
Stavudine (20,30-didehydro-30-deoxythymidine; D4T), a syn-
thetic thymidine nucleoside analogue in which the 30-hydroxyl
group is replaced by a double bond between the 20- and 30-carbon
atoms of the pentose ring, is a nucleoside reverse transcriptase
inhibitor (NRTI) [1–3], approved for its use in combination with
other antiretroviral compounds for the treatment of HIV infec-
tions in USA and European Union. The drug leads to inhibition
of viral reverse transcription, as do didanosine (ddI), lamivudine
(3TC), zalcitabine (ddC) and zidovudine (ZDV), also belonging to
the family of NRTI [1–5], with stavudine 50-triphosphate causing
competitive vs. dTTP inhibition of HIV reverse transcriptase and
termination of DNA polymerization (due to lack of 30-OH in pen-
tose ring necessary to form 30-50-phosphodiester linkage). As cur-
rent anti-HIV agents show several drawbacks, including short-
and long-term adverse effects, mitochondrial toxicity, antagonism
with other antiretroviral and development of drug resistant or
multi drug resistant HIV strains [6,7], numerous new stavudine
analogues or derivatives were synthesized and tested as antiret-
roviral compounds, with only a few showing promising activity.
For example (i) 40-thiostavudine [8] and 40-ethynylstavudine
[8,9] showed inhibitory activity against HIV-1 comparable to that
of stavudine, (ii) 50AOH group of stavudine esterified with antimi-
crobial building blocks of selected agents (ciprofloxacin, norfloxa-
cin, isoniazide, pyrazinamide, piperazine and dimetylamine acetic
acid) led to prodrugs with broad spectrum chemotherapeutic
activity [6,10], (iii) stampidine, a phosphoramidate derivative of
stavudine, was a potential anti-HIV agent, some 100-fold more
active than stavudine and twice as active as zidovudine [11]
and (iv) stampidine, 50-stavudine-[p-bromophenyl methoxyalani-
nylphosphate], with bromine at the phenyl moiety accelerating
the compound’s hydrolysis yielding N-alaninyl-stavudinemono-
phosphate [12,13].
In search of new derivatives of the drug, synthesis of boron ana-
logue of stavudine 50-phosphate group was undertaken. As a result,
two compounds were obtained, with boron atom easily forming
complexes in which an additional donor lone-pair, containing
coordinates to boron atom, yields tetracoordinates, more or less
distorted tetrahedral forms mimicking phosphate group.
Additionally, the pinacolborane stavudine derivative (2) will
possibly improve cell wall transfer properties due to low polarity
of pinacolborane anchor. The transferred compound would proba-
bly hydrolyze to free stavudine therefore improving overall stavu-
dine – cell transfer.
2. Results and discussion
2.1. Synthesis and NMR properties of 1, 2 and 3
The synthesis of 1 (stavudine, d4t) was based on previously
published work of Prusoff’s group, modified and optimized to-
wards the purity of the final product [14].
0045-2068/$ - see front matter  2009 Elsevier Inc. All rights reserved.
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Although relatively easy method of synthesis of alkoxyboron
compounds by the reaction of boric acid and given alcohol is
known, rapid equilibration could result in the formation of bis-
and trisalkoxy species. Our borane approach, though more expen-
sive and time-consuming, gives products of higher purity. Pre-
sented method of preparation of 2 and 3 is based on reaction
environment without polar and protic solvents so equilibration be-
tween alkoxy and hydroxy forms is minimized.
Compound 2, 50-O-(4,4,5,5-tetramethyl-1,3,2-dioxaboronate)-
20-30-didehydro-20-30-dideoxythymidine, a 50-pinacolborane deriv-
ative of stavudine was synthesized by direct reaction between a
large excess (25-fold molar excess over 1) of pinacolborane
(4,4,5,5-tetramethyl-[1,3,2]dioxaborolane) and unprotected 1
(Fig. 1). The obtained hydrophobic boronic ester can be easily iso-
lated from reaction mixture by a standard crystallization or extrac-
tion methods.
The reaction mechanism is typical for most of the borane com-
plexes with BAH group and involves attack of boron-attached
hydrogen atom onto 50-hydroxyl group hydrogen atom with evolu-
tion of gaseous hydrogen, followed by an attack of resultant 50-
alcoholate oxygen onto boron atom. Compound 3 was prepared
in a similar manner, with 1 being reacted with borane–dimethyl-
sulphide complex (Fig. 1) at 0 C, followed by hydrolysis of the
resulting hydride compound 50-CH2AOABH2. The proposed reac-
tion mechanism is similar to the one described for synthesis of 2,
with significant reactivity differences caused by lower electron
density on the boron-attached hydrogen atom of pinacolborane,
resulting from strong electron-withdrawing effect of the two pin-
acolborane oxygen atoms. It should be noted that no hydrobora-
tion reaction was observed under the reaction conditions used.
The 1H NMR spectra of compounds 2 and 3 are similar to that of
stavudine (1) with significant changes in the saccharide C(50) re-
gion containing two magnetically nonequivalent hydrogen atoms
(see Fig. 2).
Resonances of 50-hydrogens of 1 form a multiplet at 3.67 ppm,
whereas the hydrogen atoms at the corresponding position of com-
pound 2 resonate at 4.05. In case of 3, the steric and electronic dif-
ferentiation between 50-methylene group hydrogen atoms is large
enough to form two distinct multiplets at 3.80 and 3.93 ppm. Such
differentiation has not been observed for stavudine, the precursor
of 3. 11B NMR spectra of 2 and 3 contain broad resonances at 22.4
and 17.8 ppm for 2 and 3, respectively, in accord with previously
published data [15–18].
2.2. DFT calculations
A possibility of tetrahedral boron group to mimic the geometric
and electronic properties of phosphate group was tested with the
aid of NMR and DFT methods. The close steric and electronic sim-
ilarity of phosphates and esters of tetrahedral boric acid complexes
(Fig. 3, bottom part of figure) might have interesting implications,
such as a possibility to use boron analogs of nucleotides.
Coordination equilibrium of compounds 2 and 3 is presented in
Fig. 3. Additional electron pair donors, e.g. water, thiol, amine, alco-
hol and also hydroxyl or carboxylate anion coordinates to posi-
tively polarized boron atom, creating a very stable eight-electron
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tetrahedral adduct. As a consequence of the high stability of eight-
electron products, is the fact that vast majority of boron com-
pounds contain only traces of trigonal form. Moreover, stable
eight-electron tetrahedral complexes are often formed by intra-
or extra-molecular interactions with bond lengths of 1.5–2 Å,
found in X-ray diffraction data [19]. The stability of final products
depends on steric and electronic properties of boron-attached
groups [20].
Coordination equilibrium (vide supra) was confirmed with the
use of the 11B NMR method. The observed 11B resonance of 2 was
found at approx. 22.4 ppm in non-coordinating solvent. Addition
of 50 ll of H2O into NMR tube (approx. 20 mg of 2) resulted in a
significant upfield shift of broad 11B resonance to 10.0 ppm, with
additional 100 ll of H2O shifting the described resonance even
more upfield, up to 11.2 ppm. Titration of the sample with
additional amounts of water did not result in further shifting of
Fig. 2. 1H NMR spectra of the saccharide C(50) region of 1 (A), 2 (C) and 3 (B).
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11B resonance. Those observations confirm the equilibrium
hypothesis (Fig. 3), assuming the formation of new compound
(20H2O) of tetrahedral geometry that dominates after addition of
water. Similar behavior was also observed for 3, apparently form-
ing 30H2O. It should be noted that no significant changes were ob-
served in the 1H NMR spectrum during H2O titration, indicating
that no side reactions took place.
In accord, the 11B chemical shift was previously observed to be
strongly dependent on electronic environment of boron atom, with
formation of tetrahedral complexes, resulting from coordination of
additional lone-pair or anionic donor, shifting boron resonances
upfield even by 20–40 ppm [15–18,20].
Considering tetrahedral boron moieties as potentially capable of
mimicking the steric and also electronic properties of phosphate
group, the geometries and partial atomic charges of phosphate
and borane moieties were compared by theoretical calculations
on three model molecules: methylphosphate, methylboronic
acid–hydroxyl complex and methylboronic acid–methylamine
complex (Fig. 4). The density functional method B3LYP/LANL2DZ
was used to optimize geometries and to calculate Merz–Kollman
ESP charges [21,22] and molecular volume.
All three molecules (Fig. 4) show tetrahedral geometry. The cal-
culated Merz–Kollman charges for external (hydroxyl and P@O)
oxygen atoms are compared in Table 1. For geometry comparisons,
three parameters were used: YAO bond lengths, OAYAO bond an-
gles and YAOAC bond angles, where Y denotes P or B atom in mod-
el molecules. The bond angles are similar for all three molecules,
whereas the BAO bond lengths are by about 0.2 Å smaller than
PAO. Molecular volume was calculated for molecules 1 and 2.
The obtained volumes were similar too, being 72.6 cm3/mol for
methylphosphate and 69.3 cm3/mol for methylboronic acid–hy-
droxyl complex. The theoretical results suggest that local structure
of phosphate and borane moieties should exhibit similar short-
range (steric, determined by molecular volume, bond lengths and
angles) as well as long-range (mainly electrostatic, determined
by electronic density distribution roughly characterized by Merz–
Kollman charges) intermolecular interactions with the environ-
ment. In consequence, one can expect a similar activity of phos-
phate and borane moieties in selected biochemical systems.
3. Conclusions
Preparation routes of novel boron-containing derivatives of
anti-HIV agent stavudine (50-O-(4,4,5,5-tetramethyl-1,3,2-diox-
aboronate)-20-30-didehydro-20-30-dideoxythymidine and 50-O-
(dihydroxyboronate)-20-30-didehydro-20-30-dideoxythymidine)
are presented. The new compounds, were prepared by one-step
reaction between stavudine and commercially available pin-
acolborane or borane–dimethylsulfide complexes. Resonances
of 50-hydrogens of 1 form a multiplet at 3.67 ppm, whereas
the hydrogen atoms at the corresponding position of compound
2 resonate at 4.05. In case of 3, the steric and electronic differ-
entiation between 50-methylene group hydrogen atoms is large
enough to form two distinct multiplets at 3.80 and 3.93 ppm.
11B NMR spectra of 2 and 3 contain broad resonances at 22.4
and 17.8 ppm for 2 and 3, respectively. Coordination equilib-
rium was analyzed with the use of the 11B NMR method. The
observed 11B resonance of 2 was found at approx. 22.4 ppm
in non-coordinating solvent. Addition of small amount of water
into NMR tube with 2 or 3 solutions resulted in a significant
upfield shift of broad 11B resonances. Those observations confirm
the equilibrium hypothesis assuming the formation of new
compound of tetrahedral geometry that dominates after addi-
tion of water. The theoretical results suggest that local structure
of phosphate and borane moieties should exhibit similar short-
range as well as long-range intermolecular interactions with the
environment.
4. Experimental
4.1. Analytical methods
All NMR spectra were obtained with 500 MHz Bruker Avance II
spectrometer operating in the quadrature mode. The residual
peaks of deuterated solvents were used as internal standards.
Structures of 1, 2 and 3 were also confirmed by several 2-dimen-
sional spectra: 1H–13C Heteronuclear Single Quantum Coherence
(HSQC); 1H–1H Correlation spectroscopy, (COSY) and Distortionless
Fig. 4. The optimized geometries of stavudine-50-CH2AOAX models: methylphosphate (X = phosphate group, left) and its boron analogues: methylboronic acid–hydroxyl
complex (X ¼ ABðOHÞ3 , middle) and methylboronic acid–methylamine complex (X =AB(OH)2:NH2CH3, right).
Table 1
Selected atomic charges and geometric properties of stavudine-50-CH2AOAX models. Y = P or B atom.
Partial atomic charges Methylphosphate Methylboronic acid–hydroxyl complex Methylboronic acid–methylamine complex
O (external OAH or @O) 0.9/0.8/0.7 (for @O) 0.9/1.0/1.0 1.0/0.92
Geometry
Distances YAO 1.7/1.7/1.69/1.58 (for P@O) 1.5/1.5/1.5/1.5 1.46/1.45/1.46/1.68 (for BAN)
Angles OAYAO 106.2/99.5/115.2 105.5/114.4/108.13 115.1/116.2/99.9
Angle YAOAC 120.5 117.0 121.3
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Enhancement by Polarization Transfer (DEPT) experiments. All 11B
NMR spectra were recorded using pure quartz 5 mm NMR tube.
Elemental analysis was performed using Elementar Vario EL-3
analyzer. All other reagents and deuterated solvents of the highest
commercially available grade were purchased from Aldrich and
used without further purification. Rubber septa joints were also
purchased from Aldrich. All procedures, including preparation of
samples for the NMR measurements, were carried out under nitro-
gen atmosphere. All the computations were performed with the
Gaussian 03 program [23] on the computer cluster of ICM UW,
Warsaw.
4.2. Modified synthetic route for 20-30-didehydro-20-30-dideoxythymi-
dine (stavudine, D4T, 1)
Thymidine (5 g, 20.6 mmol) was added at 15 C to solution of
methylsulfonyl chloride (MsCl, 3.52 ml, 45.4 mmol) in pyridine
(43 ml). After 60 min. of vigorous stirring, water (1–2 C, 600 ml)
was added to the reaction mixture. Resulting mixture was stirred
at 4 C for another 24 h, and filtered off. White product was then
washed with three 10 ml rations of water (cooled to 0 C) and dried
under high vacuum.
Reaction product was dissolved in sodium hydroxide solution
(400 ml of 1.06 M solution) and refluxed for 2 h. Acetone
(300 ml) was added to the reaction mixture cooled to 4 C over a
30 min period. Precipitate that formed was filtered out, washed
twice with acetone (2  20 ml, cooled to 4 C) and vacuum dried.
The product, in the form of white/grayish crystals, was used in
the following reaction step without further purification. The crys-
tals (0.94 g) were dissolved in anhydrous DMSO (5 ml) and a solu-
tion of potassium tert-butoxide (1.02 g in 2 ml of DMSO) was
added dropwise. After the mixture was allowed to react for 2 h
at room temperature, glacial acetic acid (1:1 v/v in ethanol) was
used to neutralize it to pH  7, and the product was extracted with
hexane (2  20 ml). Hexane layer was separated and dried under
high vacuum. The resulting compound 1, obtained with 42% yield,
showed 99.5% purity, as judged from the 1H NMR spectrum. Ele-
mental analysis: C 57.62% (calculated 57.69%) H 5.87% (calculated
5.81%); N 13.42% (calculated 13.45%). 1H NMR (CDCl3, d [ppm]):
7.50 (m, J = 1.3 Hz, 1H, C(6)H); 6.82 (m, J = 1.6 Hz, 1H, C(10)H);
6.35 (m, 1H, C(20)H); 5.86 (m, 1H, C(30)H); 4.87 (m, 1H, C(40)H);
3.67 (m, 2H, C(50)H); 1.74 (d, J = 0.9 Hz, 3H, Me-C(5)).
4.3. Synthesis of 50-O-(4,4,5,5-tetramethyl-1,3,2-dioxaboronate)-20-30-
didehydro-20-30-dideoxythymidine (2)
1 (25 mg) was dissolved in anhydrous DMSO (50 ll) and added
dropwise to the solution of 4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lane (384 ll in 10 ml of anhydrous CHCl3). The reaction mixture
was refluxed for 24 h, followed by removal of solvents under vac-
uum. The resulting material was left for crystallization in tetrahy-
drofuran (5 ml, 72 h, 4 C), with crystals filtered off and liquid
fraction dried under high vacuum. Thick oil obtained from THF
fraction was containing almost pure 2. Compound 2 was obtained
with 95% yield and showed 96% purity, as judged from the 1H NMR
spectrum. Elemental analysis: C 54.85 (calculated 54.88%); H 6.69
(calculated 6.62%); N 7.99% (calculated 8.00%). 1H NMR (CDCl3, d
[ppm]): 9.48 (s, 1H, NH); 7.54 (m, J = 1.3 Hz, 1H, C(6)H); 7.00 (m,
J = 1.9 Hz, 1H, C(10)H); 6.26 (m, 1H, C(20)H); 5.79 (m, 1H, C(30)H);
4.88 (m, 1H, C(40)H); 4.05 (m, 2H, C(50)H); 1.89 (d, J = 1 Hz, 3H,
Me-C(5)); 1.20 (s, 12H, (CH3)4). 13C NMR (CDCl3, d [ppm]):
164.64, 151.35 (CC@O); 137.02 (C(6)); 133.95 (C(20); 126.97
(C(30)); 89.34 (C(10)); 86.02 (C(40)); 75.14 (O-CMe2); 65.11 (C(50));
29.69 ((CH3)4); 12.09 (C(5)-Me). 11B NMR (CDCl3, d [ppm]): 22.37.
4.4. Synthesis of 50-O-(dihydroxyboronate)-20-30-didehydro-20-30-
dideoxythymidine (3)
1 (25 mg) was dissolved in anhydrous DMSO (50 ll) and added
dropwise to the solution of borane–dimethylsulfide complex
(120 ll in 2 ml of anhydrous CH2Cl2). The reaction mixture was
stirred for 24 h (0 C), followed by removal of solvents under vac-
uum. Deoxygenated water (69 ll) in THF (2 ml) was added drop-
wise to the obtained liquid material and the mixture allowed to
react for 2 h, then extracted with water/chloroform (10 + 10 ml)
system. Organic solvents from chloroform phase were vacuum-
evaporated and the resulting solid dried under high vacuum. Com-
pound 3 was obtained with 95% yield and showed 96% purity, as
judged from the 1H NMR spectrum in. Elemental analysis: C
44.75 (calculated 44.81%); H 4.92% (calculated 4.89%); N 10.40%
(calculated 10.45%). 1H NMR (CDCl3, d [ppm]): 8.33 (s, 1H, NH);
7.47 (m, J = 1.3 Hz, 1H, C(6)H); 7.01 (m, J = 1.9 Hz, 1H, C(10)H);
6.32 (m, 1H, C(20)H); 5.84 (m, 1H, C(30)H); 4.91 (m, 1H, C(40)H);
3.93 + 3.80 (m, 2H, C(50)H); 1.86 (d, J = 1 Hz, 3H, Me-C(5)). 13C
NMR (CDCl3, d [ppm]): 163.62 (CC@O); 136.58 (C(6)); 134.50
(C(20); 125.53 (C(30)); 89.92 (C(10)); 87.08 (C(40)); 63.42 (C(50));
12.43 (C(5)-Me). 11B NMR (CDCl3, d [ppm]): 17.76.
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Abstract: Novel 
15
N-isotope enriched potassium and diammonium thiophosphoramidates were synthesized and their 
spectroscopic properties, along with reactivity towards several compounds, including histidine, thymidine, glucose and 2-
deoxyribose are presented. The application of quantum mechanical DFT calculations for estimation of 
31
P NMR chemical 
shifts for several thiophosphoramidate ions and its derivatives are also discussed. 
Keywords: NMR, thiophosphate, tiophosphoramidate, thiophosphorylation. 
Phosphates are ubiquitous in biochemistry, physico-
chemical properties allowing them to play a dominating role 
in the living world [1]. Studies on phosphorylation/ 
dephosphorylation and biological activity of phosphorylated 
compounds, as well as those aimed at drug development, 
often take advantage of thiophosphate (or phosphorothioate) 
analogues [2-5], offering, as compared to the phosphate 
congeners, potential phosphorus-centered chirality and 
increased stability towards chemical and enzymatic 
hydrolysis. [6-8]. This hydrolytic stability is of particular 
interest with studies on phosphorylation of proteins on basic 
amino-acids, as due to their acid-labile character 
phosphoramidates within proteins easily escape detection by 
analytical methods [9, 10]. Moreover, phosphohistidine, 
representing probably a major protein modification in 
eukaryotes [9], applied as a hapten has proved too unstable 
to generate antibodies [11]. Therefore methods are sought 
allowing preparation of thiophos-phoramidate-modified 
biomolecules under conditions mild enough to preserve 
biological function [12, 13], in hope that thiophospho-
ramidates will be useful as more stable substitutes and 
probes for the biological function of the corresponding 
phosphoramidates. 
In the present study we synthesized 
15
N-thiophos-
phoramidates and tested their spectroscopic properties, as 
well as potential to thiophosphorylate histidine, thymidine, 
glucose and 2-deoxyribose. 
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The most common method of preparing O- and N-
thiophosphorylated compounds is the reaction of peptide 
with a suitable kinase and ?-S-ATP [17]. A few non-
enzymatic approaches have been also described, namely the 
on-resin phosphitylation-oxidation of a protected peptide and 
the integration of a protected thiophosphorylated compound 
by traditional Boc or Fmoc synthesis methods into a peptide 
chain [18-20]. However, considering possible protein 
thiophosphorylation, aimed at monitoring of the 
modification’s influence on biological properties, the latter 
methods do not allow reaction under mild enough 
conditions. Another approach employed PSCl3 as a 
thiophosphorylation agent [13] and allowed peptide 
modification under mild conditions (room temperature, pH 
8) but the hydrophobic character and wide range of reactivity 
of thiophosphoryl chloride may cause the reaction sites to be 
difficult to control. Moreover, PSCl3 and its hydrolysis 
product PSCl2O
-
 could react as a cross-linking or bridging 
reagents. In contrast, the unifunctional reagents, anionic 
thiophosphoramidates, in analogy to the parent 
phosphoramidates [21], allow mild reaction conditions [12] 
and should provide greater specificity. 
The synthetic route applied to obtain 
15
N-enriched 
potassium thiophosphoramidate (2, see Fig. (1)) was based 
on that previously employed to synthesize the same 
compound containing natural nitrogen isotope [14].
 
The first 
reaction of the two-step synthesis is that of phosphorus 
thiochloride with 
15
N-ammonium hydroxide solution 
yielding 1 (
15
N-diammonium
 
thiophosphoramidate, 
(
15
NH4)2PS(
15
NH2)O2). The 
31
P NMR spectrum of 1 in D2O 
presents doublet resonance at 40.4 ppm belonging to 
phosphorus from 1 and much smaller resonance of 
hydrolysis product of 1 at 32.8 ppm. The resonance of 1 is in 
a form of a doublet resulting from the heteronuclear coupling 
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between 
31
P and 
15
N nuclei, each having nuclear spin of 1/2. 
The analogical doublet resonance, corresponding to nitrogen 
atom of amidate moiety was found in 
15
N NMR spectrum of 
1 at 68.3 ppm. The one-bond 
31
P-
15
N coupling constant is 
13.7 Hz being identical in both phosphorus and nitrogen 
spectra. Besides, the same 
15
N NMR spectrum of 1 shows a 
singlet resonance of ammonium ions at 19.9 ppm. 
The second step of synthesis of 2, basically an ion 
exchange reaction, is conducted at temperature of 60ºC. In 
view of our results, this step could be potentially destructive 
and was probably responsible for previously reported 
unsuccessful synthesis of 2 [13]. The reaction with 
potassium hydroxide, running under those conditions longer 
than 5 min, leads to decomposition of thiophosphoramidate 
due to hydrolysis of the P-N bond. The reaction time 
exceeding 30min results in almost quantitative hydrolysis of 
thiophosphoramidate to thiophosphate (1', Fig. (1)), the latter 
showing its 
31
P NMR singlet resonance at 36.7 ppm. No 
nitrogen resonances were found in 
15
N NMR spectrum of the 
hydrolysis product, and this observation was confirmed by 
other analytical methods demonstrating the absence of 
nitrogen in the sample. With the reaction time of approx. 5 
min, the second step of synthesis of 2 gave the expected 
product with a good yield. The 
31
P NMR spectrum of 2 is 
similar to that of 1 and presents a doublet resonance at 39.8 
ppm, this chemical shift being in agreement with earlier 
published data for the natural-nitrogen compound [14]. 
Thiophosphorylation of histidine using thiophos-
phoramidate (Fig. (2)) with natural nitrogen isotopes 
abundance was presented by Pirrung et al. [12]. The 
histidine derivatization presented in our work was conducted 
with the use of 
15
N-enriched thiophosphoramidate that gives 
more interesting mechanistic information. The mechanism of 
this reaction contains an attack of the amino acid nitrogen 
lone pair electrons on the phosphorus atom with elimination 
of the amidate group that is 
15
N-enriched in our experiments. 
The 
31
P NMR spectrum of the product shows a singlet 
resonance of 3-thiophosphohistidine, confirming the 
anticipated mechanism (vide supra). In accord with the 
latter, no 
15
N resonances were found.  
Potassium thiophosphoramidate was used for phos-
phorylation of saccharide hydroxyl groups of thymidine, 
glucose and 2-deoxyribose. Thiophosphorylation of 
thymidine leads to 5'-thiophosphate derivative (Fig. (2)) as 
judged from NMR spectra. The 
31
P NMR spectrum of the 
reaction mixture contains peaks (43.0 ppm), in the forms of a 
doublet and asymmetrical singlet, which result from the 
three-bond heteronuclear coupling between phosphorus and 
two magnetically non-equivalent 5'-hydrogen atoms. The 
explanation of this observation is the magnetic 
nonequivalence of two hydrogen atoms from 5’-methylene 
group. The nonequivalent hydrogen atoms couple to 
thiophosphate phosphorus atom with different coupling 
constant that results in doublet and asymmetrical singlet 
resonances. The doublet form is a result of coupling of 
phosphorus of ? spin with one hydrogen atom of ? spin. 
Usually for saccharide methylene group one observes two 
3
JP-H couplings with different constants. The larger coupling 
constant might result in clearly doublet form resonance, 
while smaller coupling constant may give doublet or 
unsymmetrical singlet resonance depending on resolution of 
the spectrum.  
The 
3
JP-H coupling constant for doublet resonance is in 
the typical range for heteronuclear couplings of this type - 
11.3 Hz [22]. The 
31
P NMR spectrum with hydrogen-
decoupling applied shows only one singlet resonance 
pointing to the observed resonance pattern to originate from 
a long-range P-H coupling. The latter observation was 
confirmed by application of the gradient-enhanced 
1
H-
31
P 
heteronuclear multiple bond correlation (HMBC)
 
experiment 
showing a strong coupling with 5'-hydrogen atoms at 3.82 
ppm, in accord with previously published data [23].  
Similar thiophosphorylation reaction was conducted for 
glucose (Fig. (2)). The obtained 
31
P spectra present mainly 
two doublets (40.0 and 39.4 ppm) with 
3
JP-H values of 10.3 
Hz and 10.4 Hz for glucose-1-thiophosphate ?- and ?-
anomers, respectively. Similarly to thiophosphorylated 
thymidine, the hydrogen decoupling reduces two doublets to 
two singlets at averaged chemical shift positions proving that 
the doublet resonance forms are due to proximity of 1'-
hydrogen atom. The gradient-enhanced 
1
H-
31
P HMBC
 
experiments allowed to find chemical shifts of hydrogen 
atoms participating in coupling with phosphorus. The ?- and 
?-anomers of glucose-1-thiophosphate are in 1 to 9.5 molar 
P
S
Cl Cl
Cl
P
O
S- O-
15NH2
P
O
S-
OH
15NH2
P
O
O- OH
SH
15NH4OH 1. KOH / 60oC
2. AcOH
KOH / 1h, 60oC
H2O
1 2
1'
2 15NH4
+
K+
K+
 
Fig. (1). Synthesis of 1, 1' and 2. 
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ratios respectively as calculated from integrals of resonances 
[24, 25].  
The 
31
P NMR spectrum of 2-deoxyribose thiophospho-
rylation product (Fig. (2)) also contains two doublets at 38.8 
and 38.9 ppm with 
3
JP-H values of 11.3 and 10.4 Hz for 2-
deoxyribose-1-thiophosphate ?- and ?-anomers, respectively. 
The ?- and ?-anomers of glucose-1-thiophosphate are in 1 to 
2.5 molar ratios respectively. Similarly to glucose 
thiophosphates, the gradient-enhanced 
1
H-
31
P HMBC and 
hydrogen-decoupled 
31
P 1D experiment allowed the analysis 
of the composition of the reaction mixture [25, 26]. 
 
In view of the foregoing, as well as previously published 
data, potassium and ammonium thiophosphates are 
derivation agents with a broad spectrum of use. Of particular 
importance is fact that both compounds may be used under 
conditions that should preserve protein structure. Recently 
we found both potassium and diammonium thiophospho-
ramidates capable to thiophosphorylate His, Ser and Lys 
residues (not shown) of Caenorhabditis elegans recombinant 
thymidylate synthase protein [27].
 
Several model systems have been chosen for comparison 
and for assessment of trends rather than attempting to 
reproduce absolute values of NMR parameters. Such a 
strategy stems from the fact that the calculation of shielding 
constants and spin-spin coupling constants is extremely 
sensitive to the choice of the molecular basis sets.  
For most of the theoretical calculations the B3LYP/aug-
cc-pVTZ density functional theory was used. Due to the lack 
of the standard aug-cc-pVTZ basis set for potassium, the 
Sadlej's pVTZ basis set was used instead [28-32]. During the 
course of geometry optimizations it was noted that the 
mercaptophosphinyl tautomeric form of molecule 1' 
(containing the P-SH bond) is less stable by 43.6 kJ mol
-1
 
(10.4 kcal mol
-1
) than the phosphinothioyl form, containing 
the formal P=S group. The potassium ion in this molecule is 
located between the two nucleophilic centres: the O atom 
and S atom (Supplementary Materials, Fig. (1A)). Another 
interesting case was found for molecule 1 where the protons 
originally attached to the NH4
+ 
cations were finally 
transferred to the oxygen atoms and the complex of 
thiophosphoamide with two NH3 molecules arised 
(Supplementary Materials, Fig. (2A)). The calculated 
isotropic shielding constants are included in Table 1. The 
degree of ionization of molecule 1 in the course of 
hydrolysis is expected to be reflected in values of the 
31
P 
isotropic shielding constants. For comparison, the 
31
P 
isotropic shielding constants, calculated with the 
B3LYP/aug-cc-pVTZ method, for phosphoric acid and its 
ions are: 310.73 for H3PO4; 304.18 for H2PO4
-
, 286.57 for 
HPO4
2-
 and 272.76 for PO4
3-
. The isotropic shielding 
P
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Fig. (2). Thiophosphorylation products obtained by reaction with thiophosphoramidates. A = histidine, B = D-(+)-glucose, C = thymidine, D 
= 2-deoxy-D-ribose. 
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constants calculated for PSCl3 are 237.61 ppm (P) and 
280.22 ppm (S). For molecule 2 the spin-spin coupling 
constant was also calculated, giving 
1
JP-N=17.7 Hz.  
As the accurate and reliable estimation of chemical shifts 
for 
31
P NMR method is still long-term challenge, there is 
very little knowledge describing thiophosphates and their 
derivatives. The estimation of phosphorus chemical shift ?P 
(Table 1, lowest line) based on comparison of electronic 
shielding of particular atoms can be very useful information 
regarding NMR properties of thiophosphates, a subject 
poorly described in literature. The calculated 
31
P chemical 
shifts for 1, 2 and 1’ in relation to H3PO4 (0.0 ppm) are 
having similar values lying far above 35-45 ppm range 
which is typical for thiophosphates. The only one value of 
calculated chemical shift for 1-dianion seems to be in 
thiophosphate range mentioned earlier. The similar 
comparison of shieldings in relation to HPO4
2-
 dianion gives 
much better results. The calculated chemical shifts for 1, 2 
and 1’ (Q=0) in this case are 42.3, 40.9 and 39.5 ppm 
respectively and are in much better agreement with 
experimental results. Another important observation can be 
made by comparison of shieldings of compounds with 
formal phosphorus-sulfur double and single bonds. The 
electronic shielding of ion 1’ has been calculated with both 
formal double P=S bond with protonated oxygens 
(phosphinothioyl tautomeric form, columns 6 and 7 in Table 
1) and with single P-S bond (mercaptophosphinyl tautomeric 
forms, columns 8 and 9 in Table 1). Observed and calculated 
differences between those two forms are striking. The 
calculated chemical shift of phosphinothioyl tautomer lays in 
range typical for thiophosphates, but the P-SH tautomeric 
form is upfield shifted and lies in 8-18 ppm range. This 
observation can be related to very similar NMR properties of 
S-substituted thiophosphate ions, for example with S-
thiophosphorylated sugars [25]. In conclusion, DFT methods 
can be very useful anticipating NMR chemical shifts of 
newly synthesized thiophosphate compounds as their 
31
P 
NMR chemical shifts are found in quite large range starting 
from +5 ppm, even to +80 ppm. 
The importance of thiophosphate modification of 
proteins and also smaller biologically active compounds has 
been presented several times in literature. This paper 
demonstrates that thiophosphoramidates are very promising 
and useful derivation agents with vast range of possible 
application. We have presented synthetic route to obtain 
novel 
15
N-enriched potassium thiophosphoramidate and its 
NMR properties with the use of both 
31
P- and 
15
N NMR 
methods. The published synthetic route for potassium 
thiophosphoramidate has been evaluated and optimized. It 
was shown with the use of 
15
N NMR method that the 
mechanism of thiophosphorylation of histidine and 
presumably other amino acids involves an attack of the 
amino acid nitrogen lone pair electrons on the phosphorus 
atom with the elimination of amidate group. There are also 
presented NMR properties of O-thiophosphorylation 
products of thymidine, glucose and 2-deoxyribose. We also 
present series of calculation results with the aim to estimate 
the 
31
P NMR chemical shifts by analyzing electronic 
shieldings of thiophosphoramidate and thiophosphate ions. It 
has been shown that the chemical shift of thiophosphate ions 
in phosphinothioyl tautomeric form lays in a range typical 
for thiophosphates but the mercaptophosphinyl tautomer is 
upfield shifted and lays in 8-18 ppm range, typical for S-
substituted thiophosphates. 
EXPERIMENTAL SECTION 
All NMR spectra were obtained with Bruker Avance 
spectrometer operating in the quadrature mode at 500.13 
MHz for 
1
H, 202.46 MHz for 
31
P and 50.70 MHz for 
15
N 
nuclei. The residual peaks of deuterated solvents were used 
as internal standards in 
1
H NMR method. 
31
P and 
15
N NMR 
spectra were recorded at 298K both with and without proton 
decoupling. The internal standard used in 
31
P NMR was 
inorganic phosphate (Pi) having its resonance at 2.14-2.16 
ppm (at pH 7.8), 2.00-2.05 ppm (pH 7.5), 1.60-1.70 ppm (at 
pH 5.0) and 0.0 ppm (at pH 1-1.5). All samples were 
analyzed using gradient-enhanced 
1
H-
31
P Heteronuclear 
Multiple Bond Correlation (HMBC)
 
experiments. The 
HMBC experiments were optimized for long range 
Table 1. Isotropic Shielding Constants [ppm] Estimated with the B3LYP/aug-cc-pVTZ GIAO Calculations 
 
 1 2 1’ 
   -OH, =S =O, -SH 
 Q = 0 Q=-1 Q = -2 Q = 0 Q = -1 Q = 0 Q = -1 Q = 0 Q = -1 
Atom          
P 244.3 258.0 266.7 245.8 247.0 247.1 245.7 297.9 295.3 
S 648.3 617.7 643.6 624.4 641.7 649.0 654.2 553.6 559.6 
O 170.7 168.0 126.6 130.5 146.8 137.0 149.1 111.0 108.3 
O 163.1 147.5 126.6 184.4 173.2 169.8 145.4 118.1 133.8 
O - - - - - 188.1 176.5 169.5 164.8 
N 187.0 170.1 143.2 176.7 164.4 - - - - 
?P [ppm] 
rel. to H3PO4 
66.4 52.7 44.0 64.0 63.7 63.6 65.1 12.8 15.4 
?P [ppm] 
rel. to HPO4
2- 
42.3 28.5 19.9 40.8 39.5 39.5 40.9 11.4 8.7 
The molecular total electric charge Q [a.u.] corresponds to the molecular complexes shown in the Scheme 1 (Q = 0) and to their respective anions (Q = -1 or -2) after removal of 
counter ions (NH4
+ or K+). For 1’ two geometries were considered where the P=S and P-SH bonds can appear. ?P stands for 31P chemical shift in relation to H3PO4 or HPO42-. 
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couplings by using various 
3
JP-H values (1-20Hz). The 
1
H 
NMR spectra were obtained with the use of HDO 
suppression method. Elemental analysis was performed 
using Elementar Vario EL-3 analyzer. FTIR spectra were 
recorded on Perkin Elmer Paragon 1000 apparatus. The 
15
N-
ammonium hydroxide solution (
15
N>99%) was purchased 
from SpectraGases Inc. Potassium thiophosphoramidate was 
obtained using previously described method, slightly 
modified with regard to the time of reaction (5-15 min) with 
potassium hydroxide [14]. All other reagents and deuterated 
solvents of the highest commercially available grade were 
purchased from Aldrich and used without further 
purification. Rubber septa joints were also purchased from 
Aldrich. All procedures, including preparation of samples for 
the NMR measurements, were carried out under nitrogen 
atmosphere. The theoretical calculations have been 
performed with the density functional B3LYP/aug-cc-pVTZ 
method. The optimal geometries were obtained and 
confirmed with positive harmonic frequencies. All the 
calculations were performed with the Gaussian G03 (rev. 
C.02) suite of programs [15]. The pictures of calculated 
structures were made in the ChemCraft computer program 
and are presented in Supplementary Materials [16]. 
15
N-Thiophosphoramidate Diammonium Salt (1) 
Thiophosphoryl chloride (0.25 ml, 2.45 mmol) was 
added at 0ºC to 3N solution of 
15
NH4OH (4 ml, 12 mmol). 
After 90 min. of vigorous stirring, the reaction mixture was 
separated in a separatory funnel and to the aqueous layer 
acetone (7 ml) added. Resulting mixture was stirred at 0ºC 
for 60 min and filtered, to collect white precipitate that 
formed. The product was then washed with two 10 ml 
rations of tetrahydrofurane (cooled to 0ºC), then two 10 ml 
rations of ethyl ether, and dried under high vacuum. Yield: 
0.212 g (58%). Elemental analysis: H 6.68% (calculated 
6.71%); N 29.92 (calculated 29.98%). 
31
P NMR (D2O, ? 
[ppm]): 38.02 (1, d, 
1
J31P-15N = 13.7 Hz); 53.60 (PSCl3, s); 
15
N NMR (D2O, ? [ppm]): 68.34 (1, d, 1J15N-31P = 13.7 Hz); 
19.92 (
15
NH4
+
, s, LW 0.9 Hz). 
15
N-Potassium Thiophosphoramidate (2) 
1 (0.2 g) was dissolved in 5 ml of 10% KOH and stirred 
at 60ºC for 5 min. The solution was then cooled to room 
temperature and brought to pH 6 with acetic acid. Ethanol 
(20 ml) was added (at 0ºC), the solution stirred for 30 min, 
and the resulting white precipitate collected by filtration, 
washed twice with tetrahydrofurane (10 ml rations) and dried 
under high vacuum. Elemental analysis: H 1.97% (calculated 
1.99%); N 9.84% (calculated 9.86%). 
31
P NMR (D2O, ? 
[ppm]): 39.79 (d); FTIR (KBr, cm
-1
): 3391.8, 1656.3, 
1571.9, 1410.2, 1091.0, 898.2, 871.8, 650.3, 623.3, 536.9. 
Hydrolysis of 
15
N-Potassium Thiophosphoramidate 
2 (50 mg) was dissolved in 0.6 ml of 50% KOH and 
stirred at 60ºC for 60min. The solution was then cooled to 
room temperature and brought to pH 6 with acetic acid. 
Ethanol (20 ml) was added to obtained solution (at 0ºC), and 
stirred for 30min. The white precipitate was collected by 
filtration, washed with tetrahydrofurane (2 times 10 ml) and 
dried under high vacuum. Potassium thiophosphate 
(KH2PSO3, 1') was obtained as a main product. Elemental 
analysis: H 1.40% (calculated 1.32%); N 0.0% (calculated 
0.0%). 
15
N NMR (D2O, ? [ppm]): no 15N resonances found.  
31
P NMR (D2O, ? [ppm]): 36.70 (s). 
15
N-Thiophosphorylation of Histidine 
To a sample of 10 mg histidine in 0.2M Tris-HCl buffer 
(pH 7.5, 200 μL) potassium 15N-thiophosphoramidate was 
added (2:1 potassium thiophosphoramidate to amino acid 
molar ratio) and the reaction mixture shaken for 24 h at 
298K. The NMR sample contained 200μL of reaction 
solution and 400 μL of D2O. 
31
P NMR (D2O, ? [ppm]): 34.84 
(s). 
Thiophosphorylation of ?-D-Glucose 
To a sample of 100 mg glucose in 300 μL of D2O 
potassium thiophosphoramidate was added (3:1 potassium 
thiophosphoramidate to saccharide molar ratio) and the 
reaction mixture shaken for 24 h at 298K. The NMR sample 
contained the reaction mixture and 300 μL of D2O. 
31
P NMR 
(D2O, ? [ppm]): 39.35 (d, J=10.4Hz); 39.96 (d, J=10.3Hz).  
Thiophosphorylation of Thymidine 
To the sample containing 100 mg thymidine in 300 μL of 
D2O, the potassium thiophosphoramidate was added (2.3:1 
potassium thiophosphoramidate to saccharide molar ratio). 
The sample was then shaken for 24 hours at 298K. The 
NMR sample contained reaction mixture and 300 μL of D2O. 
31
P NMR (D2O, ? [ppm]): 43.00 (d+s, Jd=11.3Hz).  
Thiophosphorylation of 2-Deoxyribose 
To a sample of 100 mg 2-deoxyribose in 300 μL of D2O 
potassium thiophosphoramidate was added (2.1:1 potassium 
thiophosphoramidate to saccharide molar ratio) and the 
resulting mixture shaken for 24 h at 298K. The NMR sample 
contained the reaction mixture and 300 μL of D2O. 
31
P NMR 
(D2O, ? [ppm]): 38.75 (d, J=11.3Hz); 38.93 (d, J=10.4Hz). 
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a b s t r a c t
In search of an activity-preserving protein thiophosphorylation method, with thymidylate synthase
recombinant protein used as a substrate, potassium thiophosphoramidate and diammonium thiophosph-
oramidate salts in Tris- and ammonium carbonate based buffer solutions were employed, proving to
serve as a non-destructive environment. Using potassium phosphoramidate or diammonium thiophosph-
oramidate, a series of phosphorylated and thiophosphorylated amino acid derivatives was prepared,
helping, together with computational (using density functional theory, DFT) estimation of 31P NMR
chemical shifts, to assign thiophosphorylated protein NMR resonances and prove the presence of
thiophosphorylated lysine, serine and histidine moieties. Methods useful for prediction of 31P NMR chem-
ical shifts of thiophosphorylated amino acid moieties, and thiophosphates in general, are also presented.
The preliminary results obtained from trypsin digestion of enzyme shows peak at m/z 1825.805 which is
in perfect agreement with the simulated isotopic pattern distributions for monothiophosphate of
TVQQQVHLNQDEYK where thiophosphate moiety is attached to histidine (His26) or lysine (Lys33) side-
chain.
 2009 Elsevier Inc. All rights reserved.
1. Introduction
Physicochemical properties of phosphates allow them to play a
dominating role in the living world [1]. Thiophosphate (or phosp-
horothioate) analogues, offering, as compared to the phosphate
congeners, potential phosphorus-centered chirality and increased
stability towards chemical and enzymatic hydrolysis [2–4], are
often used in studies on biological activity of phosphorylated com-
pounds [5–8]. The hydrolytic stability is of particular interest with
studies on phosphorylation of protein basic amino acids, as due to
their acid-labile character phosphoramidates within proteins eas-
ily escape detection by analytical methods [9,10]. Moreover, phos-
phohistidine, representing probably a major protein modification
in eukaryotes [9], applied as a hapten has proved too unstable to
generate antibodies [11]. In hope that thiophosphoramidates will
be useful as more stable substitutes and probes for the biological
function of the corresponding phosphoramidates, methods are
sought allowing preparation of thiophosphoramidate-modified
biomolecules under conditions mild enough to preserve biological
function [12,13].
The first thiophosphorylation of peptide was described by Las-
ker et al. [12]. Surprisingly, despite the successful preparation of
thiophosphohistidine by reaction with thiophosphoramidate, the
authors were unable to thiophosphorylate histidine-rich peptide.
Therefore they developed another method, employing PSCl3 as a
phosphorylation reagent.
The present study was done in search of an activity-preserving
protein thiophosphorylation, with thymidylate synthase recombi-
nant protein, found to undergo acid-labile phosphorylation [14],
used as a substrate. Instead of phosphorus thiochloride that (i)
shows high reactivity towards popular buffer ingredients, (ii) pro-
duces acidic conditions when used in water solutions and (iii)
could act as a cross-linking agent giving products difficult to
analyze [12], potassium thiophosphoramidate and diammonium
thiophosphoramidate salts in Tris- and ammonium carbonate
based buffer solutions were employed, proving to serve as a non-
destructive environment. Using potassium phosphoramidate or
diammonium thiophosphoramidate, a series of phosphorylated
and thiophosphorylated amino acid derivatives was prepared,
helping, together with computational (DFT) estimation of 31P
0045-2068/$ - see front matter  2009 Elsevier Inc. All rights reserved.
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NMR chemical shifts, to assign thiophosphorylated protein NMR
resonances and prove the presence of thiophosphorylated lysine,
serine and histidine moieties.
2. Results and discussion
2.1. NMR spectra of phosphorylated and thiophosphorylated amino
acids
The 31P NMR results for side-chain P- and TP-derivatives are
presented in Table 1.
The most upfield shifted resonances (5 to 10 ppm) among
investigated phosphorylated amino acids belongs to phosphohisti-
dines (P-His). Histidine reaction with phosphoramidates is signifi-
cantly faster than in case of other amino acids but P–N bond that
was created is vulnerable for acidic conditions as was found by
Boyer group [15]. Histidine reaction with phosphoramidate pro-
duces two isomers 1-phosphohistidine and 3-phosphohistidine,
the last one more thermodynamically stable. It should be noted
that P-His isomers differ significantly in their hydrolysis rate, with
1-phosphohistidine having a 5 min hydrolytic half-life at pH 2.4
(46 C), while 3-phosphohistidine has approx. five times longer
half-life [13]. 31P NMR spectrum of histidine and phosphoramidate
post-reaction mixture contains two major resonances. The reso-
nances at upfield region seem to belong to 1- and 3-phosphorylated
histidine derivatives, with more upfield shifted resonance (8 to
10 ppm) belonging to 1-phosphohistidine (d1-phosphohistidine)
and the other one (6 and 7 ppm) to 3-phosphohistidine (e2-
phosphohistidine). 31P NMR spectrum contains also two small sin-
glet resonances belonging to 1,3-diphosphohistidine. The assign-
ment of NMR resonances was based on previously published data
[13].
The analogical reaction, carried out with thiophosphoramidate
instead of phosphoramidate, led to histidine thiophosphates that
are more hydrolytically stable than the corresponding phosphates,
thus having significantly longer half-life [15]. The 31P NMR
spectrum of thiophosphorylated histidine contained resonances
belonging to more thermodynamically stable 3-thiophosphohisti-
dine isomer (3-TP-His; at 34.2 ppm), less stable 1-thiophosphohis-
tidine (at 34.5 ppm) and two much smaller resonances belonging
most likely to the 1,3-dithiophosphate species (at 33.7 and
34.4 ppm).
All phospho and thiophospho derivatives of cysteine, serine and
lysine showed their resonances in the form of triplets, as an effect
of the three-bond proximity of two magnetically equivalent hydro-
gen atoms. The coupling constants 3JP–H for those systems are in
the 6–9 Hz range, in agreement with published data concerning
similar compounds [16,17].
The most significant distinction between NMR properties of
phosphate and thiophosphate compounds concerns large differ-
ences between chemical shifts. While the 31P NMR resonances of
P-His are in the 7 to 10 ppm range, those of TP-His are in the
33–35 ppm region. The magnitude of those differences may reflect
a distinctly weaker electronic withdrawing effect of sulfur, as com-
pared with oxygen which causes strong electronic deshielding of
phosphorus. This downfield shifting effect is observable for all
phosphorylated and thiophosphorylated amino acid pairs, and is
especially visible for thiophosphocysteine, its two sulfur atoms
connected to phosphorus and 31P resonance shifted downfield to
54.2 ppm.
It should be noted that the averaged differences between 31P
NMR resonances of different pairs of P- and TP-amino acids are
comparable, ranging from 43.2 ppm difference with 1-P-/1-TP-
His, 43.4 ppm with P-/TP-Lys and 44.1 ppm with P-/TP-Ser to
41.0 ppm with 3-P-/3-TP-His and 38.3 ppm difference with P-/
TP-Cys. Thus knowing the mean difference value, roughly
42 ppm, may be useful in prediction of 31P NMR shifts of various
thiophosphates when chemical shifts of the corresponding phos-
phates are known.
2.2. DFT calculations of 31P shieldings of TP-amino acids
With an accurate and reliable estimation of chemical shifts for
31P NMR method being still a long-term challenge, little is known
in this respect about thiophosphates and their derivatives. While
estimation of phosphorus chemical shift dP, based on comparison
of electronic shielding of particular atoms, might provide very use-
ful information regarding NMR properties of thiophosphates, it has
so far poorly described.
Phosphorus electronic shielding calculations of side-chain
thiophosphate derivatives of selected amino acids are presented
in Table 2. The TP-amino acid models used in these calculations
were divided into three groups based on molecular charge of mod-
el compound. All of the shielding values of TP-amino acids were
converted into chemical shift values using analogically obtained
Table 1
31P NMR chemical shifts of phosphorylated and thiophosphorylated amino acids.
P- or TP-amino acid 31P NMR chemical shift [ppm] and/multiplicity Averaged P-/TP-amino acid shift difference [ppm]
P-Hisa 5 to 10/s –
P-Arg 5–6/s –
P-Lys 0–0.2/tr –
P-Cys 15.9/tr –
P-Ser 0.3/tr –
P-Tyr 3.8–0.0/s –
P-Thr 1.4/m –
TP-Hisa 32.5–34.5/s 43.2 (1-P-His)e, 41.0 (3-P-His)e
TP-Arg – –
TP-Lys 43.4/tr 43.4f
TP-Cys 54.2/tr 38.3
TP-Ser 43.8/b 44.1
PSCl3c 54.6/s, 49.7d; 28.6d; 15.7d; 0.1d/s –
a Histidine phosphorylation product contain 3-P-His, 1-P-His and diphosphate (with phosphate groups both at 1- and 3-positions) with relative integrals being 13.9:1:0.5
respectively. Also the thiophosphorylation product contain 3-TP-His, 1-TP-His and analogical dithiophosphate with relative integrals being 8.5:1:0.14.
b Two doublets.
c Common trace contaminant of thiophosphoramidates.
d Phosphorus thiochloride hydrolysis products.
e Calculated using d1-P-His = 8.7 ppm and d3-P-His = 6.8 ppm.
f dP-Lys of 0.0 ppm was used for calculations (pH 7.5–7.8); higher values up to 0.2 ppm were observed at different pH values.
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values of reference compounds – neutral H3PO4, monoanionic
H2PO

4 and HPO
2
4 dianion using the following equation:
dP ¼ rref  rx ðRef : ½15Þ
where dP is phosphorus NMR chemical shift, rref – isotropic phos-
phorus shielding of reference compound and rx – isotropic
phosphorus shielding of analyzed compound.
It should be noted that precise estimation of phosphorus NMR
chemical shift is still an unsolved and very difficult problem be-
cause of (i) unreliable estimation of concentration of neutral,
mono- and dianionic forms in solution, (ii) complexity of interac-
tions between analyzed compounds and buffer ingredients and
also (iii) calculations of shieldings of those mentioned forms being
still inaccurate. In our calculations the best match of obtained shift
values with experimental ones was achieved with neutral TP-ami-
no acid models (Table 2, Fig. 1). The experimental values of 31P
NMR chemical shifts for 3-TP-His (32.5 ppm), TP-Lys (43.4 ppm)
and TP-Ser (43.8 ppm) could be correlated with neutral TP-amino
acid models (related to H3PO4) by subtracting an additional factor
of 33.7 ppm value. This subtraction yields the following values of
correlated chemical shifts: 33.0 ppm (TP-His, 0.4 ppm differ-
ence), 42.5 ppm (TP-Lys, 0.88 ppm difference) and 44.1 ppm (TP-
Ser, 0.30 ppm difference). These values are in a good agreement
with experimental ones that showed 31P NMR shifts of phosphates
and thiophosphates to have their resonances within the range of
almost 150 ppm. The computational prediction of 31P chemical
shift for TP-Arg and TP-Thr was also made (Table 2), suggesting
chemical shifts of 28.9 ppm for TP-Arg and 44.5 ppm for TP-Thr.
Of interest is that the chemical shift values of TP-Cys phospho-
rus (see Table 2), as compared with those for TP-His, TP-Ser and TP-
Lys, are much higher, although calculated in an identical manner.
Furthermore, this value (87.3 ppm) differs considerably from
experimental one (54.2 ppm). The explanation of this phenomenon
was described previously by our research group [18]. The calcula-
tion results strongly suggest that TP-cysteine is existing in equilib-
rium of ‘thione’ tautomeric form with P@S formal double bond
along with ‘thiol’ form with P@O formal double bond and ionized
or protonated sulfur P–S/P–SH. Those ‘thiol’ tautomeric forms
are having their 31P NMR resonances upfield shifted by a factor of
20–30 ppm [18]. In order to estimate the chemical shift of ‘thiol’
form, we have conducted another set of calculations and those re-
sults are presented in Table 2 (bottom part). The calculated phos-
phorus chemical shift of neutral form of ‘thiol’ TP-Cys (in relation
to H3PO4, with 33.7 ppm correlation factor) is approx. 16.7 ppm
Table 2
Phosphorus isotropic shielding constants (rP, ppm) of side-chain thiophosphorylated amino acids estimated with the B3LYP/aug-cc-pVTZ GIAO calculations. dP stands for 31P
chemical shift in relation to H3PO4, H2PO

4 or HPO
2
4 .
Neutral TP-amino acid TP-Arg TP-Cys 3-TP-His TP-Lys TP-Ser TP-Thr
rP [ppm] 248.11 189.71 244.01 234.51 232.93 232.49
dP [ppm] rel. to H3PO4 62.62 121.02 66.72 76.22 77.80 78.24
dP [ppm] rel. to H2PO

4 56.07 114.47 60.17 69.67 71.25 71.69
dP [ppm] rel. to HPO
2
4
38.46 96.86 42.56 52.06 53.64 54.08
TP-amino acid monoanion
rP [ppm] 255.65 223.81 257.59 255.88 254.84 245.13
dP [ppm] rel. to H3PO4 55.08 86.92 53.14 54.85 55.89 65.60
dP [ppm] rel. to H2PO

4 48.53 80.37 46.59 48.30 49.34 59.04
dP [ppm] rel. to HPO
2
4
30.92 62.76 28.98 30.69 31.73 41.44
TP-amino acid dianion
rP [ppm] 276.55 216.67 255.33 266.40 256.36 244.65
dP [ppm] rel. to H3PO4 34.17 94.06 55.40 44.33 54.37 66.08
dP [ppm] rel. to H2PO

4 27.63 87.51 48.85 37.78 47.82 59.53
dP [ppm] rel. to HPO
2
4
10.02 69.90 31.24 20.17 30.21 41.92
TP-Cys ‘thiol’ form (P–SH) neutral TP-Cys ‘thiol’ form (P–SH) monoanion
rP [ppm] 261.38 rP [ppm] 275.16
dP [ppm] rel. to H3PO4 49.35 dP [ppm] rel. to H3PO4 35.57
dP [ppm] rel. to H2PO

4 42.80 dP [ppm] rel. to H2PO

4 29.02
dP [ppm] rel. to HPO
2
4
25.19 dP [ppm] rel. to HPO
2
4
11.41
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Fig. 1. Structures of the models of phosphorylated and thiophosphorylated amino acids. The symbol X denotes O or S atom.
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being very similar to previously described thiophosphate ‘thiol’
forms [18]. The almost equimolar equilibrium of ‘thione’
(87.3 ppm) and ‘thiol’ (16.7 ppm) forms should give observed value
of 54.2 ppm.
2.3. Thiophosphorylation of Caenorhabditis elegans thymidylate
synthase
Fig. 2 presents thiophosphate ‘fingerprint’ region of 31P NMR
spectrum. Spectrum B at Fig. 2 presents results of the thiophosph-
orylation of Tris–HCl buffer, identical to one used for modification
of thymidylate synthase. The thiophosphorylated Tris (fragment B
at Fig. 2) presents twomultiplets at approx. 42.3 and 43.9 ppm that
are also observable in thiophosphorylated protein NMR spectrum
(spectrum C at Fig. 2). The resonances of thiophosphorylated Tris
at 42.3, 43.9 ppm (JP–H = 7.6 Hz and 6.6 Hz respectively) are triplets
as a result of heteronuclear coupling of thiophosphate phosphorus
with two magnetically equivalent hydrogen atoms from neighbor-
ing methylene group [16]. Spectrum A in Fig. 2 presents the above
described fingerprint region of thiophosphorylated protein with
H-decoupling applied, showing clearly that thiophosphorylated
Tris resonances are singlets, thus proving the three-bond P–H
couplings.
The thiophosphorylated thymidylate synthase NMR spectrum is
presented in Fig. 2, part C. Besides the thiophosphorylated Tris res-
onances, two triplets are present at approx. 43.2 and 43.3 ppm
(coupling constants JP–H = 6.5 and 5.6 Hz respectively) and two
doublets at 43.8 ppm (JP–H = 5.7 and 8.5 Hz). Coupling constants
mentioned above are in the range typical for three-bond P–H cou-
pling [19]. All of the resonances from thiophosphorylated protein
are singlets with H-decoupling applied (Fig. 2, spectrum A), prov-
ing the three-bond proximity of thiophosphate phosphorus to the
methylene hydrogen atoms. The resonance at approx. 43.8 ppm
apparently belongs to the thiophosphorylated serine side-chain
hydroxyl. The 31P resonance of newly formed TP-Ser is in the form
of two doublets, resulting from the heteronuclear coupling with
phosphorus of two magnetically nonequivalent (shift difference
0.04 ppm) hydrogen atoms from TP-serine moiety methylene
group. Those two magnetically nonequivalent hydrogen atoms
have very similar coupling constants 3JP–H = 5.65 and 5.67 Hz. TP-
Ser thesis is strongly supported by an almost identical chemical
shift of TP-serine obtained by direct thiophosphorylation of serine
(see Table 1) and 31P–1H gradient enhanced HMBC spectra pointing
to 3.6 ppm as 1H chemical shift of phosphorus-coupled hydrogen
atoms.
Two triplet resonances at approx. 43.3 and 43.4 ppm corre-
spond apparently to TP-Lys as thiophosphorylation of free amino
acid lysine gave a very similar result (Table 1). The 31P NMR spec-
trum of TP-Lys that was measured at identical pH as thiophosph-
orylated thymidylate synthase sample, contains a triplet
resonance at 43.4 ppm. Also, the 31P–1H HMBC spectra confirm
that phosphorus-coupling hydrogen atoms have 1H NMR shifts of
approx. 3.1 ppm, corresponding to e-CH2 group of lysine moiety.
Another interesting observation that stems from the 2D spectrum
is that the phosphorus atoms of both triplet resonances in TP-ly-
sine region (43.3–43.4 ppm) are coupled to exactly the same 1H
chemical shift (3.1 ppm), suggesting those two triplets to reflect
two forms of protein TP-lysine moiety resulting probably from a
slow, at NMR-scale, protonation/deuteration of lysine e-nitrogen
atom caused by bulky thiophosphate substituent.
The results of our studies on free amino acid phosphorylation
and thiophosphorylation pointed to histidine being the fastest
reacting amino acid in the phosphorylation and thiophosphoryla-
tion reactions (not shown). Histidine thiophosphorylation reac-
tions were performed with the free amino acid, as well as C.
elegans recombinant thymidylate synthase protein (see Figs. 3
and 4, Table 1).
The free amino acid histidine thiophosphorylation reaction was
carried out in ammonium carbonate buffer (pH 7.4). Series of res-
onances were found at 32.5–34.5 ppm region that is very near to
that from an older work of Pirrung group showing approx
35 ppm chemical shift of TP-His [13]. However, that spectrum
was obtained in deuterium oxide and no exact pH or pD value were
presented; it should be noted that 31P NMR chemical shifts of ions
significantly depend on pH (or pD). The 31P NMR spectrum of
thiophosphorylated thymidylate synthase also presents two sin-
glet resonances at 32.5 and 32.7 ppm laying in the TP-His region
(Fig. 3). The more downfield shifted resonance has relative integral
of 1.0 with another upfield shifted one of 1.7. The assignment of
those two resonances was made by analysis of free histidine
thiophosphorylation NMR results and limited literature data
[13,15]. It seems that more upfield shifted resonance belongs to
hydrolytically more stable 3-thiophosphohistidine (3-TP-His) and
another one downfield shifted resonance from less hydrolytically
stable 1-thiophosphohistidine (1-TP-His).
The exceptionally interesting part of the spectrum of
thiophosphorylated thymidylate synthase is presented in Fig. 4.
There are two singlet resonances at 6.2 and 6.3 ppm laying in
region characteristic for phosphohistidines (P-His). Our free amino
acid hisitidine phosphorylation results confirm that those two sin-
glet resonances almost certainly belong to the 1-P-His and 3-P-His
being most likely a hydrolysis product of 1-TP-His and 3-TP-His
respectively. Relative integrals measured for those two resonances
A
B
C
44.0 43.5 43.0 42.5 42.0
Fig. 2. Thiophosphate fingerprint region of 31P NMR spectrum of thymidylate
synthase thiophosphorylation product with 31P–1H decoupling (A) and without H-
decoupling (C). Spectrum B shows thiophosphorylation product of Tris–HCl buffer.
33.5 33.0 32.5 32.0 31.5
TP-his
δ [ppm]
Fig. 3. Thiophosphohistidine resonances of 31P NMR spectrum of thiophosphory-
lated thymidylate synthase.
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are 1:2.4 for 1-P-His and 3-P-His respectively. Thiophosphate may
hydrolyze to phosphate in aqueous solutions, as evidenced by the
time-dependent growth of the inorganic phosphate resonance at
approx 2.2–2.4 ppm (see Fig. 4).
The enzyme thiophosphorylation was carried out also in ammo-
nium carbonate buffer, pH 7.4, with the use of diammonium thi-
ophosphoramidate. The results were similar to those obtained
with Tris buffer but for (i) much lower total amount of thiophos-
phohistidines, (ii) higher 3-TP-His/1-TP-His molar ratio and (iii)
much smaller corresponding resonances from TP-Ser and TP-Lys.
The mass spectrometry was also used to propose the location of
the thiophosphate moiety in the thymidylate synthase molecule.
The preliminary results obtained from trypsin digestion of enzyme
shows peak at m/z 1825.805 The experimental isotopic patterns of
the positively charged ion are in perfect agreement with the simu-
lated isotopic pattern distributions for monothiophosphate of
TVQQQVHLNQDEYK where thiophosphate moiety is attached to
histidine (His26) or lysine (Lys33) side-chain (Fig. 1 in supplemen-
tary material).
Potential influence of the thiophosphorylation on thymidylate
synthase activity was tested with recombinant human and C. ele-
gans preparations of the enzyme. Each preparation underwent thi-
ophosphorylation with diammonium TPA in Tris–HCl buffer, pH
7.5, at 4 C under conditions described in Material and methods,
with the enzyme activity determined in samples of the reaction
mixture taken just after addition of diammonium TPA, and at sev-
eral time points during 24 h period. Separate samples were incu-
bated under the same conditions, but without diammonium TPA
added, in order to test the enzyme stability. The results indicated
the enzyme activity to be lowered, following 24 h reaction, to
50% of the control value due to the thiophosphorylation process
alone, pointing to a possibility that the modification influences
the enzyme-catalyzed reaction parameters, as reported for phos-
phorylation [14].
3. Conclusions
The thiophosphorylation reactions of recombinant thymidylate
synthase protein were performed using potassium thiophosph-
oramidate and diammonium thiophosphoramidate salts in Tris-
and ammonium carbonate based buffer solutions at non-destruc-
tive environment. The NMR spectra of obtained modified proteins
were assigned, based on NMR spectra of thiophosphorylated amino
acid samples and the computational (DFT) estimation of 31P NMR
chemical shifts, indicating the presence of thiophosphorylated
lysine, serine and histidine moieties. Several methods presented
here should be useful for prediction of 31P NMR chemical shifts
of thiophosphorylated amino acid moieties and even thiophos-
phates in general.
4. Experimental
4.1. Materials and methods
Cellulose dialysis tubing, DE52-Cellulose, O-phosphotyrosine
and O-phosphothreonine were purchased from Sigma–Aldrich.
Diammonium- and potassium phosphoramidates (diammonium
TPA and KTPA respectively) were prepared according to Pirrung
et al. (2000).
4.2. NMR analysis
All NMR spectra were obtained with Bruker Avance spectrome-
ter operating in the quadrature mode at 500.13 MHz for 1H and
202.46 MHz for 31P nuclei. The residual peaks of deuterated sol-
vents were used as internal standards in 1H NMR method. 31P
NMR spectra were recorded at 277 K both with and without proton
decoupling. The internal standard used in 31P NMR was inorganic
phosphate (Pi) having its resonance at 2.15 ppm (at pH 7.8),
2.05 ppm (pH 7.5), 1.65 ppm (at pH 5.0) and 0.0 ppm (at pH 1.5).
All samples were analyzed using gradient enhanced 1H–31P Heter-
onuclear Multiple Bond Correlation (HMBC) experiments. The
HMBC experiments were optimized for long range couplings by
using different 3JP–H values (1–20 Hz). The 1H NMR spectra were
obtained with the use of HDO suppression method. All buffer solu-
tions used for NMR spectroscopy were based on deuterium oxide
of 100%D purity (Armar Chemicals AG).
4.3. Mass spectrometry
The mass spectrum was obtained on a Bruker MicrOTOF-Q
spectrometer (Bruker Daltonik, Bremen, Germany), equipped
with Apollo II electrospray ionization source with ion funnel.
The mass spectrometer was operated in the positive ion mode.
The instrumental parameters were as follows: scan range m/z
200–2200, dry gas–nitrogen, temperature 180 C, ion source volt-
age 4500 V, reflector voltage 1300 V, detector voltage 1920 V.
The instrument was calibrated externally with the Tunemix™
mixture (Bruker Daltonik, Germany) in quadratic regression
mode. The sample (0.1 M Tris–HCl buffer of pH 7.5 containing
approx. 50 lg of protein and traces of thiophosphoramidate
and thiophosphate salts) was diluted twice with methanol and
infused at a flow rate of 3 ll/min. The mass spectrum was
deconvoluted using the maximum entropy method.
The protein (0.2 mg) digestion was performed in the 0.2 M Tris–
HCl buffer (pH 7.5) by addition of trypsin (10 lg) the reaction mix-
ture was incubated at 24 C overnight. The solution was desalted
on C18 Sep-pak Plus Cartridges (Waters, Ireland). Washed with
water (10 ml) and eluted with acetonitrile (0.7 ml). The solution
was concentrated in vacuo and introduced to mass spectrometer.
Analysis of the obtained spectra was performed with the Bruker
Daltonics Compass DataAnalysis v.4 software The mass accuracy
together with the isotopic pattern (using SmartFormula) enabled
an unambiguous confirmation of the elemental composition of
the obtained tryptic peptides.
3 2 1 0 -1 -2 -3 -4 -5 -6 -7
P-his
Pi
δ [ppm]
Fig. 4. Phosphohistidine resonances of 31P NMR spectrum of thiophosphorylated
thymidylate synthase. Pi = inorganic phosphate.
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4.4. Calculations
The theoretical calculations have been performed with the den-
sity functional B3LYP/aug-cc-pVTZ method. To save computational
time, the structures of phosphorylatedand thiophosphorylated ami-
no acids were truncated by removing some groups of atoms remote
from the phosphorylated regions (Fig. 1). The optimal geometries
were obtained and confirmed with positive harmonic frequencies,
thenNMR shieldings formodels of phosphorylated and thiophosph-
orylated amino acids in their neutral, monoanionic and dianionic
forms were calculated. All the calculations were performed with
the Gaussian G03 (rev. C.02) suite of programs [20].
4.5. Thiophosphorylation of amino acids (L-histidine, L-arginine,
L-lysine, L-cysteine, L-serine, L-proline and L-tyrosine)
Ammonium carbonate buffer solution of amino acid (0.2 mmol
of amino acid in 500 ll of buffer at pH 7.4) was reacted with diam-
monium thiophosphoramidate (1:3 amino acid to diammonium
TPA molar ratios). Reaction mixture was shaken for 72 h at 277–
278 K temperature. NMR sample was prepared by mixing 400 ll
of post-reaction mixture with 300 ll of deuterium oxide. NMR re-
sults are presented in Table 1.
4.6. Phosphorylation of amino acids (L-histidine, L-arginine, L-lysine, L-
cysteine, L-serine, L-proline, L-tyrosine and L-threonine)
Water solution of amino acid (0.2 mmol of amino acid in 500 ll
of water) was reacted with potassium phosphoramidate (1–10
amino acid to KPA molar ratios). Reaction mixture was shaken
for 48 h at 277–278 K temperature. NMR sample was prepared
by mixing 100 ll of post-reaction mixture with 200 ll of deute-
rium oxide and 400 ll of Tris–HCl buffer (pH 7.5). NMR results
are presented in Table 1.
4.7. Thymidylate synthase purified preparations and assay of activity
Human recombinant enzyme was expressed in thymidylate
synthase-deficient E. coli TX61 strain (a kind gift from Dr. W.S.
Dallas) as previously described [21], with the use of the plasmid
construct pET17xb/hTS(LVAG) described by Pedersen-Lane et al.,
[22] and purified using the methods described for the rat enzyme
[23]. C. elegans recombinant thymidylate synthase was expressed
and purified as previously described [24]. The enzyme activity
spectrophotometric assay [25] and protein content determination
[26] were done by earlier described methods.
4.8. Thiophosphorylation of thymidylate synthase with potassium
thiophosphoramidate (KTPA)
The reaction was started by introducing potassium thiophosph-
oramidate (42.0 mg) into 290 ll of the protein (1.064 mg) in 0.2 M
Tris–HCl, pH 7.5. The reaction mixture was then shaken for 24 h at
277 K and analyzed using NMR spectrometer (300 ll of D2O was
added).
4.9. Thiophosphorylation of thymidylate synthase with diammonium
thiophosphoramidate (diammonium TPA)
The reaction mixture was obtained by mixing 290 ll of the
protein (1.065 mg) solution in 0.2 M Tris–HCl, pH 7.5, with diam-
monium thiophosphoramidate (41.0 mg). The reaction mixture
was then shaken for 24 h at 277 K. The NMR sample contained ob-
tained post-reaction mixture and 300 ll of deuterium oxide.
4.10. Thiophosphorylation of thymidylate synthase with diammonium
TPA with buffer exchange
To the protein buffer solution (1 ml of 0.2 M Tris–HCl, pH 7.5
containing 2.1 mg of protein) diammonium TPA (23.0 mg) was
added and shaken for 7 h at 277 K. Dialysis of the post-reaction
mixture was then conducted by introducing obtained mixture into
dialysis bag and dialyzed four times in ammonium carbonate buf-
fer (4  300 ml of 0.1 M ammonium carbonate buffer, pH 7.4).
NMR sample contained 0.5 ml of dialysis product and 0.3 ml of
deuterium oxide.
4.11. Thiophosphorylation of thymidylate synthase with diammonium
TPA in ammonium carbonate buffer
Diammonium TPA (13.4 mg) was introduced into protein solu-
tion (840 lg of C. elegans thymidylate synthase in 0.1 M ammo-
nium carbonate buffer pH 7.4).
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Highly purified preparations of thymidylate synthase, isolated from calf thymus, and L1210 parental
and FdUrd-resistant cells, were found to be nitrated, as indicated by a specific reaction with
anti-nitro-tyrosine antibodies, suggesting this modification to appear endogenously in normal and
tumor tissues. Each human, mouse and Ceanorhabditis elegans recombinant TS preparation, incubated
in vitro in the presence of NaHCO3, NaNO2 and H2O2 at pH 7.5, underwent tyrosine nitration, leading
to a V max
app 2-fold lower following nitration of 1 (with human or C. elegans TS) or 2 (with mouse TS)
tyrosine residues per monomer. Enzyme interactions with dUMP, meTHF or 5-fluoro-dUMP were not
distinctly influenced. Nitration under the same conditions of model tripeptides of a general formula
H2N-Gly-X-Gly-COOH (X = Phe, Tyr, Trp, Lys, Arg, His, Ser, Thr, Cys, Gly), monitored by NMR
spectroscopy, showed formation of nitro-species only for H-Gly-Tyr-Gly-OH and H-Gly-Phe-Gly-OH
peptides, the chemical shifts for nitrated H-Gly-Tyr-Gly-OH peptide being in a very good agreement
with the strongest peak found in 15N-1H HMBC spectrum of nitrated protein. MS analysis of nitrated
human and C. elegans proteins revealed several thymidylate synthase-derived peptides containing
nitro-tyrosine (at positions 33, 65, 135, 213, 230, 258 and 301 in the human enzyme) and oxidized
cysteine (human protein Cys210, with catalytically critical Cys195 remaining apparently unmodified)
residues.
Introduction
Thymidylate synthase (TS; EC 2.1.1.45), a target in chemotherapy
of a number of diseases, including cancer,1 catalyzes the N5,10-
methylenetetrahydrofolate (meTHF)-assisted C(5)-methylation of
dUMP,2 required for DNA synthesis. It is, consequently, of
interest to examine possible post-translational modifications of
the enzyme in living cells.
Nitration of protein tyrosine residues is a post-translational
modification, potentially affecting the function of a protein. It is
associated with more than 50 diseases, including cancer, involving
intensified NO biosynthesis.3 The modification in vivo appears
to be selective, with not many proteins becoming nitrated and
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only very few residues being modified in each protein. Moreover,
even with good nitration targets, the yield of protein nitro-tyrosine
formation is low.4 Nevertheless, the few known examples show that
nitration of one or two tyrosine residues is enough to cause loss
or gain of function (for physicochemical consequences of protein
tyrosine nitration, cf . ref. 4), suggesting a need for studies directed
at protein structure-function analysis of specific proteins found to
undergo nitration in vivo.5
As tetranitromethane nitration of sulfhydryl-blocked Lac-
tobacillus casei thymidylate synthase protein caused enzyme
inactivation,6 it was of interest to test the possibility of TS tyrosine
nitration in animal cells/tissue, and to determine to what extent
enzyme properties might be affected by chemical nitration of
TS tyrosine. Therefore kinetic and physicochemical (NMR, MS)
studies were undertaken of in vitro nitrated preparations of human,
mouse and Caenorhabditis elegans recombinant TSs. In order
to enable interpretation of NMR resonances found in nitrated
protein spectra, model tripeptides of a general formula H2N-Gly-
X-Gly-COOH (X = Phe, Tyr, Trp, Lys, Arg, His, Ser, Thr, Cys, Gly)
were nitrated and analyzed using NMR spectroscopy. Besides, the
theoretical calculations of 15N NMR chemical shift for models of
the nitrated tripeptides were performed and compared with those
found experimentally.
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Results and discussion
Reactivity of purified endogenous TS proteins to anti-tyrosine
antibodies
Highly purified TS proteins, isolated from calf thymus, and L1210
parental and FdUrd-resistant cells, were found to be nitrated (Fig.
1), based on a specific reaction with anti-nitrotyrosine antibodies
(Sigma-Aldrich, Anti-Nitro-tyrosine, Cat. No. N0409), suggesting
the enzyme to undergo this modification endogenously in normal
and tumor tissues. The reaction was specific to tyrosine, as the
presence of nitro-tyrosine (10 mM) in the buffer containing
anti-tyrosine antibodies (Fig. 1B), as well as the reduction
of nitro-tyrosine to amino-tyrosine with Na2S2O4 (Fig. 1C),
prevented anti-tyrosine antibodies binding with the proteins. Of
note is that the lack of the signal in panels B and C (Fig. 1) was
not caused by an insufficient amount of protein, as demonstrated
by the incubation of the same PVDF membrane with anti-TS
antibodies (Fig. 1, E–F). It should be worthwhile to add
that, according to the manufacturer, the polyclonal antibodies
preparation used is fairly specific for protein nitro-tyrosine.
While it recognizes nitrated proteins and 3-nitro-L-tyrosine, it
does not cross-react with L-tyrosine, p-nitro-L-phenylalanine,
3-amino-L-tyrosine, 3-chloro-L-tyrosine and phospho-L-tyrosine
BSA conjugates (http://www.sigmaaldrich.com/life-science/
cell-biology/antibodies/learning-center/antibody-explorer/
spotlights/anti-nitrotyrosine.html).
A comparison of nitration levels observed for the three endoge-
nous enzyme preparations (Fig. 1, lanes 5–7) and that of the in
vitro nitrated mouse recombinant enzyme determined to contain
0.8 and 1.6 mol/mol of TS monomer (Fig. 1, lanes 2 and 3,
respectively), based on the ratio of signal intensities resulting from
application of anti-nitro-tyrosine and anti-thymidylate synthase
antibodies, indicates the modification level of the endogenous
proteins to be much lower and concern presumably only a small
fraction of each of those proteins.
Recombinant TS in vitro nitration and its effect on enzyme
properties
Each human, mouse and Ceanorhabditis elegans recombinant
TS preparation, incubated in vitro at pH 7.5 in the presence of
peroxynitrite (ONOO-) producing mixture, containing NaHCO3,
NaNO2 and H2O2 (1.00 : 1.05 : 1.00), underwent [H2O2]-dependent
tyrosine nitration (Fig. 1, lanes 2–4, and Fig. 2; Note: H2O2 concen-
tration reflects concentration of the peroxynitrite producing mix-
ture, its constituents present always in constant proportion). The
reaction dependence on H2O2 concentration varied in different TS
proteins, being similar with the human (Fig. 2) and C. elegans
proteins (linear progress observed in the range of 10–70 mM
H2O2), but distinctly different with the mouse protein (linear
progress observed in the range of only 5–20 mM H2O2, with lower
nitration at higher concentrations). While this modification did not
distinctly influence the Km values reflecting enzyme interactions
with dUMP and meTHF or the inhibition and inactivation rate
constants (not shown) reflecting slow-binding of TS by 5-fluoro-
dUMP (cf. ref. 7), it affected TS activity, leading to a Vmax
app 2-
fold lower following nitration of 1 (with human or C. elegans
TS) or 2 (with mouse TS) tyrosine residues per monomer (not
shown). It should be mentioned that initial experiments, involving
Fig. 1 Nitro-tyrosine detection by specific antibodies in chemically ni-
trated mammalian recombinant TS and endogenous enzyme preparations
purified from tumour and normal tissues and separated by SDS-PAGE
(without 2-mercaptoethanol). Proteins were stained with Sypro R© Ruby
Protein Gel Stain (G) or, following transfer to PVDF membrane,
underwent first reaction with anti-nitroY antibodies (A–C), followed by
removing of anti-nitroY antibodies and treatment with anti-TS antibodies
(D–F). Negative controls included treatment with anti-nitroY antibodies
either in the presence of 10 mM nitro-tyrosine (B) or following reduction
of nitro-tyrosine to amino-tyrosine with 100 mM Na2S2O4 at pH 9,0 (C).
Nitrated BSA (positive control; lane 1), mouse recombinant TS nitrated
with 8 mM (0.8 mol nitroY/mol TS subunit; lane 2), 12 mM (1.6 mol
nitroY/mol TS subunit; lane 3) or 12 mM inactivated (negative control,
0 mol nitroY/mol TS; lane 4) peroxynitrite, and endogenous TS purified
from calf thymus (lane 5), and L1210 parental (lane 6) and FdUrd-resistant
(lane 7) cells. TS nitration presented in the bar chart was calculated as the
ratio of signals deriving from bands of nitrated protein (A) and TS protein
(D), with lighter and darker bars corresponding TS bands (marked with
lighter and darker arrows in A and B) showing lower and higher mobility,
respectively.
TS nitration with synthesized authentic peroxynitric acid, showed
the enzyme to undergo an instant inactivation (not shown), pre-
sumably due to the catalytic cysteine2 modification. In accord, ap-
plication of the peroxynitrite producing mixture, including CO3
2-,
known to inhibit sulfhydryl oxidation and enhance nitration of
aromatics,8 allowed to study nitration with the enzyme activity
preserved.
NMR analyses of nitrated model compounds
In order to enable interpretation of resonances found in nitrated
protein spectra, model compounds, including free amino acids
(Phe, Tyr and Trp) and tripeptides of a general formula H2N-Gly-
X-Gly-COOH (X = Phe, Tyr, Trp, Lys, Arg, His, Ser, Thr, Cys,
Gly), were nitrated and analyzed using NMR spectroscopy. While
the three free amino acids did not allow quantitative analysis
due to relatively low solubility of aromatic amino acids, such
a study was possible with the use of the tripeptides, serving as
simple models of proteins. The 15N chemical shifts resulting from
NMR studies, as well as DFT calculations performed for nitrated
forms of truncated amino acid moieties (Fig. 3), are presented
in Table 1. As the experimental NMR data clearly showed
formation of nitro-species only for H-Gly-Tyr-Gly-OH and
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Fig. 2 Chemical nitration of human (squares), mouse (circles) and C.
elegans (crosses) recombinant TS proteins: dependence of nitrated enzyme
catalytic potency, reflected by the V max
app value, on H2O2 concentration
in the reaction mixture (Note: H2O2 concentration reflects concentration
of the peroxynitrite producing mixture, its constituents present always in
constant proportion). V max
app value was determined at varying [dUMP]
and constant [N5,10-methylenetetrahydrofolate].
Fig. 3 Models of nitro-aminoacids used for DFT calculations: 1a –
o-NO2Phe, 1b – m-NO2Phe, 1c – p-NO2Phe, 2a – 2-NO2Trp, 2b – 4-NO2Trp,
2c – 5-NO2Trp, 2d – 6-NO2Trp, 2e – 7-NO2Trp, 3 – 3-NO2Tyr, 4a –
2-NO2-His N1-H, 4b – 5-NO2-His N1-H, 4c – 2-NO2-His N3-H, 4d –
5-NO2-His N3-H, 5 – S-NO2Cys, 6 – O-NO2Ser, 7 – O-NO2Thr, 8a –
N-w-NO2Arg, 8b – N-e-NO2Arg, 9 – N-NO2Lys.
H-Gly-Phe-Gly-OH peptides, NMR-DFT comparison of
chemical shifts was possible for these two systems. However,
calculated 15N chemical shifts, with chemical shift differences
calculated as Dd = d exp
15N – d cal
15N (d exp
15N – experimental
chemical shift; d cal
15N – calculated chemical shift) for models of
nitrated H-Gly-Tyr-Gly-OH and H-Gly-Phe-Gly-OH peptides
(Table 1, column 5) taken into consideration, could be useful
for prediction of 15N chemical shifts of similar nitro-systems
or even nitro-proteins. Of note is that recently Lehnik and
Kirsch analyzed peroxynitrite nitration of L-tyrosine and related
compounds with the use of 15N CIDNP method.9
Nitration of the tyrosine-containing tripeptide resulted in the
formation of 3-nitro-tyrosine moiety, along with only traces of
other compounds (Fig. 4). Based on the 1H NMR data, the molar
ratio of tripeptide containing nitro-tyrosine to that containing
tyrosine was 1 : 4.4. The confirmation of H-Gly-Tyr(15NO2)-Gly-
OH peptide formation was found in the 15N-1H HMBC spectrum
(Fig. 5), clearly showing the heteronuclear coupling between 15N-
nitrate group (373.4 ppm) and the adjacent aromatic hydrogen
atom at the ring C(2) (7.84 ppm). As indicated in Fig. 5, the 15N
resonance of the above mentioned nitro-moiety is a doublet, due
to the 3-bond proximity of the hydrogen atom at the ring C(2).
Of note are interesting observations resulting from studies
on the nitrated phenylalanine-containing tripeptide. The peaks
observed in the 15N-1H HMBC spectrum (not shown) suggest the
existence of two compounds, each containing nitro group attached
to the aromatic ring. The NMR data, describing the cross peak,
showing heteronuclear coupling between 15NO2 nitrogen (371.2
ppm) and aromatic hydrogen atom (8.09 ppm), are in a very good
agreement with those for 4-nitrotoluene that contains identical 4-
nitrobenzyl moiety.10 Thus the latter pair of chemical shifts points
to the formation of H-Gly-Phe(NO2)-Gly-OH peptide, with the
15NO2 group generally connected to electronically and sterically
favored para position.
The second cross peak (Fig. 5) found in 15N-1H HMBC spectrum
(7.88 ppm at H-axis and 374.1 ppm) is in a surprisingly good
agreement with our data found for H-Gly-Tyr(NO2)-Gly-OH (vide
supra). The NMR data strongly suggest the existence of nitro-
tyrosine moiety that must have been formed by nitration of tyro-
sine moiety. Consequently, the tyrosine moiety must have resulted
from phenylalanine moiety hydroxylation, a process described in
the literature.11,12 However, the yield of the overall process is very
low, as the molar ratio calculated from 1H NMR spectrum shows
the amount of nitro-tyrosine-tripeptide to be almost six-fold lower
than that of nitro-phenylalanine-tripeptide. The results obtained
by 15N NMR were validated by high resolution mass spectrometry
(HRMS). The HRMS spectra revealed the presence of peaks
corresponding to H-Gly-Phe(15NO2)-Gly-OH (MNa
+ calculated
348.0932, found 348.0932), as well as H-Gly-Tyr(15NO2)-Gly-OH
(MNa+ calculated 364.0882, found 364.0888). The intensities of
the signals assigned to the nitration products, especially to H-Gly-
Tyr(NO2)-Gly-OH, were much lower than those of H-Gly-Tyr-
Gly-OH and H-Gly-Phe(15NO2)-Gly-OH.
The NMR data for nitrated H-Gly-Trp-Gly-OH peptide demon-
strated only traces of nitrated forms as judged from 15N (369.0
ppm) and 1H (8.07 ppm) chemical shifts (not shown). The strongest
cross peak in 15N-1H HMBC spectrum showed coupling between
positions 400.7 ppm 15N and 1.66 ppm 1H of the spectrum but
the chemical shift of the 1H resonance (singlet resonance) can
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Table 1 Experimental and calculated 15N NMR chemical shifts of nitrated side chains of selected amino acid moieties
Residue
d exp
15N (experimental; rel.
to NH3(lq)) [ppm]
a
d exp
1H (experimental; H
adjacent to N) [ppm]
d cal
15N (calculated; rel. to
NH3(lq)) [ppm]
b Dd c [ppm]
Nitro-product to
substrate ratiog
o-NO2Phe 382.8 — —
m-NO2Phe 389.7 — —
p-NO2Phe 389.7 -18.5 1 : 28.8
371.2; 374.1d 8.09; 7.88d 1 : 156.3d
2-NO2Trp 394.1
e 2.78e 400.3 — —
4-NO2Trp 360.0
e 1.70e 381.9 — —
5-NO2Trp 400.7
e 1.66e 388.2 — —
6-NO2Trp 388.9 — —
7-NO2Trp 386.7 — —
7.84 (s, H-2)
3-NO2Tyr 373.4 7.37 (dd, H-6) 389.3 -15.9 1 : 4.4
6.93 (d, H-5)
2-NO2-His N1-H — — 408.0 — —
5-NO2-His N1-H 396.6
2-NO2-His N3-H 408.0
5-NO2-His N3-H 403.6
S-NO2Cys 8.38 (s)
f 370.0 — —
O-NO2Ser — 8.39 (s)
f 418.2 — —
O-NO2Thr — — 419.8 — —
N-w-NO2Arg — — 429.1 —
N-e-NO2Arg — — 416.9 —
N-NO2Lys — 8.39 (s)
f 407.7 —
a Chemical shifts for nitrated tripeptides. b Calculated chemical shifts for truncated nitrated amino acids (Fig. 3). c Dd = d exp
15N - d cal
15N. d NO2-Tyr (see
Results and discussion). e See Results and discussion. f Side chain oxidation product. g Calculated from 1H NMR spectrum.
not be associated with aromatic nitro-forms. It appears that the
above mentioned singlet resonance reflects a tryptophan ring-
cleavage product that contains an aliphatic region with 15N atom.12
Similar results, with only traces of nitro-form noticed (not shown),
were obtained when post reaction mixture containing H-Gly-His-
Gly-OH peptide was monitored. Moreover, the 15N-1H HMBC
spectrum of the nitrated H-Gly-His-Gly-OH sample did not show
any noticeable peaks corresponding to the 15N and 1H shifts of
nitro-histidine.
The NMR spectra of nitrated serine and lysine peptides showed
only traces of new forms. The 1H NMR spectra of H-Gly-Cys-
Gly-OH, H-Gly-Ser-Gly-OH and H-Gly-Lys-Gly-OH peptides
contained small resonances at 8.4 ppm, suggesting oxidation of
small percentage of peptides side chain heteroatoms to produce
aldehydes. The 1H spectra of nitrated threonine-containing peptide
also showed traces of O-nitro-threonine moiety (CH–O–NO2),
with its 1H resonance at 5.12 ppm and 15N resonance at 535.5 ppm
(not shown).
1H NMR spectrum of nitrated H-Gly-Cys-Gly-OH showed
almost all peptide used to be converted to various products.
The literature suggests that the reaction of cysteine moiety
with peroxynitrite may produce various amounts of disulfide
(RSSR), sulfenic acid (RSOH), sulfinic acid (RSO2H), sulfonic
acid (RSO3H), nitrosocysteine (RSNO), nitro-cysteine (RSNO2)
and various radicals.12 Although the existence of RSNO and
RSNO2, containing
15N-nitrogen atom originating from perox-
ynitrite, should be easy to confirm in 1D and 2D NMR spectra,
it was not apparent. Consequently, the new products found in
the 1H NMR spectrum appear to be mainly disulfide, as well as
sulfenic acid, sulfinic acid and sulfonic acid. The mass spectro-
metric analysis confirmed the presence of sulphonic acid in the
sample.
NMR analyses of nitrated TS
The nitration of protein conducted under acidic conditions (pH
2–5) resulted in the precipitation of protein and consequently
very low concentration of soluble 15N-nitro-forms that could be
analyzed by NMR method. The best results were achieved at
pD of 7.2–7.4; when in NMR tube no presence of visible solid
residues was apparent during the reaction and measurements. The
chemical shifts for the strongest peak found in 15N-1H HMBC
spectrum (7.67 ppm on the H-axis and 374.9 ppm on the 15N axis)
of nitrated protein (not shown) were in a very good agreement with
our data for nitrated H-Gly-Tyr-Gly-OH peptide (vide supra). Due
to relatively low concentrations of protein and very low yields of
nitration process, it was impossible to confirm identity of other
nitrated moieties.
MS analyses of nitrated TS
To localize the in vitro modifications of TS, nitrated human and C.
elegans proteins underwent proteolytic digestion and the resulting
peptides were analyzed by ESI. For each of the two proteins
several TS-derived peptides were found to contain nitro-tyrosine
(Table 2) and oxidized cysteine (Table 3) residues. It should be
mentioned that although sequences of several peptides listed
in Table 2 contained, besides tyrosine, also histidine residues, a
possibility of their nitration appears negligible. The nitration of
aromatic compounds is performed by the electrophilic aromatic
substitution mechanism. Susceptibility of tyrosine side chain for
electrophilic substitution is very high, in particular in its phenolate
form at pH > 7. In contrast to this, the electron density of the
imidazole ring of histidine is lower. Consequently, the electrophilic
substitution of histidine residue is much slower and requires
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Fig. 4 Aromatic regions of H-Gly-Tyr-Gly-OH peptide (top) and post-reaction mixture of peptide 15N-nitration (bottom). Asterisks indicate aromatic
hydrogens of 15N-nitro-tyrosine moiety.
Fig. 5 The fragment of 15N-1H HMBC spectrum of the nitrated H-Gly–
Tyr-Gly-OH peptide showing 15N-H(Tyr) coupling. The largest peak on
15N axis belongs to NO3- anion.
higher pH than that of tyrosine. Therefore it appears hardly
possible that in the presence of very reactive phenolate side chain
the imidazole ring of histidine would be modified. In accord,
ESI-MS analysis revealed only one nitration site in the 255–261
fragment of human thymidylate synthase, containing one tyrosine
and two histidine residues (Fig. 6). Moreover, low susceptibility
to nitration of histidine vs. tyrosine was shown also by the results
of NMR analyses of nitrated model compounds (vide supra).
While the non-nitrated counterparts of several nitrated peptides
could be identified, in most cases their proportion was probably
too low to allow unambiguous recognition.
Following nitration at pH 7.5 with 20 mM H2O2, tyrosine
modification to nitro-tyrosine was found at positions 33, 65,
135, 213, 230, 258 and 301 in human TS (Fig. 6 and 7), and
34, 66, 137, 148 and 232 (homologous to human 33, 65, 135,
146 and 230, respectively) in the C. elegans protein. Interestingly,
when 50 mM H2O2 was applied with C. elegans TS, a different
nitration profile, including positions 66, 137, 148, 204, 215 and
260 (homologous to human 65, 135, 146, 202, 213 and 258,
respectively), was apparent. Of note is a tendency for homologous
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Fig. 6 The ESI-MS spectrum of the chymotryptic products of human TS. The expanded part of spectrum corresponds to the fragment 255–261
containing the nitrated tyrosine at position 258. The monoisotopic molecular mass of the presented fragment was compared with one simulated basing
on the molecular formula.
Fig. 7 Ribbon representation of monomer A from the crystal structure
of human thymidylate synthase with bound dUMP and Tomudex (PDB
code: 1I00). Tyrosine residues are shown as sticks, labelled with sequence
numbers and marked either lighter or darker depending on whether a
residue has been found to be nitrated or not, respectively. dUMP and
Tomudex are shown as sticks and marked light.
tyrosine residues in both TS sequences to undergo nitration (Table
2). Considering localization of nitrated tyrosine residues in human
TS, those at positions 135, 230 and 258, being closest to the
active center (Fig. 7), were of particular interest, in view of the
influence of nitration on the catalytic potency (Fig. 2). It should
be mentioned that at the conditions used to nitrate the human
enzyme (pH 7.5, 20 mM H2O2) the only cysteine residue to undergo
modification was Cys210, with catalytically critical Cys195 remaining
apparently unmodified. In C. elegans, the homologous catalytic
cysteine residue TS (Cys197) underwent modification only at 50
mM H2O2, in accord with the dependence presented in Fig. 2,
and cysteine residues at positions 67, 151 and 243, oxidized at
20 mM H2O2, correspond to human TS homologous amino acid
residues different from cysteine (Ser66, Met149 and Thr241, respec-
tively).
In order to asses a potential of nitration of different tyrosine
residues to affect TS catalytic potency, a parallel molecular
modeling study (using the molecular dynamics method, followed
by post-processing of the resulting trajectories) has been per-
formed. The simulations were based on the crystal structure of the
ternary complex of human thymidylate synthase with dUMP and
Tomudex (PDB accession code 1I00), with the Tomudex molecule
replaced by the molecule of tetrahydrofolate (close analogue of
methylenetetrahydrofolate), according to the previously described
superimposition.13 Initial results indicated nitration in human TS
of either of the four residues, Tyr33, Tyr135, Tyr213 and Tyr258, to
differently influence the binding alignment between the substrate,
dUMP, and cofactor, THF, in the enzyme active site. The impact
ranges from (i) a strong misalignment that is likely to significantly
reduce the catalytic activity of TS (nitration on Tyr135) to (ii)
moderate deviations from the native alignment (nitrations on
Tyr33 and Tyr258), and (iii) the lack of deviation from the native
alignment (nitration on Tyr213) that suggests preservation of
TS native catalytic activity.14 Considering the apparent strong
influence of Tyr135 nitration on the substrates alignment, of
interest is that mutation (Y94F) of the corresponding residue
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Table 2 Mass spectrometric determination of tyrosine residues modification of –NO2 type in human and C. elegans recombinant thymidylate synthase
proteins nitrated in vitro at pH 7.5. Purified recombinant protein, following nitration, was analyzed by ESI-MS after proteolytic digestion. The peptides
listed encompass those resulting from digestion by trypsin, as well as chymotrypsin
Sequence of the modified peptide Modification site
Human TS protein nitrated at 20 mM H2O2
A228SYALL233 Tyr230
N205SELSCQLYQRSG217 Tyr213
F117LDSLGFSTREEGDLGPVYGFQW139 Tyr135
A255HIYLNH261 Tyr258
A22EPRPPHGELQYLGQIQHILRCGV45 Tyr33
T251LGDAHIY258 Tyr258
S209CQLYQRSGDMGLGVPF225 Tyr213
K292AEDFQIEGYNPHPTIKM309 Tyr301
G60MQARYSLRD69 Tyr65
C. elegans TS protein nitrated at 20 mM H2O2
-
K33YLKQVE39 Tyr34 (Tyr33)a
L133GPVY137GFQW141 Tyr137 (Tyr135)
F139QWRHFGAKYVDCHTDY155 Tyr148; Tyr155
G134PVYGFQWRHF144 Tyr137 (Tyr135)
M221GLGVPFNLASYGL234 Tyr232 (Tyr230)
E274PYAFPK280 Tyr276
G61MQSKYCLRNG71 Tyr66 (Tyr65)
C. elegans TS protein nitrated at 50 mM H2O2
G61MQSKYCLRNG71 Tyr66 (Tyr65)
Q40ILREGTRRDDRTGTGTISIFGMQSKYCLRNGTIPLLTTKRV81 Tyr66 (Tyr65)
G190QMVLPPCHTMCQFY204 Tyr204
T126SREEGDLGPVYGFQW141 Tyr137 (Tyr135)
A146KYVDCHTD154 Tyr148
Y204VDNGELSCQLYQRSGDMG222 Tyr204; Tyr215 (Tyr213)
G61MQSKYCLRNGTIPLLTTKRV81 Tyr66 (Tyr65)
T56ISIFGMQSKYCL68 Tyr66 (Tyr65)
T126SREEGDLGPVYGFQW141 Tyr137 (Tyr135)
V251HTLGDAHVY260 Tyr260 (Tyr258)
a Homologous human TS site, if also modified, is presented in parentheses.
in E. coli TS caused an apparent weakening of dUMP binding
and associated enhancement of dUMP release, resulting in both
substrates (dUMP and meTHF) interacting in a random binding
sequence.15
In view of the recently presented concept of hydrogen bond
bridges playing an important role in the reaction of protein
tyrosine nitration,16 it was of interest to extend our molecular
modeling studies to analyze how the results of nitration of
tyrosine residues in TS protein conformed to that concept.
The results were unequivocal. While the distance between the
nitrated tyrosine hydroxyl and the closest acidic/basic amino
acid side chain heavy atom matches always satisfactorily the
distance required for the nitrating species to form hydrogen bond
bridge connecting the tyrosine and corresponding charged amino
acid,16 the corresponding distances measured to heteroatoms of
the dissociable groups of the same amino acids are noticeably
different from those suggested to be optimal,16 and in accord,
orientations between those dissociable groups and the nitrated
tyrosine hydroxyls appear to be in most cases incorrect for forming
geometrically reasonable hydrogen bond bridges. However, the
latter statement should be taken with caution, as our molecular
modeling was performed for the systems that had already un-
dergone tyrosine nitration, hardly allowing evaluation of the in-
termediate conformational states occurring during nitration reac-
tions.
Conclusions
The present study suggests that thymidylate synthase protein,
expressed endogenously in normal and tumour (calf thymus and
L1210 cells) tissues undergoes nitration in vivo. The modification
may influence properties of the enzyme, as chemical reaction with
peroxynitrite (ONOO-) produced in situ at pH 7.5 of human,
mouse and C. elegans recombinant TS proteins, resulting primarily
in nitration of tyrosine residues, as confirmed by NMR and MS,
distinctly lowers the catalytic potency reflected by the V max
app value.
Experimental
Materials
Tripeptides of general formula H-Gly-X-Gly-OH where X = Phe,
Tyr, Trp, Lys, Arg, His, Ser, Thr, Cys, Gly were purchased from
Lipopharm (Poland).
Thymidylate synthase preparation
The endogenous enzyme proteins from parental and FdUrd-
resistant mouse leukemia L1210 cells,17 and calf thymus,18 were
purified as previously described. Ceanorhabditis elegans19 and
mouse20 TS coding regions were cloned into pPIGDM4+stop
vector and expressed as HisTag-free proteins in BL21(DE3)
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Table 3 Mass spectrometric determination of cysteine residues modification of –O type in human and C. elegans recombinant thymidylate synthase
proteins nitrated in vitro at pH 7.5. Purified recombinant protein, following nitration, was analyzed by ESI-MS after proteolytic digestion. The peptides
listed encompass those resulting from digestion by trypsin, as well as chymotrypsina
Sequence of the modified peptide Modification site
Human TS protein nitrated at 20 mM H2O2
N205SELSCQLYQRSG217 Cys210
C. elegans TS protein nitrated at 20 mM H2O2
G61MQSKYCLRNG71 Cys67
F144GAKYVDCHTDYSG157 Cys151
Q140WRHFGAKYVDCH152 Cys151
R142HFGAKYVDCHTDYSGQGVDQL163 Cys151
M238IAKVCGLKPGTLVH252 Cys243
C. elegans TS protein nitrated at 50 mM H2O2
G61MQSKYCLRNG71 Cys67
Q40ILREGTRRDDRTGTGTISIFGMQSKYCLRNGTIPLLTTKRV81 Cys67
G190QMVLPPCHTMCQFY204 Cys201
A146KYVDCHTD154 Cys151
K171EQPDSRRIIMSAWNPSDLGQMVLPPCHTMCQFYVDNGE209 Cys197; Cys201
G190QMVLPPCHTMCQFYVDNGELSCQL214 Cys197; Cys201; Cys212 (Cys210)
a Homologous human TS site, if also modified, is presented in parentheses.
or thymidylate synthase-deficient TX61- (a kind gift from Dr
W. S. Dallas) E. coli strain, respectively. Human TS coding
regions21 were subcloned into pET28a vector and expressed as
HisTag-containing proteins in E. coli BL21(DE3) strain. HisTag
containing proteins were purified on NiNTA His-Bind resin
(Novagen) according to manufacturer protocol, and HisTag-free
proteins were purified as previously described.22 Phosphatase
inhibitors (50 mM NaF, 5 mM Na-pyrophosphate, 0.2 mM
EGTA, 0.2 mM EDTA and 2 mM Na3VO4) were present in the
purification buffers. Each purified TS preparation was separated
from phosphorylated fraction according to Wolschin et al.,23
using metal oxide/hydroxide affinity chromatography on Al(OH)3
beads. The enzyme activity was measured and kinetic parameters
of the enzyme-catalyzed reaction were determined as previously
described.24
Thymidylate synthase tyrosine in vitro nitration
The reaction was performed at 4 ◦C in the presence of 20 mM
dUMP (stabilization in the absence of 2-mercaptoethanol) in a
reaction mixture containing 200 mM Na/K phosphate buffer
pH 7.5, equimolar concentration of NaHCO3 and H2O2 (5–
70 mM), NaNO2 at concentration by 5% exceeding the latter
(5.25–73.5 mM) and the enzyme (5 mM dimer). To start the
reaction, H2O2 was added, the sample mixed 30 s and next
incubated 5 min. While nitro-tyrosine content was determined
spectrophotometrically,25 to the remaining reaction mixture 2-
mercaptoethanol (20 mM) was added, followed by either protein
precipitation with 10% (w/v) TCA or sample dilution (≥300-
fold) with 50 mM Na/K phosphate buffer pH 7.5, containing
0.1% Triton X-100 and 10 mM 2-mercaptoethanol. The diluted
preparation preserved TS activity for at least 2 h, allowing enzyme
properties to be studied. To the control reaction mixture TS was
added after mixing and incubating the remaining components, in
order to inactivate the produced peroxynitrite.
Immunoblotting
Previously described method was used,13 with anti-tyrosine an-
tibody from Sigma–Aldrich (Cat. No. NO409) and anti-TS
antibody.19
Peptide nitration
Peptides of the general formula H-Gly-X-Gly (where X = Phe, Thr,
Trp, Lys, Cys, His, Ser, Arg, Gly) were nitrated in deuterium oxide
system using sealed 5 mm NMR tubes. Each tripeptide (8 mmol in
0.1 ml of deuterium oxide) was mixed with solutions containing
(i) 76 mmol H2O2 in 0.1 ml of D2O, (ii) 80 mmol sodium
15N-nitrite
in 0.1 ml of D2O and (iii) sodium bicarbonate (80 mmol in 0.1 ml
D2O), followed by addition of 3.3 ml of conc. sulfuric acid in 0.1 ml
of D2O and additional D2O to the final volume of 0.6 ml (resulting
pD of 1.9).
NMR analyses
All NMR spectra were obtained with Bruker Avance spectrometer
operating in the quadrature mode at 500.13 MHz for 1H and 50.69
MHz for 15N nuclei. The residual peaks of deuterated solvents
were used as internal standards in 1H NMR method. 15N NMR
spectra were recorded at 277 K both with and without proton
decoupling. All 15N chemical shifts presented in this work are
related to liquid ammonia (0.0 ppm). The internal standard used
in 15N NMR was sodium nitrite (609.6 ppm rel. to liquid NH3)
and sodium nitrate (376.5 ppm rel. to liquid NH3). All samples
were analyzed using the gradient-enhanced 1H-15N Heteronuclear
Multiple Bond Correlation (HMBC) approach. The 1H NMR
spectra were obtained with the use of the HDO suppression
method. All buffer solutions used for NMR spectroscopy were
based on deuterium oxide of ‘100%D’ purity (Armar Chemicals
AG, Germany).
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Calculations
The theoretical calculations have been performed with the density
functional B3LYP/aug-cc-pVTZ method. To save computational
time, the structures of amino acids were truncated by removing
some groups of atoms remote from the nitrated regions (Fig. 3).
Where it was possible, the calculations for full nitro-tripeptide
(GCG-NO2) were performed for comparison with the truncated
model. The optimal geometries were obtained and confirmed with
positive harmonic frequencies, then NMR shielding values for
models of nitroamino-derivatives of acids were calculated. All the
calculations were performed with the Gaussian G03 (rev. C.02)
suite of programs.
Mass spectrometry analysis
Enzymatic hydrolysis. A sample of modified protein (1 mg)
was dissolved in water (100 ml). The obtained solution (10 ml)
was diluted with 0.03 M NH4HCO3 (50 ml). After adding the
0.1% water solution of the proteolytic enzyme (5 ml; trypsin or
chymotrypsin) the mixture was incubated at r.t. for 12 h. The
products of the hydrolysis were absorbed on OMIX C4 100 ml
pipette tips (Varian). The tip was washed 10 times with water
(100 ml), than the peptides formed by proteolysis of modified
protein were eluted with 60% water solution of acetonitrile
(100 ml).
Mass spectrometry. The enzymatic digest was analyzed on
high resolution ESI-FT mass spectrometer (Apex-Ultra Qe 7T;
Bruker Daltonics; Germany) equipped with an electrospray ion-
ization (ESI) source. The instrument was operated both in the
positive and negative ion mode and calibrated with the Tunemix
mixture (Bruker Daltonics). The mass accuracy was better than
5 ppm. The instrumental parameters were as follows: scan range,
300–2500 m/z; drying gas, nitrogen; temperature of drying gas,
200 ◦C; potential between spray needle and orifice, set at 4.5 kV;
source accumulation time, 0.5 s; and ion accumulation time, 0.5 s.
The analyzed solution was infused directly to the ion source at a
flow rate 3 ml min-1. Each spectrum is an average of more than 100
individual scans.
Data analysis. The analysis of spectra was performed using the
SNAP algorithm (Data Analysis, Bruker). The generated mass
list, including m/z ratio, monoisotopic mass and z, was further
analyzed using Excel spreadsheet basing on the following assump-
tions: (i) The cleavage sites for trypsin: [K,R] and for chymotrypsin
[Y,W,F,L,M,H,N,G,I,V,E,D]; (ii) accepted chemical modifications
nitration of tyrosine and oxidation of the methionine and cysteine;
(iii) Accepted error max. 10 ppm; (iv) Peptide length max. 20
amino acid residues; (v) Only protonated peptides were accepted,
the metal adducts (Na, K, Ca) were neglected.
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